Skip to main content
Registration
ID
Week Learning Objective
Return to Sessions
and Exhibits
Chasing the Sun
Schedule
Live Sessions
On Demand Sessions
Browse by Date
Oral Abstract
Tuesday, October 13, 2020
Wednesday, October 14, 2020
Thursday, October 15, 2020
Monday, October 19, 2020
Tuesday, October 20, 2020
Wednesday, October 21, 2020
Thursday, October 22, 2020
Friday, October 23, 2020
Saturday, October 24, 2020
Sunday, October 25, 2020
Browse by Track
Browse by
Session Type
Affiliated Events
Interactive Session
Meet-the-Professor
Mini-Symposium
Named Lecture
Plenary
Premeeting Workshop
Symposium
Keyword Search
Speakers
Oral Abstracts
How to View Orals
Abstract Q&A/Discussion
Board Info
Oral Abstract Sessions
Posters
How to View Posters
Abstract Q&A/Discussion
Board Info
Poster Sessions
ePoster Gallery
Login required
Featured Speakers
FAQ
Toggle navigation
Login
Search
Home
Registration
ID
Week Learning Objective
Return to Sessions
and Exhibits
Chasing the Sun
Schedule
Live Sessions
On Demand Sessions
Browse by Date
Oral Abstract
Tuesday, October 13, 2020
Wednesday, October 14, 2020
Thursday, October 15, 2020
Monday, October 19, 2020
Tuesday, October 20, 2020
Wednesday, October 21, 2020
Thursday, October 22, 2020
Friday, October 23, 2020
Saturday, October 24, 2020
Sunday, October 25, 2020
Browse by Track
Browse by
Session Type
Affiliated Events
Interactive Session
Meet-the-Professor
Mini-Symposium
Named Lecture
Plenary
Premeeting Workshop
Symposium
Keyword Search
Speakers
Oral Abstracts
How to View Orals
Abstract Q&A/Discussion
Board Info
Oral Abstract Sessions
Posters
How to View Posters
Abstract Q&A/Discussion
Board Info
Poster Sessions
ePoster Gallery
Login required
Featured Speakers
FAQ
Register
Tweets by IDWeek 2020
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Chasing the Sun
Live
On Demand
All times are Eastern. For maximum functionality please use Google Chrome or Firefox.
Home
Poster Schedule
Poster Schedule
Type here to filter the list
Wednesday, October 21, 2020
Adolescent Vaccines
1 -
The Impact of Behavioral Nudges, Communication Training and Assessment and Feedback on Adolescent Vaccination Rates and Parent Satisfaction
Favorite
2 - Understanding Patient Preferences for Meningococcal Serogroup B Vaccines in the United States
Favorite
3 - A Review of the Clinical Development of MenACWY-TT, a Quadrivalent Meningococcal Vaccine Conjugated to Tetanus Toxoid, in Adolescents
Favorite
4 - MenACWY-TT Long-Term Antibody Persistence Following Adolescent Vaccination and Evaluation of a Booster Dose: A Review of Clinical Data
Favorite
5 - Observational Study of Routine Use of 9-Valent Human Papillomavirus Vaccine: Safe in More Than 140,000 Individuals
Favorite
6 - Pentavalent Meningococcal (MenABCWY) Vaccine is Safe and Well Tolerated With Immunogenicity Noninferior to Coadministered MenB-FHbp and MenACWY-CRM in a Phase 2 Study of Healthy Adolescents and Young Adults
Favorite
7 - Two-Dose 4CMenB Vaccination in Adolescents Elicits a Bactericidal Activity against 15 Outbreak-Representative Meningococcal Strains
Favorite
Adult Vaccines
8 -
Higher hepatitis B antibody titres induced in all adults vaccinated with a tri-antigenic hepatitis B (HBV) vaccine, compared to a mono-antigenic HBV vaccine: results from two pivotal phase 3 double-blind, randomized studies (PROTECT and CONSTANT)
Favorite
9 -
Influenza Vaccine Rates Amongst Patients With Limited English Proficiency In A Primary Health Care Clinic; Our 3 Years Experience.
Favorite
10 -
Kinetics of Post-Vaccination Seroprotection to
S. Pneumonia
for the Immune-Compromised and Vaccine-Naïve Populations
Favorite
11 -
Missed Vaccine Opportunities During the COVID-19 Pandemic
Favorite
12 -
Randomized Studies of Two
Clostridioides (Clostridium) difficile
Vaccine Formulations
Favorite
13 -
Uncommon rash and neurological symptoms related to Shingrix
Favorite
14 - A Comprehensive Real-World Analysis to Compare Adjuvanted Trivalent Influenza Vaccine and Trivalent High Dose Influenza Vaccine by Age and Period of High Influenza Activity for the 2018-19 Season among U.S. Elderly
Favorite
15 - A Novel Approach to Bacterial Vaccines:
Haemophilus influenzae
as a Paradigm
Favorite
16 - A Randomized Phase 1 Study of a Novel Pneumococcal Conjugate Vaccine in Healthy Japanese Adults in the United States
Favorite
17 - Assessment of Recombinant Zoster Vaccine Second Dose Completion in the United States
Favorite
18 - Association Between State-level Voting Patterns and Prior Receipt of the HPV Vaccine, an Analysis Using Data from the Behavioral Risk Factor Surveillance System 2016 – 2018
Favorite
20 - Cost-Effectiveness of Implementing 13-Valent Pneumococcal Conjugate Vaccine (Pcv13) for Adults Aged ≥19 Years with Underlying Conditions
Favorite
21 - Current and Nadir CD4+ Counts Are Associated with Heplisav-B Seroprotection Rates in People with HIV
Favorite
22 - Description of Hospitalized Patients with Influenza Vaccine Failure
Favorite
23 - Did You Pneu?: Impact of an Adult Pneumococcal Immunization Campaign Across Independent Community Pharmacies
Favorite
24 - Economic Burden of Herpes Zoster Among Individuals with Chronic Obstructive Pulmonary Disease: A Retrospective Cohort Study
Favorite
25 - Effectiveness of High Dose Influenza Vaccine in HIV-positive Patients for the Winter 2017-2018 Season
Favorite
26 - Factors Associated with Meningococcal Vaccination among Patients with Newly Diagnosed High-Risk Conditions
Favorite
27 - Hepatitis B Virus Screening and Vaccination in Patients with HIV: A Survey of Physicians’ Current Clinical Practices
Favorite
28 - Immunogenicity of rVSVΔG-ZEBOV-GP Ebola Vaccine (ERVEBO™) in Participants by Age, Sex, and Baseline GP-ELISA Titer: A Post Hoc Analysis of Three Phase 2/3 Trials
Favorite
29 - Impact of Enhanced Influenza Vaccines on Direct Healthcare Costs for the U.S. Elderly: A Comprehensive Real-World Evaluation of Adjuvanted Trivalent Influenza Vaccine Compared to Trivalent High-Dose Influenza Vaccine for the 2018-19 Influenza Season
Favorite
30 - Impact of Pharmacist Assertiveness Training in Recommending Pneumococcal Vaccination among High-Risk Adults
Favorite
31 - Influenza Vaccination During Pregnancy: A Descriptive Cross-sectional Survey of the Knowledge, Beliefs, and Attitudes of Mexican Gynecologists and Family Physicians.
Favorite
32 - Influenza Vaccination Prevalence Among Adults with and without HIV by Race, Age, and Sex
Favorite
33 - Intranasal M2SR (
M2
-deficient
S
ingle
R
eplication) Live H3N2 Influenza Investigational Vaccine Induces Serum HAI & Broad Immune Responses in High Proportion of Adults
Favorite
34 - Oops, I Didn't Follow My Post Vaccinaton Instructions
Favorite
35 - Pneumococcal Vaccination in High-Risk Adults: An Initial Analysis Incorporating Social Determinants of Health
Favorite
36 - Safety and Reactogenicity of the Adjuvanted Recombinant Zoster Vaccine after Allogeneic Hematopoietic Stem Cell Transplantation
Favorite
37 - Safety Profile of the Adjuvanted Recombinant Zoster Vaccine (RZV) in Immunocompromised Populations: an Overview of 6 Trials
Favorite
38 - Strategies to Improve HPV Vaccination Rates Among Eligible Undergraduates and Graduate Students at Johns Hopkins University
Favorite
39 - Survey of Hepatitis B Vaccination Rates in Adult Patients with Diabetes at a Large Internal Medicine/Geriatrics Clinic
Favorite
40 - The Role of Health Literacy in Vaccination Disparities: Do Patients Understand the Health Messages?
Favorite
Antimicrobial Stewardship: Outcomes Assessment (clinical and economic)
42 - A Pharmacist-Led Intervention to Decrease Anaerobic Coverage for Hospitalized Patients with Community-Acquired Pneumonia
Favorite
43 - A Pharmacoepidemiologic Evaluation of Echinocandin Use
Favorite
44 - Antibiotic Class-Based Distribution and Analysis of Reported Beta-Lactam Allergies amongst Hospitalized Patients
Favorite
45 - Antimicrobial Stewardship for Urinary Tract Infection in Three Emergency Departments Across a Health System
Favorite
46 - Antimicrobial Stewardship’s Selective Antibiotic Suppression Does Not Lead to Adverse Outcomes in Neutropenic Patients with Gram-Negative Bacteremia
Favorite
48 - Association of Rapid Pathogen Identification and Pharmacist Intervention on Time to Optimal Antimicrobial Therapy for Bloodstream Infections at Two Community Hospitals
Favorite
49 - Clinical Utility of Oseltamivir Restriction Policy
Favorite
50 - Comparative Incidence of Acute Kidney Injury in Septic Patients Treated with Vancomycin in Combination with Piperacillin/Tazobactam vs. Cefepime
Favorite
51 - Development and Assessment of a Process to Describe the Timing of Antibiotic Changes in Adult Inpatients
Favorite
52 - Development and Implementation of a Short Duration of Antibiotic Therapy Algorithm for Uncomplicated Gram-Negative Bacteremia
Favorite
53 - Effect of Rapid Identification of Bloodstream Isolates on Antibiotic Management Using a Pharmacist-based Treatment Algorithm
Favorite
54 - Effectiveness of a Venous Catheter Stewardship Intervention Targeting Parenteral Antimicrobial Therapy at Hospital Discharge
Favorite
55 - Ertapenem for Surgical Prophylaxis: The Impact of Antimicrobial Stewardship Interventions on Inappropriate Carbapenem Utilization at a Community Teaching Hospital
Favorite
56 - Ertapenem Utilization: "CRE"ating Solutions for Improving Hospital Stay and Stewardship
Favorite
57 - Evaluating the Utility of a Penicillin Allergy Reconciliation Program within an Infectious Diseases Consult Population in a Community Health System
Favorite
58 - Evaluation of a Disease State Stewardship Intervention for Urinary Tract Infections at an Academic Medical Center
Favorite
59 - Evaluation of Drug-Bug Mismatch Alerts and Their Value in an Antimicrobial Stewardship Program
Favorite
60 - Evaluation of Outcomes Associated with Intermittent Versus Extended Infusion of Piperacillin/tazobactam in Acutely Ill Veterans.
Favorite
61 - Evaluation of the Impact of a Micafungin Time-Out Protocol for Hospitalized Patients
Favorite
62 - Factors Associated with 30-Day ED Readmission Following Initial ED Discharge for Suspected Sepsis
Favorite
63 - Frequency and Outcomes of Patients Prescribed Antibiotics for Extended Durations on Discharge from the Hospital to Nursing Homes
Favorite
64 - Impact of a Duration Bundle on Antimicrobial Use in a Pediatric Hospital
Favorite
65 - Impact of a Multifaceted Stewardship Intervention on Oral Fosfomycin Prescribing for Treatment of Resistant Organisms in Cystitis
Favorite
66 - Impact of a Pharmacist-Driven Azithromycin De-escalation Protocol for Community-Acquired Pneumonia
Favorite
67 - Impact of a Pharmacist-Driven Collaborative Initiative on
Staphylococcus aureus
Bacteremia Management
Favorite
68 - Impact of a Pharmacy-Driven Antimicrobial Time-out on Duration of Therapy in Community-Acquired Pneumonia
Favorite
69 - Impact of Antimicrobial Stewardship Interventions on Post-elective Caesarean Antibiotic Prophylaxis and Surgical Site Infections
Favorite
70 - Impact of Fluoroquinolone Susceptibility Suppression on Discharge Prescribing for Acute Uncomplicated Cystitis
Favorite
71 - Impact of Prospective Audit and Feedback on Fluoroquinolone Use: A Large Academic Medical Center Experience
Favorite
72 - Improving Antibiotic Prescribing in Interventional Radiology Using Clinical Decision Support Tools to Assess Penicillin Allergies
Favorite
73 - Improving Cephalosporin Utilization in the Emergency Department for Penicillin Allergic Patients
Favorite
74 - Interrupted Time Series Analysis of the Impact of Fluoroquinolone Cascade Reporting
Favorite
75 - Less is More: A Physician-Driven Quality Improvement Stewardship Initiative to Reduce Excessive Duration of Antibiotic Therapy in Veterans Hospitalized with Community-Acquired Pneumonia
Favorite
76 - Optimizing Clinical Outcomes in Geriatric Patients through a Multidisciplinary Hospital Antimicrobial Stewardship Program
Favorite
77 - Out of Sight, Out of Mind: Impact of an Antimicrobial Stewardship Bundle on Fluoroquinolone Utilization
Favorite
78 - Outcomes and adherence to institutional empiric therapy guidelines for the treatment of cystitis in ambulatory male veterans
Favorite
79 - Outcomes Associated with the Utilization of the Methicillin-Resistant
Staphylococcus aureus
(MRSA) Nasal Polymerase Chain Reaction (PCR) Assay to De-escalate Vancomycin Therapy in Patients with Suspected Pneumonia at a Rural Community Hospital
Favorite
80 - Pharmacoeconomic Analysis Comparing the Empiric Utilization of Cefepime Versus Piperacillin/tazobactam
Favorite
81 - Physicians’ Knowledge, Attitude, and Practice regarding Prolonged Antimicrobial Use
Favorite
82 - Post-Prescription Review with Threat of Infectious Disease Consultation and Sustained Reduction in Meropenem Use Over Four Years
Favorite
83 - Staff Pharmacist-driven Prospective Audit and Feedback at a Community Hospital: Assessing an all Hands on Deck Approach to Antimicrobial Stewardship
Favorite
84 - T2Candida Panel Use Evaluation: a Quality Improvement Project
Favorite
85 - The Impact of Carbapenem-Sparing Interventions on the Evolution of Resistance in
P
seudomonas aeruginosa
in the USA
Favorite
86 - Use of a Novel Clinical Decision Support Tool for Pharmacist-Led Antimicrobial Stewardship in Patients with Normal Procalcitonin
Favorite
87 - Utilization of Methicillin-Sensitive/Resistant
Staphylococcus aureus
Nares Screen to Decrease Vancomycin and Linezolid Use in Hospitalized Patients with Respiratory Infections
Favorite
Antimicrobial Stewardship: Diagnostics/Diagnostic Stewardship
88 -
A Behavioral Economic Approach to
C. difficile
Testing Stewardship
Favorite
89 -
A Collaborative & Novel Antimicrobial Stewardship Initiative– Mandatory Approval of Peripherally Inserted Central Venous Catheters
Favorite
90 -
Impact of Discrepant Rapid Diagnostic Test (RDT) Results on Antimicrobial Stewardship Program (ASP) Interventions in Patients with Bloodstream Infections (BSI) due to Gram-Negative Bacilli (GNB)
Favorite
91 -
Implementing Criteria to Reduce Blood Cultures Ordering: A Pre- and Post-Intervention Retrospective Study in a Critical Access Hospital
Favorite
92 -
Utility of Sinus CT in the Evaluation of Patients with Febrile Neutropenia
Favorite
93 - A Diagnostic Stewardship Intervention to Improve Utilization of 1,3-β-D-glucan Testing
Favorite
94 - Appropriate Urine Legionella Antigen Testing: A Step Towards Diagnostic Stewardship.
Favorite
95 - Assess reasons for continuing antibiotics in persons with positive respiratory viruses PCR in the emergency room.
Favorite
96 - Assessing the Impact of the Meningitis/encephalitis Diagnostic Panel on Antimicrobial Stewardship
Favorite
97 - Assessment of the accuracy of direct antimicrobial susceptibility testing from positive blood cultures in pediatric patients and its utility as an antimicrobial stewardship tool
Favorite
98 - Clinical and Pharmacoeconomic Impact of Rapid Diagnostic Pneumonia Panel in Critically Ill Patients Admitted with Nosocomial Pneumonia
Favorite
99 - Comparison of Procalcitonin Testing to a Targeted Audit-and Feedback Strategy on Prescribed Durations of Therapy for Community-Acquired Pneumonia
Favorite
100 - Development and Implementation of a 2-Tier Testing Algorithm for
Clostridioides difficile:
An Evaluation of Outcomes on Patients with Indeterminate Results at 90 Days
Favorite
101 - Diagnostic Utility of a Multiplex PCR Meningitis/Encephalitis Panel and Impact on Antibiotic Use
Favorite
102 - Effects of an Antimicrobial Stewardship-guided MRSA Nasal Screening Review on Vancomycin Utilization for Respiratory Infections: A Quasi-Experimental Study
Favorite
103 - Empiric Antibiotic Susceptibility Using a Traditional vs. Syndromic Antibiogram-Implications for Antimicrobial Stewardship Programs
Favorite
104 - Evaluation of a 2-Step Testing Algorithm for
Clostridioides difficile
Infection
Favorite
105 - Evaluation of a Multiplex PCR Panel for the Microbiologic Diagnosis of Pneumonia in Hospitalized Patients: A Retrospective Analysis from an Academic Medical Center
Favorite
106 - Impact and Evaluation of BioFire® FilmArray® Respiratory Panel on Clinical Decision Making and Antibiotic Prescribing
Favorite
107 - Impact of a Rapid Blood Culture Identification Panel at a Community Teaching Hospital: a Pre-Post Quasi-Experiment
Favorite
108 - Impact of Accelerate Pheno System in the Management of Gram-Negative Rod Bacteremia
Favorite
109 - Impact of Accelerate Pheno
TM
System on Time to De-escalation of Antimicrobial Therapy
Favorite
110 - Impact of Diagnostic and Antimicrobial Stewardship on Time-to-Appropriate Therapy and Clinical Outcomes in Multi-Drug Resistant Pseudomonas Infections
Favorite
111 - Impact of Microbiology Laboratory Result Presentation on Antibiotic Stewardship: Process Use Evaluation
Favorite
112 - Impact of Respiratory Viral PCR Panels (RVP) and Serum Procalcitonin (PCT) on Antibiotic Days of Therapy (DOT) in Patients Admitted with Lower Respiratory Tract Infections (LRTI)
Favorite
113 - Impact of Urinalysis with Reflex to Culture on Antimicrobial Prescribing Patterns for Patients with a Positive Urine Culture
Favorite
114 - Implementation of an Empiric Organism Specific Guidelines for Gram-negative Bacteremia in conjunction with Rapid Diagnostic Testing
Favorite
115 - Influence of Antimicrobial Stewardship and Molecular Rapid Diagnostic Test on Antimicrobial Prescribing for Extended-spectrum Beta-lactamase and Carbapenemase-producing Bacteria in Bloodstream Infections
Favorite
116 - Leveraging the Use of the PCR-based Methicillin-Resistant
Staphylococcus aureus
(MRSA) Nasal Swab in the Emergency Department to Optimize Vancomycin Use in the Inpatient Setting
Favorite
117 - Natural Language Processing: An Automated Alternative to Determining Inappropriate Group A Streptococcal Testing
Favorite
118 - Optimizing the management of coagulase-negative staphylococci (CoNS) contaminants by reporting the species name
Favorite
119 - Procalcitonin to Guide Antibiotic Therapy for Respiratory Infection: A Systematic Review of Systematic Reviews
Favorite
120 - Stewardship Driven Reduction of Inappropriate
Clostridioides difficile
Testing at a Tertiary Military Medical Facility
Favorite
121 - Temporal Trends in Urine Culture Rates in the U.S. Acute Care Hospitals During 2012-2017
Favorite
122 - The Buck Stops Here. PICC Line Utilization: Stewardship Is Not Only About Antimicrobials Any More
Favorite
123 - Utilization of the BioFire® FilmArray® Pneumonia Panel in Critically Ill Patients with Influenza Pneumonia
Favorite
Antimicrobial Stewardship: Non-Inpatient Settings
124 -
Acute Uncomplicated Cystitis in Urgent Care Centers: Changes in Antibiotic Prescribing Practices Before and After Provider Education
Favorite
125 -
Comparison of Diagnosis and Prescribing Practices between Virtual Visits and Office Visits for Adults Diagnosed with Uncomplicated Urinary Tract Infections within a Primary Care Network
Favorite
126 -
Implementation of the core elements of an outpatient antimicrobial stewardship program in pediatric emergency departments and urgent care clinics
Favorite
127 - A Retrospective Review of Antibiotic Appropriateness for Urinary Tract Infections in Ambulatory Patients
Favorite
128 - Antibiotic Prophylaxis Prior to Dental Visits in the Veterans Health Administration (VHA), 2015-2018
Favorite
129 - Antimicrobial Stewardship Intervention Bundle Decreases Fluoroquinolone Prescribing for Urinary Tract Infection in Urgent Care and Primary Care Clinics
Favorite
130 - Antimicrobial Stewardship Practices in Community Pharmacies Across the United States
Favorite
131 - Antimicrobial Usage for Respiratory Infections in Urgent Care Settings within the University of Washington Medicine Network
Favorite
132 - Assessment of the Long-Term Effects of Training Consultant Pharmacists to Promote Antimicrobial Stewardship in Long-Term Care Facilities
Favorite
133 - Creation of an Emergency Department (ED)-Specific Urine Antibiogram and Evaluation of Urinary Tract Infection (UTI) Prescribing Practices at a Tertiary Academic Medical Center
Favorite
134 - Derivation of novel phenotypes of outpatient pediatrician prescribing patterns
Favorite
136 - Don’t Sweat the Small Stuff: Solutions for Large-Scale Stewardship Obstacles
Favorite
137 - Evaluating a Novel Antibiogram Format for use in Wisconsin Nursing Homes
Favorite
138 - Focused Outpatient Antibiograms: Time for Widespread Implementation?
Favorite
139 - Impact of Pharmacist Driven Outpatient Fluoroquinolone Stewardship Initiative in Community Based Setting
Favorite
140 - Impact of Pharmacist-led Audit & Feedback on Outpatient Antibiotic Prescribing for UTIs and SSTIs
Favorite
141 - Implementation of Veterans Affairs Outpatient Antimicrobial Stewardship Interventions for Asymptomatic Bacteriuria and Acute Respiratory Infections, a Stepped Wedge Randomized Study
Favorite
142 - Implementing an Antimicrobial Stewardship Program in the Outpatient Setting
Favorite
143 - Initial Impact of COVID-19 on Ambulatory Antibiotic Prescribing for Respiratory Viral Infections
Favorite
144 - Little evidence of same-day, oral antibiotic prescribing at ambulatory surgery centers
Favorite
145 - Monthly Antibiotic Prescribing Peer Comparison Combined with In-person Education Decreases Antibiotic Prescribing for Acute Respiratory Infections
Favorite
146 - Outpatient Antibiotic Stewardship in the COVID Era: Trends in antibiotic prescription in a statewide Veteran’s Affairs health care system
Favorite
147 - Pharmacist Attitudes Towards Using Clinical Decision Support in Community Pharmacies to Promote Antibiotic Stewardship in the Treatment of Uncomplicated UTI
Favorite
148 - Post-Extraction Infection and Antibiotic Prescribing Among Veterans Receiving Dental Extractions
Favorite
149 - Unmet Informational Needs among Nursing Home Residents Receiving Antibiotics: A Qualitative Study
Favorite
150 - Using audit-and-feedback to improve antibiotic-prescribing in Emergency Departments: a quasi-experimental study across 4 sites in the Veterans Health Administration
Favorite
Antimicrobial Stewardship: Program Development and Implementation
152 -
Applying
A Difference-in-Difference Analysis to Assess
Effect of Antimicrobial Stewardship Strategies on Changes in Antimicrobial Use
Favorite
153 -
Development of a Pathway for Removal of Inappropriate Penicillin Allergy Labels in
Hospitalized
Patients
Favorite
154 -
Development of an Electronic Algorithm to Target Outpatient Antimicrobial Stewardship Efforts for Adults with Acute Pharyngitis
Favorite
155 -
Development of antibiotic classification for measuring antibiotic usage in Korean hospitals using a modified Delphi method
Favorite
156 -
Evaluating Antibiotic Use and Developing a Tool to Optimize Prescribing in a Pediatric HIV Clinic in Eswatini
Favorite
157 - A Multidisciplinary Approach to Carbapenem Stewardship at a Large Community Hospital in Brooklyn, New York
Favorite
158 - A multi-site, prospective study of antimicrobial prescribing practices in three low- or middle-income country hospitals
Favorite
159 - A Novel Framework to Guide Antibiotic Stewardship Nursing Practice
Favorite
160 - A Pre- and Post-intervention Study to Implement a Successful Antimicrobial Stewardship Program in Palliative Care
Favorite
161 - Assessing Antimicrobial Stewardship Engagement among Frontline Oncology Nurses and Chartering a Path Forward
Favorite
162 - Assessment of Beta-lactam Allergies as Rationale for Receipt of Vancomycin for Surgical Prophylaxis
Favorite
163 - Automation of an Inpatient Provider Specific Antimicrobial Use Report
Favorite
164 - Avoiding Complacency: Assessing the Perceived Impact and Value of Antimicrobial Stewardship at a Academic Medical Center
Favorite
166 - Barriers to implementing antimicrobial stewardship programs in low- or middle-income country settings: findings from a multi-site qualitative study
Favorite
167 - Communication is Key: A Multifaceted Approach to Improving Essential ASP Metrics in Surgical Services
Favorite
168 - Creation and Internal Validation of a Clinical Predictive Model for Fluconazole Resistance in Patients with
Candida
Bloodstream Infection
Favorite
169 - Development of a Real Time Electronic Algorithm to Identify Hospitalized Patients with Community-Acquired Pneumonia
Favorite
170 - Development of Key Indicators for Appropriate Antibiotic Use in Republic of Korea: a Systematic Review followed by Delphi Procedure
Favorite
171 - Effectiveness and Feasibility of Pharmacist-Driven Penicillin Allergy De-Labeling Pilot Program
Favorite
172 - Evaluation of Multifaceted Antimicrobial Stewardship Interventions on The Treatment of Asymptomatic Bacteriuria
Favorite
173 - Identification of Inappropriate Antibiotic Orders During a Pharmacy-Supported Antimicrobial Stewardship Program in the Primary Care Setting: A Retrospective Analysis.
Favorite
174 - Impact of Cascade Reporting of Antimicrobial Susceptibility on Antimicrobial Consumption at a Veterans Affairs Medical Center
Favorite
175 - Impact of Infectious Diseases Pharmacist Interventions on Appropriateness of Antibiotics Prescribed at Hospital Discharge
Favorite
176 - Impact of pharmacist electronic communication on the appropriateness of antimicrobial therapy at renewal time
Favorite
177 - Implementation of Pharmacist-Driven Penicillin Allergy Evaluation and Testing with a Focus on Bypassing Penicillin Skin Testing at an Academic Medical Center
Favorite
178 - Implementation of the Core Elements of Antibiotic Stewardship in Nursing Homes – National Healthcare Safety Network (NHSN), 2016-2018
Favorite
179 - Integrating Antibiotic Stewardship Core Elements into Nurse Residency Programs
Favorite
180 - Leveraging the Electronic Medical Record as a Method of Antibiotic Stewardship
Favorite
181 - Limited Effectiveness of an EMR Alert-Based Antibiotic Timeout Procedure in Solid Tumor Cancer Patients
Favorite
182 - Missed Opportunities to Discontinue Unnecessary Vancomycin During Pharmacist Therapeutic Monitoring
Favorite
183 - Optimization of an Outpatient Antimicrobial Stewardship Process for Patients Discharged from the Emergency Department at an Academic Medical Center.
Favorite
184 - Pharmacist role in antimicrobial stewardship research: a 30-year experience
Favorite
185 - Pilot of a Face-to-Face Model of Stewardship (Handshake Stewardship) in a General Medicine Ward
Favorite
186 - Prescriber-Led Antibiotic Timeout Alert Responses: A Retrospective Multicenter Study
Favorite
187 - Significant Decline in Carbapenem Use with Multifaceted Antimicrobial Stewardship Program (ASP) Interventions
Favorite
188 - Sustainability of Antibiotic Stewardship Programs: Perceptions & Experiences of Nursing Home Staff
Favorite
189 - Validating a Hospitalist-Specific Antibiotic Prescribing Metric across Four Acute Care Hospitals
Favorite
190 - Which antibiotic are you? Evaluation of a global antibiotic awareness personality quiz
Favorite
Antimicrobial Stewardship: Special Populations
191 -
The impact of antibiotic use on clinical outcomes in cancer patients treated with immune checkpoint inhibitors: a systematic review and meta-analysis
Favorite
192 - A Hematology/Oncology Unit-Specific Antibiogram Emphasizes the Need for Intensified Local Stewardship
Favorite
193 - Adding
Insalt
to Injury: Evaluating the Consequences of Sepsis Protocols on Patients with Heart Failure
Favorite
194 - Antibiotic-resistant bloodstream infections in pediatric oncology patients on levofloxacin prophylaxis
Favorite
195 - Antimicrobial Stewardship Incorporating New Antimicrobials for Use against Multi-Drug Resistant
Pseudomonas aeruginosa
in Cystic Fibrosis
Favorite
196 - Assessing the Clinical Impact of Intravenous Acyclovir Dosing in Obese Patients: Should We Be Using Ideal, Adjusted, or Total Body Weight?
Favorite
197 - Bridging the Divide Between Antimicrobial Stewardship and Surgical Services: Successful Use of Handshake Stewardship with Hepato-Pancreato-Biliary Surgical Services in Adult Patients at a Large Academic Medical Center
Favorite
198 - Clinical Prediction of Bacteremia and the Need for Early Antibiotic Therapy in Solid Tumor Cancer Patients
Favorite
199 - Evaluating long-term care pharmacy dispense data to monitor antibiotic use in U.S. nursing homes
Favorite
200 - Frequency and Characteristics of Patients Switched from Intravenous to Oral Antibiotic Therapy on Discharge to Nursing Homes
Favorite
201 - Healthcare utilization outcomes of patients prescribed fluoroquinolones on discharge from the hospital to nursing homes
Favorite
202 - Implementation of an Outpatient Parenteral Antimicrobial Therapy (OPAT) Collaborative for Patients with
Staphylococcus aureus
or Gram-Negative Bacilli Bacteremia Requiring Home Infusion: The PANTHIR Program
Favorite
203 - Opportunities for Antimicrobial Stewardship in Febrile Neutropenia
Favorite
204 - Post-Liver Transplant Antimicrobial Use after the Expansion of a Pharmacist-Lead Antimicrobial Stewardship Program
Favorite
205 - Rectal Stool Surveillance Cultures to Guide Empiric Antibiotic Therapy in Patients with Hematologic Malignancies with or without Hematopoietic Stem Cell Transplantation
Favorite
206 - The Utility of Lactate as a Biomarker for Sepsis in Cancer Patients
Favorite
207 - Travel Related Risk Behaviors and Antibiotic Use among Older Travelers
Favorite
208 - Variation in Clinical Practice and Attitudes in the Management of Fever and Neutropenia in Patients With Hematologic Malignancy: A Survey of Cancer Centers Across the United States
Favorite
Antimicrobial Stewardship: Trends in Antimicrobial Prescribing
209 -
Antibiotic Utilization During the COVID-19 Surge in Detroit
Favorite
210 -
Vancomycin Infusion Frequency and Intensity: Analysis of Real-World Data Generated from Automated Infusion Devices
Favorite
211 - A Comprehensive Assessment of Carbapenem Use across 90 Veterans Health Administration Hospitals with Defined Stewardship Strategies for Carbapenems
Favorite
212 - Acute Kidney Injury with Piperacillin-tazobactam versus Cefepime in Combination with Vancomycin
Favorite
213 - An Analysis of the Impact of Gastrointestinal Polymerase Chain Reaction Panel Use on Antimicrobial use at a Tertiary Care Academic Medical Center
Favorite
214 - Antibiotic Use for Common Infections in British Columbia: A Review of Outpatient Prescribing from 2000 - 2018.
Favorite
216 - Are Automatic Antimicrobial Stop Orders an Effective Stewardship Tool for Urinary Tract and Intra-Abdominal Infections?
Favorite
217 - Broad Spectrum Antibiotic use in Outpatient Parenteral Antibiotic Therapy (OPAT): Opportunities for Antibiotic Stewardship
Favorite
218 - Changes in Dental Antibiotic Prescribing in the United States, 2012-2017
Favorite
219 - Characteristics Associated with Inappropriate Antibiotic Prescribing in Patients with Asymptomatic Bacteriuria (ASB)
Favorite
220 - Comparing Antibiotic Prescription Practices, and Provider’s Perceptions of Such Rates, Among Urgent Care and Non-Urgent Care Clinicians at One of the Nation’s Largest Federally Qualified Health Centers.
Favorite
221 - Comparison of dental antibiotic prescribing between Australia, England, the United States and British Columbia in 2017
Favorite
222 - Comparison of Outpatient Antibiotic Prescriptions in a High Prescribing State, 2016–2018
Favorite
223 - Difference in Carbapenem Use by ASP Intervention in Japanese Healthcare Facilities
Favorite
224 - Effect of Easing Overnight Restrictions on Antimicrobial Starts
Favorite
225 - Evaluating Appropriateness of Antibiotic Prescribing in Pediatric Inpatients
Favorite
226 - Evaluating the Unnecessary Use of Intravenous Broad-Spectrum Antibiotics in Patients Based on Systemic Inflammatory Response Syndrome Criteria in the Emergency Department (ED)
Favorite
227 - Evaluation of Empiric Vancomycin Utilization at 72 Hours Post Admission: is De-escalation of Vancomycin Appropriate?
Favorite
228 - Fluoroquinolone Prescribing for Diabetic Foot Infections following an FDA Drug Safety Communication for Aortic Aneurysm Risk
Favorite
229 - Hospitalists Antimicrobial Scorecard Improves Antibiotic Prescribing at a Community Teaching Hospital
Favorite
230 - Impact of 10-day versus 5-day Duration Default on Length of Antibiotic Outpatient Prescriptions from the Emergency Department
Favorite
231 - Impact of DRIP Score Documentation at Time of Physician Order Entry on Combination Antimicrobials in Treatment of Community Acquired Pneumonia
Favorite
232 - Impact of Weekend Initiation of Vancomycin or Piperacillin/Tazobactam on Days of Therapy Received upon Hospital Admission
Favorite
233 - Improved Penicillin Susceptibility of
Streptococcus pneumoniae
and Increased Penicillin Consumption in Japan, 2013-18
Favorite
234 - Improving Antibiotic Prophylaxis Selection for Patients Undergoing Urology Procedures
Favorite
235 - In outpatient clinics serving Veterans, antibiotic prescriptions precede a minority of antibiotic-associated adverse events.
Favorite
236 - Incorporating Clinical Guidance into Computerized Prescriber Order Entry May Reduce Fluoroquinolone Utilization for the Treatment of Diverticulitis at a Rural Community Health System
Favorite
237 - Inpatient and Discharge Antibiotic Use for Hospitalized Patients Growing Multi-Drug Resistant Bacteria in Urine Cultures
Favorite
239 - Outcomes Associated with Empiric Aztreonam Use Compared to Anti-Pseudomonal β-lactams in Patients with Sepsis: An Opportunity for Allergy Stewardship
Favorite
240 - Reduction of antibiotic use in children admitted with viral respiratory tract infections
Favorite
241 - Rural-urban differences in antibiotic prescribing for uncomplicated urinary tract infections
Favorite
242 - Seasonality in antibiotic use and resistance across multiple bacterial pathogens and antibiotic classes
Favorite
243 - Temporal Trends in Appropriateness of Ambulatory Antibiotic Prescribing in South Carolina
Favorite
244 - The Double-Edged Sword of Cost Effectiveness in Evaluating Antimicrobial Stewardship Interventions
Favorite
245 - The impact of patient safety report and sentinel events on the prescribing and practice habits of infectious disease physicians
Favorite
246 - Title: Antibiotic Prescribing Patterns for Residents in Assisted Living Facilities
Favorite
247 - Validation of the Use of Oral Vancomycin Following Positive Admission Screening Testing for
C. difficile
Favorite
248 - Why so Much Vancomycin and Piperacillin/Tazobactam Usage Given Known Risks of Nephrotoxicity
Favorite
Bacteremia
251 -
High prevalence of the cefazolin inoculum effect in methicillin-susceptible
Staphylococcus aureus
causing bloodstream infections in a hospital network in Houston, TX
Favorite
252 -
Increased incidence rates of positive blood cultures shortly after chemotherapy treatment initiation among individuals treated for solid malignant tumours
Favorite
253 -
Is Echocardiogram always indicated in Bacteremia?
Favorite
254 -
Review of Clinical Outcomes in Patients Treated with Beta-lactam vs Non-beta-lactam Therapy for AmpC Producing Bacterial Bloodstream Infections
Favorite
255 -
Ticagrelor Aids Platelet-Mediated Clearance in a Refractory
Staphylococcus aureus
Endovascular Infection with Septic Emboli
Favorite
256 -
Serratia Marcescens
Bacteremia and Endocarditis: A Treatment Assessment from an Academic Medical Center
Favorite
257 -
Staphylococcus aureus
Bacteremia: Does Intravenous Drug Use Impact Quality of Care and Clinical Outcomes?
Favorite
258 - A Comparison of Cefprozil and Fluoroquinolones for Gram-Negative Bacteremia
Favorite
259 - A Prospective, Stewardship-Driven IV to PO Conversion in Uncomplicated Bacteremia
Favorite
260 - A Rare Case of Severe Group B
Streptococcal
Infection with Toxic Shock-like Syndrome and Diffuse Metastatic Infection.
Favorite
261 - A Single-Center Case Series of Methicillin-Resistant
S. aureus
Bacteremia with Elevated Minimal Inhibitory Concentrations to Vancomycin
Favorite
262 - A Systematic Review and Meta-Analysis of the Impact of Delayed Appropriate Antibiotic Therapy on Mortality in Patients with Gram-Positive Bacteremia
Favorite
263 - An Evaluation of Quality Indicators for the Management of
Staphylococcus aureus
Bacteremia: A Nested Case-Control Study
Favorite
264 - Anti-platelet Therapy Significantly Reduces Inpatient Mortality in Patients with
Staphylococcus aureus
Bacteremia
Favorite
265 - Blood culture results pre- and post- antimicrobial administration in the Medicine Intensive Care Unit: a retrospective study in South Bronx
Favorite
266 - Ceftriaxone Versus Cefazolin for the Treatment of Methicillin-Susceptible
Staphylococcus aureus
Bacteremia
Favorite
267 - Characteristics and Trends of Serratia Blood Stream Infections
Favorite
268 - Clinical Characteristics and Mortality Associated with Culture Positivity in Adult Inpatients with Sepsis: A 15-Year Cohort Study of 48,706 Patients at a Tertiary Medical Center in Taiwan
Favorite
269 - Clinical Characteristics and Outcomes of Persistent
Staphylococcus aureus
Bacteremia
Favorite
270 - Clinical Outcomes of Ceftriaxone versus Penicillin G for Complicated Viridans Group Streptococci Bacteremia
Favorite
271 - Clinical Outcomes Treating Gram-Negative Bacteremia with Oral Beta-Lactams vs. Trimethoprim-Sulfamethoxazole or Fluoroquinolone Step-Down Therapy
Favorite
272 - Clinical Outcomes with Continuation of Combination Antibiotic Therapy versus De-escalation to Monotherapy for Patients with MRSA Bacteremia
Favorite
273 - Comparative Effectiveness of Ampicillin in the Treatment of
Enterococcus faecalis
Bloodstream Infections in Patients With Cancer
Favorite
274 - Comparison of Cefazolin Susceptibilities of
Enterobacterales
with an Automated Susceptibility Testing Platform versus
In Vitro
Antimicrobial Testing
Favorite
275 - Comparison of Cefazolin versus Nafcillin for Methicillin-Susceptible
Staphylococcus aureus
Bacteremia with a Deep-Seated Source
Favorite
276 - Comparison of Ceftaroline in Combination with Either Vancomycin or Daptomycin for the Treatment of Methicillin-resistant
Staphylococcus aureus
Bacteremia
Favorite
277 - Comparison of Oral Beta-Lactams and Fluoroquinolones for Step-Down in Uncomplicated
Enterobacterales
Blood Stream Infections
Favorite
278 - Comparison of Oral Cephalexin Versus Oral Levofloxacin for Treatment of Uncomplicated
Enterobacterales
Bacteremia
Favorite
279 - Dalbavancin for Bloodstream Infections and Endocarditis: Real-World Outcomes From the DRIVE Registry
Favorite
280 - Description of Transesophageal Echocardiography Prescribing Practices in non-
Staphylococcus aureus
Bacteremia with Application of Scoring Systems
Favorite
281 - Detecting bacterial sepsis among allogeneic HCT recipients with population-specific bedside tools
Favorite
282 - Epidemiological Evaluation of Methicillin-Resistant
Staphylococcus aureus
(MRSA) and Methicillin-Susceptible
Staphylococcus aureus
(MSSA) Bacteremia: A Comprehensive Cancer Center’s 10-Year Experience
Favorite
283 - Epidemiology and Clinical Significance of Persistent Bacteremia in Severely Burned Patients
Favorite
284 - Evaluation of Oral Step-Down Therapy for Enterobacteriaceae Bloodstream Infection
Favorite
285 - Evaluation of the ePlex® Blood Culture Identification (BCID) Panels for Gram-positive/Gram-negative bacteria and yeasts
Favorite
286 - Exploratory Cost-Effectiveness Analysis for Treatment of Methicillin-Resistant
Staphylococcus aureus
Bloodstream Infections: Are Daptomycin and Linezolid Favored over Vancomycin and Other Antibiotics?
Favorite
288 - Follow-Up Blood Cultures in Gram-Negative Bacteremia: How Do They Impact Outcomes
Favorite
289 - Impact of Clinician Specialty on the Use of Oral Antibiotic Therapy for Definitive Treatment of Uncomplicated Bloodstream Infections
Favorite
290 - Impact of follow up blood cultures on outcomes of patients with gram-negative bloodstream infections
Favorite
291 - Impact of Surveillance and Offered Infectious Diseases Consults for Staphylococcus aureus Bacteremia on Quality of Care Indicators
Favorite
292 - Impact of the BACT/ALERT VIRTUO blood culture system in the management of
Staphylococcus aureus
bacteremia
Favorite
293 - Influence of a Pharmacist Led Treatment Algorithm for the Management of Staphylococcus Bacteremia
Favorite
294 - Interim Analysis of an Evidence-Based Bundle Intervention for Uncomplicated Enterobacterales Bacteremia
Favorite
295 - Is Herd Immunity from Pneumococcal Conjugate Vaccines Changing the Clinical Features of Invasive Pneumococcal Disease in Adults?
Favorite
296 - IV-to-PO Antibiotic Step-down Therapy for Treatment of Uncomplicated Streptococcal Bloodstream Infections
Favorite
297 - Lactobacillus: Friend or Foe
Favorite
298 - Multicenter retrospective cohort study of the clinical significance of
Staphylococcus lugdunensis
isolated from a single blood culture set
Favorite
299 - Paediatric Collaborative Network on Infections in Canada (PICNIC) Study of the Current Landscape of Gram Negative Bacteremias
Favorite
300 - Pediatric Center Evaluation of the BioFire
®
Blood Culture Identification 2 Panel Versus the Original BioFire
®
FilmArray
®
Blood Culture Identification Panel for the Detection of Microorganisms and Resistance Markers in Positive Blood Cultures
Favorite
301 - Penicillin Versus Cefazolin or Anti-staphylococcal Penicillins for Penicillin-Susceptible
Staphylococcus aureus
Bacteremia
Favorite
303 - Physiological Changes Due to Bloodstream Infection in Intensive Care Unit Patients Differ According to Transplant Status
Favorite
304 - Predictors of mortality in carbapenem-resistant
Enterobacteriales
bacteremia
Favorite
305 - Prevalence of Ceftriaxone Susceptible, Piperacillin-tazobactam Non-susceptible
Escherichia coli
Bacteremia in Patients with Hematologic Malignancy
Favorite
306 - Rapid Detection Of Bloodstream Infections, Including Molecular Characterization, From Whole Blood
Favorite
307 - Rapid Resistance Development to Three Antistaphylococcal Therapies in Daptomycin-tolerant
Staphylococcus aureus
Bacteremia
Favorite
308 - Re-purposing Beta-lactam Antibiotics as Fluoroquinolone Sparing Stepdown Therapy for the Treatment of Enterobacteriales Bloodstream Infections
Favorite
309 - The Impact of Addiction Medicine Consultation on Discharges Against Medical Advice in Patients with Opioid Use Disorder and Staphylococcus Aureus Bacteremia
Favorite
310 - The Impact of Microscan versus Vitek-2 for Automated Susceptibility Testing on the Utilization of Vancomycin Alternatives for the Treatment of Methicillin-Resistant
Staphylococcus aureus
Bacteremia
Favorite
311 - The Role of Transthoracic Echocardiography in
Staphylococcus aureus
Bacteremia; A Retrospective Chart Review
Favorite
312 - Unplanned Readmission after Hospitalization with
Staphylococcus aureus
Bacteremia in Children: a Multistate Population Based Study
Favorite
313 - Using a Clinical Decision Prediction Tool to Improve Empirical Antimicrobial Therapy in Ceftriaxone-Resistant
Enterobacterales
Bloodstream Infections
Favorite
Bone and Joint
314 - A Retrospective Review of Dalbavancin Utilization at an Academic Medical Center
Favorite
315 - Alternating Magnetic Fields (AMF) and Antibiotics Eradicate Biofilm on Metal in a Synergistic Fashion
Favorite
316 - Application of New Consensus Definition Identifies High Numbers of Fracture Related Infections with Negative Cultures.
Favorite
317 - Case Series of Echinococcus Infections at Mayo Clinic Florida
Favorite
318 - Deferring Amputation in Diabetic Foot Osteomyelitis: Doing more Harm than Good?
Favorite
319 - Distribution of Joint Involvement for Arbovirus-Associated Persistent Arthralgia May Help Distinguish Between Similar Diseases
Favorite
320 - Does Guideline-Based Management of Diabetic Foot Osteomyelitis Reduce Risk of Further Proximal Amputations?
Favorite
321 - Eleven-year Case Series of the Anatomy and Microbiology of Musculoskeletal Infections in People who Inject Drugs
Favorite
322 - Evaluation of the BioFire® Bone and Joint Infection (BJI) Panel for the Detection of Microorganisms and Antimicrobial Resistance Genes in Synovial Fluid Specimens
Favorite
323 - First case of Prosthetic joint infection due to
Nocardia veterana-elegans
Favorite
324 - Implant Sonication Improves Microbiologic Diagnosis of Elbow Prosthetic Joint Infection
Favorite
325 - Invasive and Non-Invasive Osteomyelitis Caused by Group B Streptococcus Infection Among Veterans
Favorite
326 - More Specialties, Less Problems: Creating collaborative competency between Infectious Disease, Podiatry, and Pathology co-managing diabetic foot infections
Favorite
327 - Oritavancin Activity against
Staphylococcus aureus
Isolates Causing Bone and Joint Infections in European Hospitals (2010-2019)
Favorite
328 - Outcomes in Spinal Cord Injury Patients with Stage 3 and 4 Pressure Injuries at a Veterans’ Affairs Hospital
Favorite
329 - Performance of Next Generation Sequencing in Isolating a Pathogen in Pediatric Osteoarticular Infections
Favorite
330 - Risk Factors for Acute Kidney Injury after the Use of Antibiotic Loaded Bone Cement in Orthopedic Surgery – a Retrospective Case-control Study
Favorite
332 - Spinal Infections: Clinical and Microbiological Characteristics in our Urban Referral Health Center
Favorite
333 - Tedizolid Activity against Gram-Positive Bacterial Isolates Causing Bone and Joint Infections in the United States (2015-2019)
Favorite
334 - Treatment Duration of Antibiotics for Sacral Osteomyelitis After Skin Flap Procedure
Favorite
335 - Using high temperatures to eradicate prosthetic joint associated biofilms on metal implants using alternating magnetic field: Efficacy and safety implications
Favorite
Care Strategies for Transplant Patients
568 -
Healthcare Cost and Length of Stay for Cytomegalovirus (CMV) Infection-Related Hospitalizations in Allogeneic Hematopoietic Cell Transplant (allo-HCT) recipients: A Multicenter Analysis
Favorite
569 - A Multidisciplinary Approach to the Pre-evaluation Process of Pediatric Solid Organ Transplant Patients
Favorite
570 - “I don’t know”: The Typical Response When Taking Pneumococcal Immunization Histories in Kidney Transplant Candidates
Favorite
571 - “Real world” Impact of Letermovir for Prevention of Cytomegalovirus Infection in Hematopoietic-Cell Transplantation
Favorite
572 - Antiviral Toxicities Among Pediatric Solid Organ Transplant Recipients
Favorite
574 - De-escalation of Broad Spectrum Antibiotics during Cytokine Release Syndrome with Haploidentical Hematopoietic Stem Cell Transplantation
Favorite
575 - Effectiveness of Short vs Long Course Perioperative Antibiotics in Lung Transplant Recipients with Donor Positive Respiratory Cultures
Favorite
576 - Half-dose Valganciclovir Prophylaxis is Safe and Cost-effective in CMV Seropositive Renal Transplant Recipients
Favorite
577 - Incidence and Outcomes of Positive Outpatient Surveillance Blood Cultures in Hematopoietic Stem Cell Transplant (HSCT) Patients with Graft Versus Host Disease (GvHD) On High Dose ≥ 0.5 mg/kg/day (HD) and Low Dose < 0.5mg/kg/day (LD) Steroid Therapy
Favorite
578 - Infections in Patients Treated with Chimeric Antigen Receptor T-cells (CAR-T) therapy
Favorite
579 - Prophylactic Antibiotics Did Not Decrease Recurrent Cholangitis in Patients with Biliary Atresia After Kasai Portoenterostomy
Favorite
580 - Refractory and Resistant CMV Infections in Hematopoietic Cell Transplant Recipients in the Letermovir Primary Prophylaxis Era
Favorite
581 - Risks versus Benefits of Metronidazole Use for the Prevention of Acute GVHD in Allogeneic Stem Cell Transplant Recipients
Favorite
582 - Safety and Efficacy of High-Dose Ganciclovir versus Standard Dosing for Cytomegalovirus Viremia in Solid Organ Transplant (SOT) Recipients
Favorite
583 - Successful prevention of
Strongyloides
reactivation in liver transplant recipients with individualized screening and treatment: 10 year experience at a large transplant center in New York City
Favorite
584 - Ventricular assist device infections with
Pseudomonas aeruginosa
Favorite
Clinical Practice Issues
585 -
A Cost-Effective Implementation Reducing The Number Of Urine Cultures In An Acute Care Community Hospital
Favorite
587 -
Equity in academic advancement: findings from an IDSA-sponsored survey of infectious disease physicians
Favorite
588 -
Implementation of a standardized OPAT SmartForm was associated with improved post-discharge outcomes
Favorite
589 -
Use of Dalbavancin in Facilitating Discharge of High Risk Patients in Low Resource Settings
Favorite
590 -
Vancomycin Infusion: Algorithmic Analysis of Unstructured Real-World Data Captured from Automated Infusion Devices
Favorite
591 - A Model for assessing staffing needs for an Outpatient Parenteral Antibiotic Therapy (OPAT) program
Favorite
592 - A Pilot Program to Evaluate Home Telemedicine Visits in an OPAT Program
Favorite
593 - Additional medical expenditures attributable to pneumococcal disease in Japan
Favorite
594 - Characteristics of an At-Risk Patient Population Presenting to a Philadelphia Student-Run Free Clinic within 30 Days of Hospital Visit
Favorite
595 - Characteristics of Antimicrobials Which Affect Parenteral Antibiotic Therapy Outcomes
Favorite
596 - Clinical outcomes and healthcare utilization in uninsured patients requiring long-term antibiotic therapy
Favorite
597 - Comparison of Vancomycin and Daptomycin Complications and Interventions in Outpatient Parenteral Antimicrobial Therapy
Favorite
598 - Correlation of International Classification of Diseases (ICD) codes to initial provider-selected antibiotic indications in hospitalized adult patients within the Duke Antimicrobial Stewardship Outreach Network (DASON)
Favorite
599 - Dalbavancin Utilization in Rural Healthcare Setting: A Single Center Three Years’ Experience
Favorite
600 - Decreased Hospital Readmission After Programmatic Strengthening of an Outpatient Parenteral Antimicrobial Therapy (OPAT) Program
Favorite
601 - Disparities in Diabetes Care: Smoking Cessation among Women and Minorities Living with HIV at an Urban Academic Medical Center
Favorite
602 - Do These Labs Really Matter? Searching for the Benefit of Laboratory Monitoring in Outpatient Parenteral Antimicrobial Therapy (OPAT)
Favorite
603 - Evaluating the Effects of Centers for Medicare & Medicaid Services Sepsis Core Measure in a Community Hospital
Favorite
604 - Factors Associated with Adverse Drug Reactions Leading to Discontinuation of Vancomycin in Outpatient Parenteral Antimicrobial Therapy
Favorite
605 - Factors Underlying Antifungal Price Trends in the United States
Favorite
606 - HIV Homecare: Understanding its Impact for Lost-to-Follow-Up Populations
Favorite
607 - Identifying Intervention Opportunities to Prevent Readmissions during OPAT
Favorite
608 - Impact of Implementing Pharmacist Review and Monitoring of Outpatient Parenteral Antimicrobial Therapy
Favorite
609 - Implementation and Post-implementation Analysis of a Pilot Program for Inpatient Review of Outpatient Parenteral Antimicrobial Therapy Prior to Discharge
Favorite
610 - Incidence of Acute Kidney Injury in Outpatient Parenteral Antimicrobial Therapy (OPAT) Patients Receiving Vancomycin
Favorite
611 - Infectious Disease Management of Homeless and Non-Homeless Populations in United States Emergency Departments
Favorite
612 - In-Person vs Tele-Infectious Disease Care: Is One Better?
Favorite
613 - Lessons learned from a Rhode Island academic out-patient Lyme and tick-borne disease clinic
Favorite
614 - Long-Acting Lipoglycopeptides for the Treatment of Bone and Joint Infections and Bacteremia in Infectious Disease Outpatient Infusion Clinics
Favorite
615 - Overlooking those at Intermediate Risk? ASCVD Prevention Measures among People Living with HIV at an Urban Academic Medical Center
Favorite
616 - Patients Experiencing Homelessness and Opioid Use Disorder with Infectious Complications Treated with OPAT at Medical Respite: Evaluation of Retention in Care at 30 days and Role of Addictions Consultation
Favorite
617 - Physician Perspective: Utilization of Advanced Practice Providers (APPs) in the ID Workforce
Favorite
618 - Post-discharge Care Coordination Telephone Call for Patients Enrolled in the UNC OPAT Program
Favorite
619 - Quantifying the non-billable workload of Outpatient Parenteral Antibiotic Therapy (OPAT) services in a University Infectious Diseases (ID) Clinic
Favorite
620 - Real-World Insights on HIV Treatment Decision-Making in Federal and Public Healthcare Settings
Favorite
621 - Reporting Behaviors and Perceptions Towards the National Healthcare Safety Network Antimicrobial Use (AU) and Antimicrobial Resistance (AR) Options
Favorite
622 - Risk Factors for 30-Day Unplanned Readmissions in Patients Discharged with Outpatient Parenteral Antimicrobial Therapy
Favorite
623 - Self-Administered Outpatient Parenteral Antimicrobial Therapy (S-OPAT) in Uninsured Patients
Favorite
624 - Significant Institutional Cost Savings from OPAT-Facilitated Discharge for Patients with Challenging Situations
Favorite
625 - Sustained Efforts Improve Adherence to Monitoring for Solid Tumor Patients Discharged on Outpatient Parenteral Antimicrobial Therapy (OPAT) at a Comprehensive Cancer Center
Favorite
626 - Tackling the HIV Epidemic in South Florida: Patient Insights on Approaches for HIV Counseling, Testing, and Access to Prevention or Treatment
Favorite
627 - Tele-OPAT Outcomes at Two Community Hospitals
Favorite
628 - The Role of the Advanced Practice Provider in Infectious Disease: Opportunities for Growth
Favorite
629 - Understanding the Effects of Social Determinants of Health on Outcome When Discharging Veterans on Parenteral Antibiotic Therapy
Favorite
Clinical Trials
630 -
A 5-mRNA host response whole-blood classifier trained using patients with non-COVID-19 viral infections accurately predicts severity of COVID-19
Favorite
631 -
Preliminary safety and pharmacokinetic profile of VIR-2482: a monoclonal antibody for the prevention of influenza A illness
Favorite
632 - A Randomized, Placebo-Controlled, Double-Blind, Clinical Trial Evaluating Two Dose Regimens of Rifaximin (550mg daily or twice-daily) for Chemoprophylaxis Against Travelers’ Diarrhea Among Deployed U.S. and U.K. Military Personnel (PREVENT TD)
Favorite
633 - Bictegravir/Emtricitabine/Tenofovir Alafenamide (B/F/TAF) Efficacy in Participants with Pre-Existing Primary Integrase Inhibitor Resistance Through 48 Weeks of Phase 3 Clinical Trials
Favorite
634 - Chlorhexidine Oral Rinses to Alter the Oral and Sputum Microbiota in COPD (CLIMB): a Randomized, Double-blinded, Placebo-controlled, Parallel-group Pilot Study
Favorite
635 - Efficacy, Pharmacokinetics (PK), and Safety Profile of MEDI3902, an Anti-
Pseudomonas aeruginosa
Bispecific Human Monoclonal Antibody in Mechanically Ventilated Intensive Care Unit Patients; Results of the Phase 2 EVADE Study Conducted by the Public-Private COMBACTE-MAGNET Consortium in the Innovative Medicines Initiative (IMI) Program.
Favorite
636 - Immunogenicity, Safety and Tolerability of a Booster Dose of
Clostridium difficile
Vaccine and 4 Year Antibody Persistence
Favorite
637 - Outcomes by Body Mass Index (BMI) in the STRIVE Phase 2 Trial of Once-Weekly Rezafungin for Treatment of Candidemia and Invasive Candidiasis Compared with Caspofungin
Favorite
638 - Safety, Efficacy, and Durability of Long-Acting CAB and RPV as Maintenance Therapy for HIV-1 Infection: LATTE-2 Week 256 Results
Favorite
639 - Short Course Therapy for Urinary Tract Infections (SCOUT) in Children
Favorite
CNS Infection
336 -
Neurocysticercosis in a non-endemic region: A large case series from New York City
Favorite
338 - Analysis of Etiologies of Aseptic Meningitis within a Nation-Wide Hospital Network
Favorite
339 - Assessing Utilization of the Venereal Disease Research Laboratory Test in Cerebrospinal Fluid for the Diagnosis of Neurosyphilis: A Cohort Study
Favorite
340 - Association between Meningococcal Meningitis and Santa Ana Winds in Mexican Children and Adolescents from Tijuana, Baja-California, Mexico.
Favorite
342 - Clinical Utility of a Next Generation Sequencing Test for Pathogen Detection in Pediatric Central Nervous System Infections
Favorite
343 - CNS Mold Masquerading as Brain Metastases
Favorite
344 - Demographics of Patients with Central Nervous System Infections: A 10-year Mayo Clinic-Multicenter-Based Population Descriptive Study
Favorite
345 - Early Oral Therapy for
Streptococcus anginosus
Purulent Brain Infections: A Single Center Experience
Favorite
346 - Eastern Equine Encephalitis and Use of Intravenous Immunoglobulin Therapy and High-Dose Steroids
Favorite
347 - Etiologies in a Cohort of Pediatric Patients Who Underwent CSF Metagenomic Next Generation Sequencing
Favorite
348 - Etiology of Eosinophilic Meningitis in Korea
Favorite
349 - Hardware-Associated Multidrug-resistant
Pseudomonas
aeruginosa
Meningitis Treated with Ceftolozane-Tazobactam
Favorite
350 - Neurocysticercosis – Gender Differences in Clinical Presentations.
Favorite
351 - Neurocysticercosis: Clinical Experience in Large Urban Safety Net Hospital in Chicago
Favorite
352 - Seronegative Relapse of Brucellosis in the Central Nervous System
Favorite
353 - Starry Night, Starry Bright, A Lil’ Doxy Will Help You See the Light
Favorite
354 - The Epidemiology and Clinical Features of
Acanthamoeba
Disease in the United States, 1956–2018
Favorite
355 - Variability in the Current Evaluation and Management of Pediatric Encephalitis: Survey Results from an Emerging Infections Network Survey
Favorite
COVID-19 Complications, Co-infections, and Clinical Outcomes
356 -
Clinical characteristics of critically ill patients with COVID-19 and invasive pulmonary aspergillosis: a case series from Mexico City
Favorite
357 -
Complications and Outcomes of Obese Patients Hospitalized with COVID-19
Favorite
358 -
Sociodemographic and clinical features of children and adolescents with SARS-CoV-2 infection in Nashville, Tennessee
Favorite
360 - A Case Control Study of COVID-19 in Patients with End Stage Renal Disease (ESRD)
Favorite
361 - A Case Control Study of COVID-19 Outcome in Patients with HIV
Favorite
362 - A Modified Early Warning Score Predicts Decompensation in COVID-19 Patients
Favorite
363 - Acute Kidney Injury and Renal Replacement Therapy in Hospitalized COVID-19 Patients in the United States and Other Geographic Regions
Favorite
364 - Baseline characteristics, comorbidities, and outcomes of COVID-19 patients hospitalized in Southwest Georgia, U.S. – an interim analysis of an early hot spot
Favorite
365 - Characteristics and outcomes of COVID-19 patients admitted to a regional health system in the southeast
Favorite
366 - Characteristics and Outcomes of COVID-19 Patients with Fungal Infections
Favorite
367 - Clinical Characteristics and Outcomes in Patients with Pneumonia secondary to Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)
Favorite
369 - Clinical Characteristics of the First 177 Patients Admitted with COVID-19 at a Bronx Community Hospital
Favorite
370 - Clinical Features and Outcomes of COVID-19 Infection Among Cancer Patients in Seattle, Washington
Favorite
371 - Cluster of carbapenemase-producing Enterobacterales secondary infections during the COVID-19 crisis at a New York City hospital
Favorite
372 - Comparing the Outcome of COVID-19 in Cancer and Non-Cancer Patients: an International Multicenter Study
Favorite
373 - Comparison of the Epidemiology and Pathogens Cultured from Patients Hospitalized with SARS-CoV-2 Positive versus SARS-CoV-2 Negative in the US: A Multicenter Evaluation
Favorite
374 - Complication with Bacterial Pneumonia in Hospitalized Patients with Coronavirus Disease 2019 (COVID-19)
Favorite
375 - COVID 19 infection in a Massachusetts community hospital.
Favorite
377 - Diabetes as a prognostic factor for mortality in Coronavirus Disease 19 (COVID-19): a systematic review and meta-analysis comprising 18,506 patients
Favorite
378 - E-cigarette or Vaping Associated Lung Injury in the Time of COVID-19
Favorite
379 - Epidemiology of Antimicrobial Use Among SARS-CoV-2 Positive and Negative Admissions in the US: A Multicenter Evaluation
Favorite
380 - First Reports of Salivary Gland Involvement in Corona Virus Disease 2019
Favorite
381 - HIV Patients with COVID-19 Hospitalized in a Tertiary Care Center in Mexico City
Favorite
382 - Incidence of Hospital-Acquired and Ventilator-Associated Pneumonia in Patients with Severe COVID 19 on High Flow Oxygen
Favorite
383 - Increased Need for Antimicrobial Stewardship during a COVID-19 Outbreak in New York City
Favorite
384 - Invasive aspergillosis in COVID-19 patients in an intensive care unit in Mexico City
Favorite
385 - Kawasaki's Disease and Sars-Cov-2: an Unexpected Pediatric Global Crisis?
Favorite
386 - Long-term Complications Associated with COVID-19 Infection
Favorite
387 - Markers for Mortality in COVID-19 Patients with Atrial Fibrillation or Flutter
Favorite
388 - Multidrug Resistant Gram Negative Organisms Prevalence in Hospitalized Patients in an Italian Tertiary Level Hospital During COVID-19 Pandemia: First Detection is More Frequent in Clinical Samples than in Surveillance Rectal Swabs with Respect to the Previous 14-Month Period
Favorite
389 - Neutrophil-lymphocyte index, platelet-lymphocyte index and systemic inflammation-immunity index in patients with Covid-19 pneumonia in Veracruz, Mexico.
Favorite
390 - Non-invasive Detection of Co-infections in Hospitalized Patients with COVID-19 using the Karius Test, A Plasma-based Next-Generation Sequencing Test for Microbial Cell-free DNA
Favorite
391 - Outcomes of Empiric Antimicrobial Therapy in COVID-19 Positive Patients
Favorite
392 - Predictors of Mortality in Hospitalized Patients with COVID-19; A Single Centered Retrospective Analysis.
Favorite
393 - Prevalence of HIV in Patients Hospitalized for COVID-19 and Associated Mortality Outcomes: A Systematic Review and Meta-analysis
Favorite
394 - Pseudo-outbreak of Coagulase-negative
Staphylococcus
Species from Blood Cultures Highlights Unique Challenges in Care of Critically Ill Patients With COVID-19
Favorite
395 - Rapid, Non-invasive Detection of Infection Using Plasma-based Next-Generation Sequencing for Microbial Cell-free DNA in Individuals Testing Negative for SARS-CoV-2 in a Pandemic Setting
Favorite
396 - Relationship Between Patient Characteristics and Critical Illness in Patients Admitted for CoVID-19
Favorite
397 - Respiratory Coinfections with COVID-19 in Veterans Health Administration (VA), 2020
Favorite
398 - Risk Factors Associated with Requiring Invasive Mechanical Ventilation in Patients with SARS-CoV-2 Infection: Experience in a Tertiary Care Hospital in Mexico City
Favorite
399 - Risk Factors for Mortality in COVID-19 Patients in a Community Teaching Hospital
Favorite
400 - Secondary Infections in COVID-19 Patients Receiving Tocilizumab in a Community Hospital
Favorite
401 - Short Term Outcomes in Multisystem Inflammatory Syndrome in Children (MIS-C) Related to COVID-19
Favorite
402 - Spontaneous pneumothorax in COVID-19
Favorite
403 - Study of early and late readmissions with COVID-19: A retrospective analysis
Favorite
404 - The occurrence of stroke in COVID-19
Favorite
405 - Trend in blood culture results in Washington DC during and prior to Pandemic COVID-19
Favorite
406 - Utility of Tracheal Aspirates in Guiding Antibiotic Use in Mechanically Ventilated Patients with COVID-19
Favorite
407 - Utilization of Blood Cultures, Risk factors and Outcomes of Bloodstream Infections in Patients Hospitalized with COVID-19
Favorite
COVID-19 Diagnostics
408 -
Evaluation of the negative predictive value of the SARS-CoV-2 PCR respiratory assays in asymptomatic children undergoing surgery
Favorite
409 -
Rapid Development of a Multiplexed PCR Prototype Method that Offers a Syndromic Diagnostic Option by Integrating Severe Acute Respiratory Syndrome Coronavirus 2
(
SARS-CoV-2) Detection with Twenty-One Other Common Respiratory Pathogens
Favorite
411 - Application of a SARS-CoV-2-specific serologic assay for translational research and surveillance
Favorite
412 - Assessment and Capability of SARS-CoV-2 Detection in the Veterans Health Administration
Favorite
413 - Association of SARS-CoV-2 Genomic Load in Nasopharyngeal Samples with Adverse COVID-19 Patient Outcomes: A Retrospective Analysis from an Academic Hospital Center in New York City
Favorite
414 - Association of SARS-CoV-2 Genomic Load Trends with Clinical Status in COVID-19:A Retrospective Analysis from an Academic Hospital Center in New York City
Favorite
415 - Clinical Impact of Molecular Point-of-Care Testing for COVID-19 in Adults Presenting to Hospital: A Prospective, Interventional, Non-Randomised, Controlled Study
Favorite
417 - Comparative Assessment of Multiple SARS-CoV-2 Antibody and Neutralization Assays from Blood Samples in COVID-19 Infected Patients.
Favorite
418 - Comparison of the Abbott SARS-CoV-2 IgG and DiaSorin LIASON SARS-CoV-2 S1/S2 IgG Antibody Assays
Favorite
419 - Diagnostic Utility of a Ferritin to Procalcitonin Ratio to Differentiate Patients with COVID-19 from Those with Bacterial Pneumonia
Favorite
420 - Diagnostic Utility of Chest CT scan for COVID-19, in the Early Stage of the Pandemic in Brooklyn, New York
Favorite
421 - If at first you do not succeed…. Repeat SARS-COV2 PCR testing
Favorite
423 - SARS-CoV-2 NGS Assay Powered by Biotia COVID-DX Software
Favorite
424 - Sensitivity Results for the Abbott m2000 PCR Assay of SARS-CoV-2 at a Denver, Colorado Medical Center
Favorite
425 - The Utility of Paired Upper and Lower COVID-19 Sampling in Patients with Artificial Airways
Favorite
426 - Use of Real Time IP-10 Measurements to Identify and Monitor the Dysregulated Immune Response in COVID-19 Patients
Favorite
427 - Variation in SARS-CoV-2 molecular diagnostic test performance in symptomatic versus asymptomatic populations
Favorite
428 - Very High Clinical Likelihood (VHCL) Of COVID-19 Infection: Peering Beyond A Negative Nasopharyngeal Swab.
Favorite
COVID-19 Epidemiology and Screening
430 -
Frontline doctors infected with Covid-19 during a hospital outbreak in Veracruz, Mexico.
Favorite
432 -
High concordance between self-collected nasal swabs and saliva samples for detection of SARS-CoV-2
Favorite
433 -
Mathematical Modeling of COVID-19 Transmission by a k Phases SEIR Model
Favorite
434 -
Tracking COVID-19 in Real Time: Leveraging Public Data Sources to Inform Infection Prevention Practices
Favorite
436 - Assessing SARS-CoV-2 Infection among Persons Experiencing Homelessness — Atlanta, GA, 2020
Favorite
437 - Asymptomatic Healthcare Worker COVID-19 Testing Program
Favorite
439 - Clinical Characteristics and Mortality of an Initial Cohort of COVID-19 Patients in México City.
Favorite
441 - Clinical Characteristics of Pediatric SARS-CoV-2 Infection and Coronavirus Disease 2019 (COVID-19) in Kuwait
Favorite
442 - Common symptoms of outpatient COVID-19 compared to non-COVID-19 Cases: A prospective epidemiologic study in a major US metropolitan area
Favorite
443 - Comparison of Clinical Characteristics of Endemic vs. SARS-CoV-2 Coronavirus Infection in Patients Admitted to a Community Teaching Hospital
Favorite
444 - Coronavirus Disease 2019 (COVID-19) Among Healthcare Workers in Southeast Michigan
Favorite
446 - COVID 19 Pandemicity: a global situation report as of June 9, 2020
Favorite
447 - COVID-19 Prevalence Among COVID-19 Exposed Health Care Workers at a Tertiary Care Center in San Bernardino County, Ca.
Favorite
448 - Disproportionate Burden of COVID-19 on Latinx Residents among Hospitalized Patients at San Francisco’s Public Health Hospital
Favorite
450 - Evaluating First Responders for SARS-CoV-2 Infection in Broward County, Florida
Favorite
451 - Evaluation of Exposure History in Healthcare Personnel with Coronavirus 2019 Disease
Favorite
452 - Familial Cluster of COVID-19 Cases Associated with High Prevalence of Anosmia, Ageusia, and Gastrointestinal Symptoms
Favorite
453 - Frequency of Symptoms and Asymptomatic SARS-CoV-2 Infection in New Orleans, Louisiana
Favorite
454 - Healthcare Workers with COVID-19 infection: Experience from a Designated COVID-19 Clinic
Favorite
455 - Hepatic Laboratory Abnormalities Associated with Disease Severity in Patients with
COVID-19
: A Pooled Analysis of 6 Retrospective Cohort Studies Including 755 Patients
Favorite
456 - Implementing an At-Home Smell Test for Early Assessment of COVID-19 in High-Risk Healthcare Workers
Favorite
457 - Low Rates of COVID-19 in a Vulnerable Population: Learning from Early and Decisive Public Health Policies
Favorite
458 - Molecular SARS-CoV-2 Testing During the COVID-19 Outbreak: Experiences of a Hospital in Southeast Michigan, USA
Favorite
459 - Outcomes and Factors Associated with a SARS-CoV-2 Positive Test in Asymptomatic and Symptomatic Healthcare Workers of a Mexican Hospital Converted to Treat COVID-19 Patients.
Favorite
460 - Point-of-Care, In-Home SARS-CoV-2 IgG Antibody Testing to Assess Seroprevalence in At-Risk Health Care Workers
Favorite
461 - Presentation and Demographics of Veterans Tested for COVID-19 Infection
Favorite
462 - Prevalence and Outcome of Asymptomatic Procedural Patients with COVID-19 Infection
Favorite
464 - Rapid whole genome sequence typing reveals multiple waves of SARS-CoV-2 spread
Favorite
465 - Risk Factors Associated with Critical COVID-19 Requiring Mechanical Ventilation
Favorite
466 - SARS-CoV-2 Diagnosis And Point Prevalence in a Non-Cohorted Tertiary Care Center
Favorite
470 - The Effects of Arrival Quarantine on Subsequent COVID-19 Testing in a Cohort of Military Basic Trainees
Favorite
472 - The Utility of Infectious Diseases E-consults in the Era of COVID-19
Favorite
473 - Using Serosurveillance for SARS-CoV-2 to Conserve PCR Tests in a Resource Constrained Combat Environment
Favorite
474 - Using telemedicine to provide virtual care for COVID-19 patients at home
Favorite
COVID-19 Global Response/Response in Low Resource Settings
475 - Describing the impact of the COVID-19 pandemic on HIV care in Latin America
Favorite
476 - Gilead Sciences’ Commitment to the COVID-19 Pandemic
Favorite
477 - Implementing a Follow-up Call Program for Ambulatory patients with COVID-19 in a Tertiary Center in Mexico City
Favorite
478 - Psychological Distress among Infectious Disease Physicians during the Response to the COVID-19 Outbreak in the Republic of Korea
Favorite
COVID-19 Impact of Social Distancing/Mitigation Measures
479 -
Mobility Restrictions and COVID-19 Pandemic Outbreak Control
Favorite
480 -
Outbreak of COVID-19 Among School Auction Attendees: Was it a “Silent Auction” or “Silent Transmission”?
Favorite
481 - Epidemic – Pandemic Impacts Inventory (EPII) Survey Results for Persons Living with HIV in Chicago’s West and Southwest Communities
Favorite
482 - Impact of COVID-19 Pandemic on Psychosocial and Clinical Factors among people with and without HIV living in Miami
Favorite
483 - OPAT Delivery during COVID-19
Favorite
484 - The Impact of SARS-CoV-2 on Reproduction Rates of Seasonal Influenza and RSV
Favorite
485 - Title: The Porous Boundaries Between Communities and Correctional Facilities: The Introduction of a Medical Recovery Site Resulting in Reduced COVID-19 Household Transmission Tied to Recently Incarcerated Individuals
Favorite
486 - Understanding Public Perception of COVID-19 Social Distancing on Twitter
Favorite
COVID-19 Infection Prevention
487 -
Patient Outcomes of Contact Tracing for COVID-19 in a Pediatric Hospital
Favorite
488 -
SARS-CoV-2 Preparedness among Community Hospitals in Southeastern United States
Favorite
490 - A Randomized Crossover Study to Evaluate Interventions to Reduce Contamination during Reuse of N95 Respirators
Favorite
491 - Aerosol-Generating Medical Procedures: Transmission of SARS-CoV-2 and Emerging Viruses
Favorite
492 - Canadian consensus of COVID-19 policy and management aspects
Favorite
493 - Clinical and Epidemiological Features of Healthcare Workers Detected with Coronavirus Disease
Favorite
494 - COVID-19 Outbreak: A Tale of Two Psych Units
Favorite
495 - Effectiveness of Personal Protective Equipment in Preventing Transmission of COVID-19 in Healthcare Workers
Favorite
496 - Higher SARS-CoV-2 RT-PCR Cycle Threshold (Ct) Values Associated with Longer Symptom Duration Among Patients Hospitalized with COVID-19
Favorite
497 - Impact of a customized travel and exposure screening tool during the COVID-19 pandemic
Favorite
498 - Impact of COVID-19 on UK Foundation Doctors: Education and Safety
Favorite
499 - Infection with Coronavirus Disease 19 (COVID-19) in Healthcare Personnel with Exposure to COVID-19
Favorite
500 - Novel Use of a Targeted Ultraviolet Light Device for the Decontamination of a Single-Use Filtering Facepiece Respirator
Favorite
501 - Serum IgG Antibody Testing Against Severe Acute Respiratory Syndrome Coronavirus 2 in Healthcare Workers
Favorite
502 - The Impact of Combating COVID-19 on Blood Culture Contamination and Central Line Associated Bloodstream Infection Rates
Favorite
504 - Transmission of SARS-CoV-2 to Household Members of COVID Positive Healthcare Workers
Favorite
505 - Use of CLABSI Prevention Bundle Audits to Decrease CLABSI Rates in COVID Positive ICU Patients in an Acute Care Hospital in New York City During the COVID-19 Epidemic
Favorite
506 - Variation in Occupational Activities and Infection Prevention Practices in Healthcare Personnel Based on Exposure to COVID-19 Units
Favorite
COVID-19 Pathogenesis
507 - Activation of Macrophages Enhances Susceptibility to SARS-CoV-2 Antibody-Dependent Enhancement and Promotes Damage to Downstream Epithelial Cells
Favorite
508 - Biomarker elevation during COVID-19: Differences between ambulatory and hospitalized individuals
Favorite
509 - Comparision of CD4+ T Cells in Patients with Severe vs Critical COVID -19
Favorite
510 - Elevated IL-1β level as a predictor of inflammation and death in COVID-19
Favorite
511 - Hospitalized COVID-19 Patients with Elevated Cardiac Troponin I Have Increased Length Of Stay But Similar Ventilation Time
Favorite
512 - Kinetics of SARS-CoV-2 IgG responses among hospitalized patients with COVID-19
Favorite
513 - Viral kinetics of SARS-CoV-2 in patients with COVID-19
Favorite
COVID-19 Research
514 -
Clinical features and outcomes of 112 patients with SARS-CoV-2 infections requiring intensive care in a public healthcare system in South Florida
Favorite
515 -
Risk Factors for Death, Intubation and Cardiac Arrest among COVID-19 Patients Hospitalized in Eastern North Carolina
Favorite
516 -
SARS-CoV-2 Exhibits Clade-specific Differences in Nasopharyngeal Viral Loads
Favorite
517 - Association of the predictive risk scores of CALL points and COVID-GRAM with IL-6, duration of oxygen therapy, D-dimer among patients with COVID-19
Favorite
518 - Factors Associated with Severe COVID-19 among Patients Hospitalized in Rhode Island
Favorite
519 - Immune responses and COVID-19 severity
Favorite
520 - Longitudinal Analysis of SARS-CoV-2 Viruses in Hospitalized Adults
Favorite
521 - Similarities and Differences in Transcriptomic Host Response between SARS-CoV-2 and Other Viral Infections
Favorite
522 - The Simple and Novel SAS Score to Predict Mortality at Presentation in 2541 Hospitalized COVID-19 Patients
Favorite
COVID-19 Special Populations
523 -
COVID-19 Preparedness in Hospice and Palliative Care
Favorite
524 -
COVID 19
Infection in Pregnant Women and Newborn Infants at a Single U.S. Center: What Disparities, Testing and Isolation Practices can Teach Us.
Favorite
525 - Characteristics of HIV SARS-COV-2 Coinfection in a Highly HIV Seropositive Population in New York City
Favorite
526 - Clinical Presenting Characteristics of Pediatric COVID-19 Infection in a Tertiary Care Children’s Hospital in Detroit
Favorite
527 - Corona Virus Disease-19 (COVID-19) in a Veterans Affairs Hospital at Suffolk County, Long Island, New York
Favorite
528 - Coronavirus Disease 2019 in Children Cared for at Texas Children’s Hospital: Implications of Repeat Testing on Infection Control Strategies
Favorite
529 - COVID-19 Antibody Responses in Solid Organ Transplant Recipients
Favorite
530 - COVID-19 in kidney transplant recipients: Single-center experience and case-control study
Favorite
531 - COVID-19 infection outcome in African American Renal Transplant recipients: Detroit Medical Center experience
Favorite
532 - COVID-19 Pneumonia in Patients with Hematologic Malignancies – A Report from the US Epicenter
Favorite
533 - Demographic and Prognostic Indicators in COVID-19 Patients with ESRD: A Single Center Retrospective Study
Favorite
534 - Halting a SARS-COV2 Outbreak in a Veterans Affairs Nursing Home.
Favorite
535 - Harm reduction strategies and positive behaviors of medical providers in mitigating the effects of COVID-19 among HIV-infected children and HIV-exposed infants
Favorite
536 - HIV Patients with COVID-19 in the Bronx: A Retrospective Cohort Study
Favorite
537 - Outpatient Parenteral Antimicrobial Therapy Readmissions from Post-Acute Care Facilities due to Coronavirus Disease 2019
Favorite
538 - Percent Positivity of COVID-19 Testing in Children of Racial/Ethnic Minority Groups in Mississippi
Favorite
539 - Prevalence of Symptomatic and Asymptomatic COVID-19 Infection in Pregnant Women and Their Infants in an Urban Hospital
Favorite
540 - Prolonged Viral Shedding of SARS-CoV-2 In Solid Organ Transplant Recipients
Favorite
541 - Rapid Migration to Telemedicine in a Boston Community Health Center is Associated with Maintenance of Effective Engagement in HIV Care
Favorite
543 - SARS-CoV-2 Viral Dynamics For Symptomatic People Living with HIV Requiring Hospitalization For COVID-19
Favorite
545 - The Impact of COVID-19 on African Americans’ Health Attitudes and Information Seeking Behavior
Favorite
COVID-19 Treatment
546 -
Capturing Clinician’s Experiences Repurposing Drugs to Inform Future Studies During COVID-19
Favorite
547 - A Retrospective Cohort Study of Treatment Patterns and Clinical Outcomes in Patients with COVID-19
Favorite
548 - Baseline characteristics associated with clinical improvement and mortality in hospitalized patients with moderate COVID-19
Favorite
549 - Clinical Characteristics and Outcomes of Patients with COVID-19 treated with Convalescent Plasma in Miami, Florida
Favorite
550 - Clinical impact of Tocilizumab therapy in SARS-CoV-2 respiratory infections in ICU and non-ICU patients
Favorite
551 - Convalescent plasma early in disease course improves survival in COVID-19
Favorite
552 - Could Anticoagulant Use Prior to Infection with COVID-19 Decrease Mortality?
Favorite
553 - Critically Ill patients Receiving Tocilizumab Compared With Those Not Receiving Tocilizumab for Treatment of COVID-19
Favorite
554 - Early Clinical Outcomes with Tocilizumab for Covid-19: A Two-Center Retrospective Study
Favorite
555 - Effectiveness of a Treatment Team on Adherence to Health System Guidelines for Hydroxychloroquine Use During Two Phases of the COVID-19 Epidemic
Favorite
556 - Evaluation of Hydroxychloroquine-based Combination Therapies for the Treatment of COVID-19
Favorite
557 - Impact of Concomitant Hydroxychloroquine Use on Safety and Efficacy of Remdesivir in Moderate COVID-19 Patients
Favorite
558 - Innovative CME Tools in the Teaching of Evolving Strategies in the Management and Prevention of COVID-19
Favorite
559 - Outcomes of Convalescent Plasma Transfusion for SARS-CoV2 Patients in the Intensive Care Unit
Favorite
560 - Repurposing Eravacycline for the Treatment of SARS-CoV-2 Infections
Favorite
561 - Safety of Remdesivir vs Standard Care in Patients with Moderate Covid-19
Favorite
562 - Tocilizumab for the Treatment of Severe COVID-19: A Retrospective, Multi-Center, Case-Matched Series
Favorite
563 - Tocilizumab in the Treatment of Critical COVID-19 Pneumonia
Favorite
564 - Tocilizumab Induces Rapid, Sustained Improvement of Inflammatory Markers in COVID-19.
Favorite
565 - Tocilizumab Use in COVID-19: Act(emra) to
Inhibit
Intubation and Decompensation
Favorite
566 - Tocilizumab: A Friend or a Foe in COVID-19 Management?
Favorite
Diagnostics: Bacteriology/mycobacteriology
640 -
Analytical Validation of the BioFire
®
Bone and Joint Infection (BJI) Panel for the Identification of Bacteria, Yeast, and Antimicrobial Resistance Genes from Synovial Fluid
Favorite
642 -
Trends and cost burden of
Legionella
urine antigen test
Favorite
644 -
Borrelia miyamotoi
and
Borrelia burgdorferi
Seroprevalence in New England
Favorite
645 - Absence of Toxemia in
Clostridioides difficile
infection: Results from Ultrasensitive Toxin Assay of Serum
Favorite
646 - Adapting the modified Carbapenem Inactivation Method to assess for possible beta-lactamase mediated resistance in Piperacillin-Tazobactam resistant/ Ceftriaxone susceptible Escherichia. coli and Klebsiella pneumoniae
Favorite
648 - BioFire
®
FilmArray
®
Pneumonia
plus
Panel Performance Evaluation: A Multicenter, International Collaborative Study
Favorite
650 - Clinical Performance Evaluation of Virtuo Blood Culture System in a Tertiary Care Hospital
Favorite
651 - Comparative Analysis Between Bacterial And Fungal Malignant Otitis Externa
Favorite
652 - Comparison of fosfomycin (FOF) activity and prevalence of subpopulations between
Escherichia coli
(EC) and
Klebsiella pneumoniae
(KP) during susceptibility testing
Favorite
653 - Comparison of Yeasts identification by Biofire, Culture and ePlex for Quality Assurance purpose
Favorite
654 - Core Antibiotic-Induced Transcriptional Signatures Reflect Susceptibility to All Members of an Antibiotic Class
Favorite
656 - Development and Application of a Pragmatic Algorithm for the Detection of Carbapenemase-Producing
Pseudomonas aeruginosa
(CP-PA)
Favorite
657 - Diagnostic Utility of Dedicated Fungal Blood Cultures for Diagnosis of Candidemia
Favorite
658 - Effect of HIV Status on Tuberculosis Load as Detected by Xpert MTB/RIF in Sputum vs. Saliva Samples
Favorite
659 - Evaluation of Four Chromogenic Agars for Urine Culture Including Time and Cost Savings Analysis
Favorite
660 - Evaluation of Qvella’s FAST-Prep™ Liquid Colony™ for Early Antimicrobial Sensitivity Testing of Positive Blood Culture by Disk Diffusion Method
Favorite
661 - Futility of Bacterial Bone Marrow Cultures: Experience over a 19 Year Period
Favorite
662 - Identification of Clinically Relevant Microbes with the MasSpec Pen
Favorite
663 - Improved Detection of ESBL and AmpC Beta-Lactamase Producing Isolates of
Enterobacteriaceae
in Pediatric Patients with Bloodstream Infections Using Combined Genotypic and Phenotypic Antimicrobial Susceptibility Testing
Favorite
664 - LiaX as a Surrogate Marker of Daptomycin Susceptibility in Multidrug-Resistant
Enterococcus faecium
Recovered from Cancer Patients
Favorite
665 - Lower Indeterminate Rates and Resolution by Retesting Using a Single Lithium-Heparin Tube Blood Collection Method for the QuantiFERON
®
-TB Gold Plus (QFT
®
-Plus)
Favorite
666 - Microbial Cell-Free DNA Sequencing for Evaluation of Response to Antibiotic Therapy in Patients with Relapsed or Refractory Leukemia
Favorite
667 - Multicenter Assessment of
Enterobacterales
,
Salmonella
spp. and
Pseudomonas aeruginosa
Using Updated CLSI Levofloxacin Breakpoints on MicroScan Dried Gram Negative MIC Panels
Favorite
668 - Rapid Identification and Antimicrobial Susceptibility Testing of Gram-Negative Rod Bacteremia: Impact on Duration of Hospital Admission
Favorite
669 - Rapid Molecular Testing of Sputum for Identification of Pulmonary Tuberculosis: Impact on Duration of Respiratory Isolation
Favorite
670 - Rapid, Non-invasive Detection of Invasive
Mycoplasma hominis
Infection using the Karius Test, A Next-Generation Sequencing Test for Microbial Cell-free DNA in Plasma
Favorite
671 - Same Day Identification of
Enterobacteriaceae
Directly from Urine Samples
Favorite
672 - The Pediatric Endotracheal Aspirate Culture Survey (Petacs): Examining Practice Variation Across Pediatric Microbiology Laboratories in the United States
Favorite
673 - Updated CLSI Ciprofloxacin Breakpoints from a Multicenter Assessment for
Enterobacterales
,
Salmonella
spp. and
Pseudomonas aeruginosa
Using MicroScan Dried Gram Negative MIC Panels
Favorite
674 - Variations in Agreement and Epidemiological Cutoff Value (ECV) between Fosfomycin (FOF) Agar Dilution and Broth Microdilution Using Standard- and High-Inoculum Protocols for
Klebsiella pneumoniae
(KP)
Favorite
Diagnostics: Typing/sequencing
677 - Plasma Metagenomic Next Generation Sequencing Assay for Identifying Pathogens: A Retrospective Review of Test Utilization in a Large Children’s Hospital
Favorite
679 - Predominance of
Acinetobacter baumannii
Sequence Type 2 (ST2) among Clinical Isolates from Two Detroit Hospitals using Whole Genome Sequencing
Favorite
680 - The Use of Plasma Next-Generation Sequencing Test in the Management of Immunocompetent and Immunocompromised Patients – A Single Center Retrospective Study
Favorite
Diagnostics: Virology
681 -
Induction Immunosuppression Selection in People Living with HIV Undergoing Deceased Donor Kidney Transplantation: U.S. National Trends from 2000 to 2018
Favorite
682 -
Is There a Role for the Early Use of Tocilizumab and Interleukin-6 Levels in the Management of SARS-CoV-2 Patients with Early Respiratory Failure?
Favorite
684 -
The impact of rapid molecular respiratory testing on provider and parental decision making for children with respiratory illness evaluated in an ED setting
Favorite
685 - Comparison of Singleplex qPCR and the Luminex MAGPIX Platform for the Detection of Viral Pathogens
Favorite
686 - Elevations in TNFα and IL-18 are Associated with Increased Risk of Probable Cytomegalovirus Tissue Invasive Disease in Solid Organ Transplant Recipients
Favorite
687 - Iatrogenic Kaposi's Sarcoma Following Treatment with Vedolizumab
Favorite
688 - Marginal Structure Models to Estimate the Effect of Cytomegalovirus Infection on Hospitalization Among Children Undergoing Allogeneic Hematopoietic Cell Transplantation
Favorite
689 - Nasal versus Nasopharyngeal Sample Collection for Diagnostic Nucleic Acid Amplification Testing for Influenza A, Influenza B, and Respiratory Syncytial Viruses
Favorite
690 - Oka-Strain Varicella-Zoster Virus Meningitis in a Healthy Adolescent.
Favorite
691 - Results of Repeat HIV-1 DNA Resistance Tests Are Highly Concordant
Favorite
692 - Secondary Infections and Coinfections in Coronavirus Disease 2019 (COVID-19)
Favorite
693 - Shaking Things Up: Direct-to-PCR Viral Detection off Swabs Using Shaker-Mill Homogenization
Favorite
694 - Unexpected Diversity of Rotavirus Genotypes in Pediatric Population
Favorite
Endocarditis
695 -
Infective endocarditis in people who inject drugs (PWID) at UK Medical Center
Favorite
696 -
Bartonella quintana
Endocarditis, A Case Series
Favorite
697 - 8 Years of Characteristics and Outcomes of Patients with MRSA Endocarditis Based on Vancomycin Minimum Inhibitory Concentration: Experience at a Tertiary Care Hospital
Favorite
698 - 8 Years of Infective Endocarditis in Intravenous and Non-Intravenous Drug Users a Single Center Experience
Favorite
699 - A Retrospective Review of the Progression of Cardiac Vegetations with treatment
Favorite
700 - Ampicillin-Ceftriaxone Versus Ampicillin-Gentamicin for Definitive Therapy of
Enterococcus faecalis
Infective Endocarditis: A Propensity Score-Matched,Retrospective Cohort Analysis
Favorite
701 - Blood Stream Infection And Risk Of Endocarditis Following Cardiac Valve Repair: A Population-Based Study
Favorite
702 - Characteristics of Infective Endocarditis (IE) and Predictors of 90-day Mortality Among People Who Do and Do Not Inject Drugs with IE in Seattle, Washington
Favorite
703 - Do Patients with Drug Use-Associated Infective Endocarditis Receive Differential Care?
Favorite
704 - Evaluation of Risk Factors and Outcomes of Early Left Ventricular Assist Device Infections
Favorite
705 - Factors Associated with Local Invasion in Infective Endocarditis: a Nested Case-control Study
Favorite
706 - Impact of Infectious Disease Consultation on Management and Clinical Outcomes of Infective Endocarditis: Results of an interrupted time series analysis
Favorite
707 - Infective Endocarditis and Medication Assisted Treatment in Opioid Use Disorder
Favorite
708 - Infective Endocarditis Complicating Delivery in Pregnancy: Risk Factors, Complications, and Delivery Outcomes
Favorite
709 - Multidisciplinary Drug Use Endocarditis Team (DUET): Results From an Academic Center Cohort
Favorite
710 - Non-invasive Diagnosis of Whipple Endocarditis Using Next-Generation Sequencing for Microbial Cell-free DNA in Plasma
Favorite
711 - Rapid, non-invasive detection and monitoring of
Bartonella quintana
endocarditis by plasma-based next-generation sequencing of microbial cell-free DNA
Favorite
712 - Risk of Infective Endocarditis after Transcatheter Aortic Valve Replacement in Patients with Bloodstream Infection: A Population-Based Study
Favorite
Enteric Infection
714 -
Increase in Multidrug-resistant
Salmonella
Serotype I 4,[5],12:i:- Infections Linked to Pork—United States, 2009–2018
Favorite
715 - A 79 year old Female with Bloody Diarrhea and Hypovolemic Shock: Keep the Differential Diagnosis Open
Favorite
716 - A Case of Symptomatic Intestinal Spirochetosis
Favorite
717 - Antibiotic treatment of Shiga toxin-producing
Escherichia coli
related gastroenteritis and the risk of hemolytic uremic syndrome: a population based matched case-control study in Japan
Favorite
718 - Asymptomatic campylobacteriosis as a risk factor for developing acute neurological syndromes in Veracruz, Mexico
Favorite
719 - Clinical Outcomes of Single versus Double Anaerobic Coverage for Intra-abdominal Infections
Favorite
720 - Clinical Performance of Film Array Gastrointestinal Pathogen Panel in Diarrhea
Favorite
721 - Effect of Gastrointestinal Pathogen Panel (GIP) in Antibiotic Management
Favorite
722 - Effectiveness of Fidaxomicin versus Oral Vancomycin in the Treatment of Recurrent
Clostridioides
difficile
Favorite
723 - Epidemiology, Risk Factors, and Treatment Considerations for Pyogenic Liver Abscess (PLA) in the Calgary Health Zone (CHZ) Revisited: A Population-Based Study.
Favorite
724 - Gastrointestinal (GI) PCR vs Stool Cultures: Impact on Length of Hospital Stay (LOS) and Antibiotic Use
Favorite
725 - Influence of An Emerging Pathogen,
Streptococcus anginosus,
on Clinical Outcomes in Pediatric Appendiceal Abscess
Favorite
726 - Investigation of Epidemiological Characteristics and Outcomes in Enteropathogenic
Escherichia coli
positive patients
Favorite
727 - Outcomes of Antibiotic Use in Ischemic Colitis
Favorite
728 - Prophylactic Vancomycin Therapy in Long Term Care Patients Colonized with
Clostridioides difficile
to Reduce Hospital-Acquired
C
.
diff
Infection
Favorite
729 - Real World Efficacy of Bezlotoxumab for Prevention of
Clostridioides Difficile
Recurrence in Immunosuppressed Patients
Favorite
730 - Severity Of
Clostridioides
difficile
Infection Based On Toxin Analysis, Acid Suppressant Medications and Antibiotics.
Favorite
731 - The Emergence of Mobile Colistin Resistance (
mcr
) Genes among Enteric Pathogens in the United States — 2008–2019
Favorite
Eukaryotic Diagnostics
733 -
Ibrexafungerp Demonstrates Potent and Consistent
In Vitro
Activity Against >400 Global
Candida auris
Isolates, Including isolates with Elevated MIC’s to Echinocandins
Favorite
735 -
Trends and Cost Analysis of Aspergillus Galactomannan testing at a Tertiary Medical Center.
Favorite
736 -
Babesia microti
: A study of 38 cases
Favorite
737 - A Descriptive Analysis of Fluconazole Utilization at Two Academic Medical Centers in the Valley Fever Corridor of Arizona
Favorite
738 - A Novel Molecular Diagnostic Assay for Identification of Fungal Pathogens
Favorite
739 - A Two-Center Assessment of Histopathologic Diagnostic Performance for Fungal Organism Identification
Favorite
741 - Antifungal Resistant
Candida
glabrata
Are Most Commonly Colonized in
Clostridioides difficile
Infection (CDI) Patient Guts in Texas
Favorite
742 - Breakthrough Invasive Fungal Infections with Isavuconazonium Sulfate versus Voriconazole as Primary Antifungal Prophylaxis in Patients with Acute Myeloid Leukemia (AML) who Received Induction Chemotherapy
Favorite
743 - Characteristics of Candidemia in a Coccidioidomycosis Endemic Region: The impact of Increased Azole Use in the Selection of
Candida
species
Favorite
744 - Clinical Performance of Real-time PCR in the Diagnosis of
Pneumocystis jirovecii
Pneumonia compared with Immunofluorescence Assay
Favorite
745 - Combination Treatment of Liposomal Amphotericin B and Isavuconazole is Synergistic in Treating Experimental Mucormycosis
Favorite
746 - Comparing Hospital Course in Hospitalized Patients Infected with Babesiosis Versus Patients Coinfected with Lyme Disease and Babesiosis
Favorite
747 - Diagnostic Performance of Bronchoalveolar Lavage Fluid Galactomannan Assay in Patients with Negative Serum Galactomannan Assay Suspected with Invasive Pulmonary Aspergillosis
Favorite
748 - Epidemiology and Outcomes of Invasive Fungal Infections Following Civilian Trauma
Favorite
749 - Impact of Infectious Disease Consultation in Patients with Candidemia: A Retrospective study, Systematic Literature Review and Meta-analysis
Favorite
750 - Isavuconazole Cerebrospinal Fluid Concentration in Refractory Coccidioidal Meningitis - A Three-Patient Case Series
Favorite
751 - Karius Cell-Free DNA Metagenomic Assay of Plasma Detects Pulmonary and Disseminated
Trichosporon
Infections in Patients with Hematological Malignancies
Favorite
752 - Management of 20 Patients Diagnosed with Posaconazole-Induced Pseudohyperaldosteronism
Favorite
753 - Performance Characteristics of Diagnostic Assays in Blastomycosis
Favorite
754 - Performance Characterization of a Real Time PCR Assay for
Pneumocystis jirovecii
in Bronchoalveolar Lavage Fluid and Sputum
Favorite
755 - Posaconazole versus voriconazole as antifungal prophylaxis for invasive fungal diseases in patients with hematological malignancies
Favorite
756 - Use Risk Factors to Early Screen Pneumocystis Pneumonia in Hospitalized Patients
Favorite
Global Health
757 -
Association between cumulative febrile, respiratory and diarrheal illness in the first year of life and neurodevelopmental and growth outcomes among a cohort of children in rural Guatemala.
Favorite
758 -
Epidemiology of Tick-Borne Encephalitis (TBE): A Traveler´s Perspective
Favorite
759 -
Where can we find active TB? Case finding at community sites and alcohol based venues (ABVs) in rural South Africa.
Favorite
760 - A Silent Threat: Seroprevalence of Chagas Disease in Latin Americans Living in Long Island, New York
Favorite
761 - Antimicrobial Resistance Trends at a Pediatric Hospital in Guatemala City, 2005-2019
Favorite
763 - Correlates of Antiretroviral Therapy Initiation Among Newly Diagnosed Older People with HIV in Ukraine
Favorite
764 - Correlates of Lost to Follow-up Among Newly Diagnosed Older People with HIV in Ukraine
Favorite
765 - Epidemiological And Clinical Features Of Rickettsiosis
Favorite
766 - Everything Old is New Again-A Case Series of New World Leishmaniasis in African Children in Portland, Maine
Favorite
767 - Identification and Management of Diarrhea in Children Under Five in Bamako, Mali
Favorite
768 - Malaria in a Non-Endemic Setting: A Retrospective Review of Malaria Hospitalisations in Ireland over a Four Year Period
Favorite
769 - Mortality Among Inpatients After the Initiation of ‘Treat All’ With Dolutegravir in Botswana
Favorite
770 - Otherwise Unavailable Non-Malarial Parasitic Disease Treatment Drugs in the United States: an Update from CDC Parasitic Diseases Drug Service
Favorite
771 - Prospective validation of the universal vital assessment (UVA) score to predict the in-hospital mortality of patients with acute illness admitted to a government district hospital in KwaZulu-Natal, South Africa
Favorite
772 - Respiratory Syncytial Virus Acute Respiratory Infections in Young Children in Jordan: A Prospective Surveillance Study
Favorite
773 - Screening for Chagas disease in East Boston, Massachusetts from 2017 – 2020 reveals 0.9% prevalence
Favorite
774 - Sexual Behaviors and Attitudes of Intimate Partners of Ebola Survivors
Favorite
775 - The Burden of Arboviral Infection in the Military Health System, 2011-2019
Favorite
776 - The prevalence of HIV among hospitalized persons with acute febrile illness in rural Uganda, August 2019-June 2020
Favorite
777 - Travel Destination, Demographics, and Underlying Medical Conditions Among Travelers Seeking Yellow Fever Vaccination at a Large Academic Medical Center in the U.S.
Favorite
778 - Travel-Acquired Tropical Illness in Children Under the Age of 5: A Scoping Review
Favorite
HAI: C. difficile
780 -
How Much Does Prior Hospitalization Contribute to Readmission with Community-onset Clostridioides difficile Infection?
Favorite
781 -
C.difficile
PCR+/ Toxin EIA- treat or not treat? A clinician survey
Favorite
782 -
Clostridioides difficile
environmental contamination in hospitalized patients with diarrhea: a pilot study
Favorite
783 -
Clostridioides difficile
Infection among Maintenance Hemodialysis Patients
Favorite
784 - A Novel Method to Assess Virulence of
Clostridioides difficile
: Focus on
C. difficile
Ribotype 106
Favorite
785 - Association between Prevalence of Laboratory-Identified
Clostridioides difficile
Infections (CDIs) and CDI Antibiotic Treatment in U.S. Acute Care Hospitals, 2018
Favorite
786 - Diagnostic stewardship of C difficile PCR testing with two step algorithm- A rural community hospital experience
Favorite
787 - Evaluation of
Clostridioides difficile
Environmental Contamination Surrounding
C. difficile
Patients vs. non-
C. difficile
Patients in Outpatient Infusion Centers
Favorite
788 - Evaluation of a Multiplex PCR Panel and Confirmatory Cytotoxin Testing on
Clostridioides difficile
at a Pediatric Hospital
Favorite
789 - Evaluation of Bezlotoxumab for Prevention of Recurrent
Clostridioides difficile
Infection in Patients at High Risk for Recurrence
Favorite
790 - Evaluation of Connecticut Medical Providers Concordance with 2017 IDSA/SHEA
Clostridioides difficile
Treatment Guidelines in New Haven County, 2017-2019
Favorite
791 - Evaluation of NSAID Exposure as a Risk Factor for
Clostridium difficile
infection: A Propensity-Score-Matched Case-Control Study
Favorite
792 - Evaluation of Persistent Diarrhea and Recurrence Following Fecal Microbiota Transplantation for Recurrent
Clostridioides difficile
Infection
Favorite
794 - Healthcare-Associated Urinary Tract Infection (HA-UTI): A Risk Factor for
Clostridioides difficile
Infection (CDI)? Results of a Real-World Data Analysis
Favorite
795 - Impact of Revised Infectious Diseases Society of America and Society for Healthcare Epidemiology of America Guideline on the Classification of
Clostridioides difficile
Infection Severity
Favorite
796 - Improving
Clostridioides difficile
Infection Treatment and Outcomes Using a Web-based Tool to Support a Care Coordination Intervention
Favorite
797 - Management of Patients with Multiple
Clostridioides difficile
Infection Recurrences using a Tapered-Pulsed Fidaxomicin Strategy
Favorite
798 - Metronidazole Exposure Prior to
Clostridiodes difficile
Infection (CDI) is a Risk Factor for Severe
C. difficile
Disease in Cancer Patients
Favorite
799 - Mini Root Cause Analysis Reveals Opportunities for Reducing
Clostridioides difficile
Infection Rates
Favorite
800 - Oral Vancomycin Prophylaxis Against
Clostridioides difficile
in Patients Admitted to a Tertiary Academic Medical Center
Favorite
801 - Patients with
Clostridioides difficile
Infection Following Dental Antibiotic Prescription
Favorite
803 - Risk factors associated with
Clostridioides difficile
infection in hospitalized patients with community-acquired pneumonia
Favorite
804 - Use of a Trained Canine to Detect
Clostridioides difficile
in the Hospital Environment
Favorite
HAI: Device-Associated (CLABSI, CAUTI, VAP)
805 - A Single Institution Pre/Post Comparison After Introduction of an External Urinary Collection Device for Female Medical Patients
Favorite
806 - Decreasing Central Line-associated Bloodstream Infections Through Quality Improvement Initiative on a High Acuity Transplant Unit
Favorite
807 - Effect of Inter-Hospital Transfer on Nosocomial Infection Rates in Patients Receiving Extracorporeal Membrane Oxygenation
Favorite
808 - Evaluating the Incidence of Bacteriuria in Female Patients Before and After Implementation of External Catheter Devices
Favorite
809 - Modified Laboratory Reporting to Prevent Catheter-Associated Urinary Tract Infections (CAUTIs)
Favorite
810 - Resistance to the Minocycline-Rifampin-Chlorhexidine (MRCH) combination does not emerge in biofilms of Tetracycline and Rifampin resistant bacteria grown on MRCH catheters depleted below antimicrobially effective concentrations
Favorite
811 - Utilizing IV team in Reducing the Central Line Associated Infections
Favorite
HAI: Disinfection/Sterilization & Environmental Infection Prevention
813 -
The Reduction of the acquisition rate of carbapenem resistant
Acinetobacter baumannii
after room privatization in the intensive care unit.
Favorite
814 - A Quasi-Experimental Study on Stethoscopes Contamination with Multidrug-Resistant Bacteria: Its Role as a Vehicle of Transmission
Favorite
815 - Biofilm Accumulation in New Flexible Gastroscope Channels within 30 Days in Clinical Use
Favorite
816 - Effectiveness of Aseptic Stethoscope Barriers in Allowing Clean Contact for
Clostridioides Difficile-
Contaminated Stethoscopes
Favorite
817 - Exploring Microbial Community Alterations during Hospital Animal-Assisted Intervention Programs
Favorite
818 - Healthcare Worker Feedback Regarding the Implementation of a New Disinfection Tracking System
Favorite
820 - Impact of pulsed xenon ultraviolet (PX-UV) light disinfection for reduction of pathogens on high touch surfaces following hospitalization
Favorite
821 - Portable Medical Equipment Disinfection: How often does it occur?
Favorite
822 - Structural Damage and Biofilm Accumulation on Patient-Ready Orthopaedic Implant (Least Used Cortical Screws), Acquired through Loaner System
Favorite
HAI: Epidemiologic Methods
823 -
How to Compare standardized Healthcare-associated Infection (HAI) Rates? Benchmark 2D and 3D
Favorite
825 - An Academic-Information Technology Partnership to Create an Infectious Diseases Translational Science Database
Favorite
826 - Comparative Epidemiological Analysis of
Serratia marcescens
using PFGE and Whole Genome Sequence Methods
Favorite
828 - Evaluation of Home Time as a Patient-Centered Metric for Pneumonia Hospitalizations: A Retrospective Cohort Study of Medicare Fee-For-Service Beneficiaries
Favorite
829 - Identification of Congenital Cytomegalovirus Infection Using Real-World Healthcare Data
Favorite
830 - The effect of a long-stay patient on transmission of a pathogen to shorter-stay patients in a small multi-bed hospital unit: Implications for infection control
Favorite
HAI: Gram-negatives (MDR-GNR)
831 - Analysis of a Worldwide Collection of
Klebsiella pneumoniae
CC258 with Reference to Carbapenemase Production Using the 1928 Core Genome (cg) Multilocus Sequence Type (MLST) Reveals Endemicity and Global Dissemination of Clones
Favorite
832 - Assessment of Risk Factors Associated with Wide-resistance Gram-negative Bacteria Infections
Favorite
833 - Characteristics and Utilization Patterns of Colistin Compared with Newer Agents in Gram-Negative Infections
Favorite
834 - Clinical Outcomes with Carbapenem-Resistant
Pseudomonas aeruginosa
that Retain Susceptibility to Traditional Antipseudomonal β-lactams: Atlanta, 2016-2018
Favorite
835 - Comparison of the outcomes of patients with KPC and NDM-1-producing
Enterobacteriaceae
Favorite
836 - Complete genome sequencing reveals a melting pot of diverse
Klebsiella pneumoniae
pathogens in two Detroit hospitals
Favorite
837 - Contamination of Hospital Drains by Carbapenemase-Producing Enterobacterales (CPE) in Ontario, Canada
Favorite
838 - Drivers of empiric carbapenem use: How important is history of extended-spectrum beta-lactamase (ESBL) infection?
Favorite
839 - Epidemiology of Extended-Spectrum Beta-lactamase (ESBL) Producing Enterobacteriaceae in the South East Tennessee, October-December 2017
Favorite
840 - First Report of
Pseudomonas aeruginosa
Isolates Harboring the CTX-M2 and PER genes in Algeria.
Favorite
841 - Frequency of carbapenemase-encoding genes among Imipenem-Resistant Gram-negative Bacilli isolated from Latin America: Is there a Role for Imipenem/Relebactam? Results from SMART 2017-2018
Favorite
842 - Impact of Active Treatment of Carbapenem-Resistant
Acinetobacter baumannii
Infections in US Hospitals Between 2014 and 2019
Favorite
843 - Increased Carbapenemase Testing Following Implementation of VA Guidelines for Carbapenem-Resistant
Enterobacteriaceae
(CRE)
Favorite
844 - Nosocomial
Pseudomonas aeruginosa
Blood-Stream Infections; Susceptibility Pattern and Mortality at a Tertiary Care Centre in Edmonton, Alberta, Canada
Favorite
845 - Trends and Regional Differences in Community-Onset Fluoroquinolone-Resistant
E. coli
in Hospitalized Adults in the United States
Favorite
846 - Trends in A
cinetobacter baumanii
Antibiotic Resistance Rates
Favorite
847 - Trends in S
tenotrophomonas
maltophilia
Antibiotic Resistance Rates
Favorite
848 - Trends of Carbapenem Resistance in Enterobacterales in the US Between 2015 and 2019
Favorite
849 - Whole Genome Sequencing Analysis of
Klebsiella pneumoniae
Isolates Reveals Diversity in Genetic Antibiotic Resistance Patterns.
Favorite
HAI: Gram-positives (MRSA, MSSA, VRE)
850 -
External Validation of the Methicillin-Resistant Staphylococcus aureus Bacteremia Score
Favorite
851 - Compliance with Guidelines for Management of
Staphylococcus aureus
Bacteremia and its Effect on Mortality
Favorite
852 - Genomic Clusters of Methicillin-Resistant
Staphylococcus aureus
(MRSA) Causing Bloodstream Infections (BSIs) in Hospitalized Adults, 2018-19
Favorite
853 - Hospital-acquired Infections by Vancomycin-Resistant
Enterococcus
(VRE): Results in 3 Years of Multicenter Study
Favorite
854 - Infection Prevention vs. Antimicrobial Stewardship: Does Nasal Povidone-Iodine Interfere with Methicillin Resistant
Staphylococcus aureus
(MRSA) Screening?
Favorite
855 - Significance of Invasive Infections due to Methicillin Sensitive
Staphylococcus aureus
in the neonatal population
Favorite
HAI: Hand Hygiene/Transmission-Based Precautions
856 - Assessment of Hand Hygiene amongst Health Care Professionals at Jimma University Medical Center
Favorite
857 - Contact Precautions as a Barrier to Hand Hygiene: PDSA to Improve Compliance with Gloved Hand Hygiene
Favorite
858 - Inter-rater Reliability of Hand Hygiene Observers with an Electronic Monitoring System
Favorite
859 - Remote Video Auditing (RVA) To Assess Personal Protective Equipment (PPE) Compliance In Rooms With
Clostridioides difficile
Patients
Favorite
HAI: Non-Bacterial (Fungal, Viral)
860 - A Proposed Standard for Hospital Bioaerosol Monitoring in Avoiding Nosocomial Mould Infections.
Favorite
861 - Evolution of Antifungal Use Over Fifteen Years in a Burn Intensive Care Unit
Favorite
862 - Impact of Caregiver Health on Pediatric Healthcare-Associated Viral Respiratory Infections (HAVRIs): A Retrospective Study.
Favorite
863 - Outcomes of Healthcare-Associated Respiratory Viral Infections in a Pediatric Hospital: A Historical Cohort Study
Favorite
864 - Whole Genome Sequencing is Unable to Track
Candida auris
Transmission
Favorite
HAI: Occupational Infection Prevention
865 -
Methicillin-resistant
Staphylococcus aureus
(MRSA) prevalence among healthcare workers (HCW) in contact tracings in a Dutch teaching hospital, 2010-2018
Favorite
866 - Assessment of Infection Control Training among Healthcare Workers in Three Tertiary Care Public Hospitals, Bangladesh, 2015-17
Favorite
867 - The Scope of a Weekly Infection Control Team Rounding in an Acute-care Teaching Hospital
Favorite
HAI: Outbreaks
868 -
Investigations of Healthcare-Associated
Elizabethkingia
Infections – United States, 2013-2019
Favorite
869 -
Outbreak of Vancomycin Resistant Enterococcus faecium (VREfm) in a Hematology Unit Identified Through Whole Genome Sequencing
Favorite
870 -
Mycobacterium chimaera
Outbreak: Infection Control and Clinical Experiences in Edmonton, Alberta
Favorite
871 - Assessment of the Wide-resistant
Pseudomonas aeruginosa
Outbreak at a University Hospital in Brazil: Have We Lost This War?!
Favorite
872 - Burden of Influenza Outbreaks in Long-Term Care Facilities in Philadelphia, 2012-2020
Favorite
873 - Clusters of Postpartum Group A
Streptococcus
(GAS) Infections on a Labor and Delivery (L&D) Unit June-October 2019
Favorite
874 - Pseudo-outbreak of Adenovirus in Bronchoscopy Suite
Favorite
875 - Pseudo-outbreak of C
lostridioides
(
Clostridium
)
difficile
amongst post-operative Oncology Patients
Favorite
877 - Use of Statistical Process Control Charts for Early Detection of Healthcare Facility-Associated Nontuberculous Mycobacterial Outbreaks
Favorite
HAI: Surgical Site Infections
878 - Antimicrobial Susceptibility of Pathogens Isolated from Surgical Site Infections in Japan: Comparison of Data from Nationwide Surveillance Studies Conducted in 2010, 2014–2015 and 2018-2019
Favorite
879 - Artificial Neural Networks to Predict Infection in the Surgical Site in Patients over 70 Years Old
Favorite
880 - Artificial Neural Networks to Predict Surgical Site Infection in Aorta Artery Aneurysm Correction
Favorite
881 - Efficacy of Antibiotic Prophylaxis with Vancomycin in Cardiothoracic Surgery
Favorite
882 - Evaluating the Risk Factors in Postoperative Infections Following Hysterectomy Procedures: Is Antibiotic Prophylaxis the Issue?
Favorite
883 - Evaluation of Post-operative Antibiotic Prophylaxis in Patients Undergoing Urologic Procedures
Favorite
884 - Evaluation of Surgical Site Infections in Solid Organ Transplant Recipients with Beta-Lactam Allergies
Favorite
885 - Feasibility of Observing Traffic Patterns (FOOT Patter) in Veterans Health Administration Operating Rooms
Favorite
886 - Impact of Type of Surgical Management on the Incidence of Recurrent Surgical Site Infections Following Hip and Knee replacements in Calgary, Alberta
Favorite
887 - Implementation of a Surgical Site Infection (SSI) Prevention Bundle: Patient Compliance and Experience
Favorite
888 - Improving outcomes with revised preoperative universal decolonization protocol
Favorite
889 - Improving patient compliance with preoperative universal decolonization to reduce surgical infection rate and costs
Favorite
890 - Incidence and Microbiology of Surgical Site Infection (SSI) after Breast Surgery
Favorite
891 - Is Post-discharge Surveillance of Surgical Patients Really Worth It? Results Observed in Three Years of a Multicenter Study
Favorite
892 - Meningitis after Ventricular Shunt Operations: Multicenter Study to Identify Etiology, Incidence and Risk Factors
Favorite
893 - Occurrence's Prediction of Surgical Site Infection in Limb Amputation Surgery
Favorite
894 - Patient and Surgery Characteristics on Wound Complication and Surgical Site Infection in Sarcoma Patients undergoing Hemipelvectomy
Favorite
895 - Prediction of Occurrence for Surgical Site Infection in Infected Surgeries
Favorite
896 - Prediction of Surgical Site Infection Risk in Patients Undergoing Bariatric Surgery
Favorite
897 - Prediction of Surgical Site Infections in Colon Surgery in Belo Horizonte Hospitals
Favorite
899 - Reduction of Surgical Site Infections Post Cesarean Section through Implementation of Novel Evidenced Based Bundle
Favorite
900 - Retrospective Review of Microbiological profile in Post Surgical Spine Infections and Assess the Appropriateness of Current Pre-Op Antibiotic Prophylaxis Policy
Favorite
901 - Risk Prediction for Surgical Site Infection in Patients Subject to Knee Arthroplasty Surgery
Favorite
902 - Selection of Antibiotics for Prophylaxis of Left Ventricular Assist Device Surgical Infections: More is Not More
Favorite
903 - SSI Trends in Community Hospitals from 2013 to 2018
Favorite
904 - Surgical Site Infection After Bariatric Surgery: a Small Risk that Defines Life and Death of Patients
Favorite
905 - Surgical Site Infections Following Colon Surgery in a Large Network of Community Hospitals
Favorite
906 - Surgical Site Infections in Children with Beta-Lactam Allergy: A Matched Cohort Study
Favorite
907 - Technology and Medicine: Prediction of Surgical Site Infection in Clean Surgeries using Artificial Neural Networks
Favorite
HAI: Surveillance
908 -
Evaluation of Blood Culture Submission Rates in Japan
Favorite
909 -
Reassessing Pathogens Eligible for the
Centers for Disease Control and Prevention’s (CDC’s)
National Healthcare Safety Network (NHSN) “Mucosal Barrier Injury-Laboratory Confirmed Bloodstream Infection” Criteria
Favorite
910 - A Comprehensive, One Year, Hospital-Wide Snapshot of All Serious Infectious Complications in People Who Inject Drugs
Favorite
911 - Assessment of Representativeness of IPD Surveillance Conducted by the National Microbiology Laboratory of Canada
Favorite
912 - Beyond the Usual Suspects in Invasive Mold Infections: Public Health Surveillance Identifies Clinical Diversity
Favorite
913 - Distribution of Respiratory Viral Pathogens in Infants Across Different Clinical Settings from December 2019 to April 2020
Favorite
914 - Epidemiology of Patients with ESKAPE Pathogen Bloodstream Infection in the US Military Health System
Favorite
915 - Global 2018 Surveillance of Eravacycline Against Gram-positive Pathogens, Including Resistant Isolates
Favorite
916 - National Estimates of the Proportion of Bacterial Pathogens Expressing Resistant Phenotypes in US Hospitals, 2012-2017
Favorite
917 - Persistence of Multidrug-Resistant Organisms during Occupancy Changes in the Nursing Home Setting, and Impact of Patient Hand Hygiene Assistance
Favorite
918 - Pilot Surveillance for Carbapenemase Gene-positive Organisms Among Hospitalized Solid Organ Transplant Recipients
Favorite
919 - Understanding Intermittent Detection of Multidrug-Resistant Organisms (MDROs) in Rectally Colonized Patients
Favorite
920 - Use of the Web by State and Territorial Health Departments to Promote the Dissemination of State Antimicrobial Resistance Surveillance Data, United States
Favorite
Hepatitis
1050 -
Hepatitis C Infection amongst People who Inject Drugs (PWID): Injection Practices and Risk Factors
Favorite
1051 -
Rapid onset of seroprotection rates in young adults immunized with a tri-antigenic hepatitis B virus (HBV) vaccine compared to a mono-antigenic HBV vaccine
Favorite
1052 -
Serologic vs. molecular testing for screening for hepatitis C virus infection in patients with hematologic malignancies with and without
prior hematopoietic cell transplant recipients.
Favorite
1053 -
The Ecological Relationship Between County-Level HCV Case Rates and Office-Based Buprenorphine in Ohio.
Favorite
1054 - A Randomized Controlled Trial of Hepatitis B virus (HBV) Revaccination among Men Who Have Sex with Men and Were Born in the Era of Universal Neonatal HBV Immunization
Favorite
1055 - Assessing the Impact of the Routine Childhood Hepatitis B Immunization and the Need for Hepatitis B Vaccine Birth Dose in Sierra Leone, 2018
Favorite
1056 - At the Intersection of Drug Use, Motherhood, and Hepatitis C: An Evaluation of Our Present State
Favorite
1057 - CpG-adjuvanted Hepatitis B vaccination improves seroprotection rates in Veterans with HIV
Favorite
1058 - Demographics of Hepatitis C Virus Antibody and RNA Positivity within an Emergency Department Screening Program
Favorite
1059 - Evaluating Hepatitis C Screening Rates and Successful Interventions at an Outpatient Medicine/Pediatrics Practice
Favorite
1060 - Evaluation of ALT at Sustained Virologic Response (SVR) in Patients with Treated Hepatitis C Virus (HCV) Infection
Favorite
1061 - False Positive Human Immunodeficiency Virus Testing Due to Acute Hepatitis A Infection: A Case Series
Favorite
1063 - Healthcare Utilization and Opportunities for HCV Testing and Treatment among Persons under Community Supervision in Pawtucket, RI
Favorite
1064 - Hepatitis C Epidemiology at the Dallas County Jail: A Changing Demographic
Favorite
1065 - Hepatitis C Virus Care Cascade Assessment–One Step Closer to Micro-Elimination
Favorite
1066 - Immune Escape Mutant Detection Using Commercially Available Methods for Hepatitis B Surface Antigen Serological Testing
Favorite
1067 - Interferon-free Hepatitis C Treatment Increases Surrogates of Cardiovascular Disease Risk in Black Veterans
Favorite
1069 - Loss to follow-up does not impact SVR for HCV infection
Favorite
1070 - Risk factors for failed linkage to Hepatitis C care
Favorite
1071 - Social Determinants of health (SDOH) among PWID living with HCV
Favorite
1072 - The Impact of Hepatitis C-Related Knowledge on Perceptions of Stigma Among Infected Individuals
Favorite
1073 - The Time is Now for Rapid Initiation of Hepatitis C Virus (HCV) Treatment
Favorite
1074 - Understanding Screening Practices for Hepatitis B Prior to Starting Biologics at an Academic Medical Center.
Favorite
HIV: Complications and Special Populations
922 -
Increasing incidence of obstructive sleep apnea in patients with HIV: A nationwide database analysis
Favorite
923 -
Long
-term Mortality after Histoplasma Infection in People Living with HIV
Favorite
925 - Adverse Events Due to Inappropriate Prescribing in Older Adults Living with HIV
Favorite
926 - Antibody Response to HPV Vaccination in Pediatric and Adolescent People Living with HIV (PLWH).
Favorite
927 - Antiretroviral Laboratory Monitoring and Implications for HIV Clinical Care in the Era of COVID-19 and Beyond
Favorite
928 - Barriers to Hepatitis C Elimination in an Urban Clinic Offering Integrated HIV/HCV Treatment
Favorite
929 - Characteristics Associated with Pain in Older People Living with HIV
Favorite
930 - Clinical Presentation, Treatment, and Outcomes for People with HIV with Histoplasmosis in Memphis, Tennessee
Favorite
931 - Congestive Heart Failure in Persons Living with HIV: Are we providing standard of care?
Favorite
932 - Creating a Statewide HCV Treatment Cascade for HIV/HCV Co-Infected Persons Using a Partnership with DPH
Favorite
933 - Cured vs. Not Yet Treated: Population Differences for HIV/HCV Co-infected Patients Navigating the HCV Care Cascade in 11 Connecticut Clinics
Favorite
934 - Diagnostic Utility of Blood (1- >3)-β-D-Glucan Testing in Patients with HIV in Arkansas
Favorite
935 - Effect of Tesamorelin in People with HIV with and without Dorsocervical Fat: Post Hoc Analysis of Phase III Double Blind Placebo Control Trial
Favorite
936 - Evaluating the Impact of Polypharmacy on Virologic Success in People with HIV
Favorite
937 - Factors Associated with Metabolic Syndrome in People with HIV under 40 Years in Guatemala
Favorite
938 - Identifying Gaps in the Treatment of Hepatitis C in Patients Co-Infected with HIV in Edmonton, Alberta
Favorite
939 - Immunity to Hepatitis A and/or Hepatitis B Viruses Among Inmates Living with HIV
Favorite
940 - Impact of Using Arts Programming to Support Treatment in Adolescents Living with HIV in Eswatini
Favorite
941 - Incarcerated patients living with HIV: Atherosclerotic cardiovascular disease risk and management
Favorite
942 - Lung Cancer Screening in at-risk patients with HIV in a Midwestern Clinic
Favorite
943 - Older Gay Black Men Living with HIV Report Higher Quality of Life than Older Gay White Men, Despite Facing Additional Burdens
Favorite
944 - Pneumocystis-Tuberculosis Co-infection in the HIV Positive Host.
Favorite
945 - Prevalence of HIV Associated Non-AIDS Conditions and Associated Risk Factors among Hospitalized HIV-infected Patients in India
Favorite
946 - Risk factors and Metabolic Implications of Integrase Inhibitor Associated Weight Gain
Favorite
947 - Stroke demographics and risk factor profile in HIV infected individuals in Florida
Favorite
948 - The Changing Dynamics of Hospitalizations Among People Living with HIV Over Time
Favorite
949 - Use of Optical Coherence Tomography Angiography to Assess Microvascular Health Among Persons with HIV: Employing the Retina as a Convenient Window
Favorite
950 - Venous Thromboembolism in Persons Living with HIV (PLWH): A Single Center Retrospective Cohort Study
Favorite
951 - Weight Gain Associated With Antiretroviral Therapy
Favorite
952 - Weight-Gain in Treatment Naive Newly Diagnosed HIV-Infected Persons After Initiation on Integrase Strand Inhibitor Based Treatment Regimens
Favorite
HIV: Epidemiology and Screening
953 -
Frailty Among People Living with HIV In Miami, A Cross Sectional Pilot Study.
Favorite
954 -
Missed opportunities for HIV Screening in the Emergency Department
Favorite
955 - Addressing Gaps and Disparities in HIV testing in the Emergency Department
Favorite
956 - Delayed HIV diagnosis in Philadelphia
Favorite
957 - Efficacy of Using Disease Intervention Specialists (DIS) to Re-engage Out of Care HIV/HCV Co-Infected Persons into HCV Treatment
Favorite
958 - Feasibility and Acceptability of HIV Self-Test Kit Distribution Through PrEP Clients’ Friendship and Sexual Networks
Favorite
959 - HIV-1 DNA Testing Identifies Drug Resistance in Viremic Patients with Pan-Sensitive Plasma Virus
Favorite
960 - Implementation and Evaluation of Alcohol Screening Tool in HIV Patients.
Favorite
961 - Implementing an HIV Ambulatory Curriculum in Internal Medicine Residency Programs
Favorite
962 - Linkage to Care Outcomes among Known HIV-Positive Patients at a High Prevalence Urban Hospital Emergency Department
Favorite
963 - Non-Invasive Detection of Cardiovascular Risk in People Living with HIV in Miami
Favorite
964 - Opt-Out HIV- Hepatitis C (HCV) Testing at a Primary Care Resident Clinic in Columbia, SC: Who Gets Tested and Who Opts Out of Testing?
Favorite
965 - Partnering with State Health Departments: A Road Map for Collaboration Using Public Health Enhanced HIV/AIDS Reporting System (eHARS)”
Favorite
966 - Pregnancy Outcomes and Engagement in HIV Care for Pregnant Women Living with HIV in Rhode Island 2012-2019
Favorite
967 - The Association between PrEP Awareness and Behavioral, Demographic, and Socioeconomic Factors in NYC
Favorite
968 - The Impact of Opt-Out HIV Screening and Patient Navigator-Assisted Linkage to Care of Newly Diagnosed Persons with HIV in a High-Prevalence Emergency Department
Favorite
969 - TNF-alpha inhibition in the setting of undiagnosed HIV infection: a call for enhanced screening guidelines
Favorite
970 - Transmitted Antiretroviral Drug Resistance Over a Period of 11 years at a Single Center in Southeast, USA
Favorite
971 - Unmasking the Undetectable: Identifying and Troubleshooting a Series of Falsely Elevated HIV Viral Load Results in a Group of Patients in a Community Clinic in San Antonio, Texas
Favorite
HIV: Prevention
972 -
Infection and Overdose Prevention for Persons with Injection Drug Use-Related Infections: Evaluation of an Inpatient Quality Improvement Program
Favorite
973 -
PrEP Care Continuum among Transgender Women at a Patient-Centered PrEP Program in Atlanta, GA
Favorite
974 -
The Effects of Changes in State-Level Policies Affecting Eligibility for the Supplemental Nutrition Assistance Program (SNAP) on Annual HIV Diagnoses in the United States
Favorite
976 - A Descriptive Retrospective Data Analysis of Maternal Sociodemographic Factors and Access of Healthcare Resources within the African Cohort Study, an Integrated Multicountry Preventative Mother to Child Transmission Program
Favorite
977 - Bacterial STI Diagnoses as Missed Opportunities for HIV Pre-Exposure Prophylaxis
Favorite
978 - Barriers to Recruitment of Latino Men who Have Sex with Men and Transgender Women to Behavioral HIV Seroprevalence Studies
Favorite
979 - Disparities in PrEP uptake and adherence among cisgender women using a pharmacologic measure
Favorite
980 - Drexel Medicine Resident Knowledge, Practices and Attitudes Regarding Pre-exposure prophylaxis (PrEP)
Favorite
981 - Extended Adherence and Persistence to HIV PrEP in a Multidisciplinary PrEP Clinic
Favorite
982 - Formal Education Improves Southeastern United States Primary Care Residents' Understanding and Attitudes Towards HIV Pre-Exposure Prophylaxis: Results of a Regional Survey
Favorite
983 - Hand Hygiene not only the Motion but the Moments
Favorite
984 - HIV Pre-Exposure Prophylaxis (PrEP) Prescription Rates Among Adolescents and Young adults (AYAs) at an Urban Academic Medical Center in Newark, NJ from 2017-2019: A Quality Assessment of HIV Prevention for High Risk Youth within the Epicenter of the NJ HIV Epidemic
Favorite
985 - Impact of Age and Medical Comorbidities on Renal Outcomes in the DISCOVER Trial
Favorite
986 - Improvement in Administration of HIV Post-Exposure Prophylaxis in the Emergency Department Following Sexual Assault
Favorite
987 - Improving Patient Access to HIV Post-Exposure Prophylaxis with Pharmacist Involvement
Favorite
988 - Overcoming Prescriber Concerns through Successful Access and Affordability of PrEP
Favorite
989 - Pre-exposure Prophylaxis (PrEP) Short-Term Retention Among Heavy Alcohol Users in Rural South Africa
Favorite
990 - Prophylaxis against spontaneous bacterial peritonitis: too much or too little?
Favorite
991 - Psychosocial Factors and HIV Risk among Transgender Women Living in Miami
Favorite
992 - Rethinking the 28-day HIV nPEP Dispensing Practice: A Pediatric ID Clinic Analysis
Favorite
993 - Risk Factors for Periconception Non-Suppression Among Women Living with HIV in Kisumu, Kenya
Favorite
994 - Risk for Viral Rebound in the Era of U=U; A CNICS Analysis
Favorite
995 - Safety and Efficacy of F/TAF and F/TDF for PrEP in DISCOVER Participants Taking F/TDF for PrEP at Baseline
Favorite
996 - The Potential for Reducing Opioid and Analgesic Prescriptions Via Herpes Zoster Vaccination
Favorite
997 - The Purview Paradox: PrEP Utilization at a Major Southern California County Teaching Hospital and Affiliated Clinics
Favorite
998 - Understanding Retention in PrEP Care in the South: Insights from an Academic HIV Prevention Clinic
Favorite
999 - Using the F/TDF Adherence-Efficacy Relationship to Calculate Background HIV incidence: Results from the DISCOVER trial
Favorite
HIV: Treatment
1001 -
HIV RNA monitoring after hospitalization for non-HIV-related illness in patients on combination antiretroviral therapy prior to admission
Favorite
1002 - A Daily Single Tablet Regimen (STR) of Bictegravir/Emtricitabine/Tenofovir Alafenamide (B/F/TAF) in Virologically-Suppressed Adults Living with HIV and End Stage Renal Disease on Chronic Hemodialysis
Favorite
1003 - BIC/FTC/TAF Maintains Viral Suppression in Patients with Documented M184V/I Mutations: A Real World Experience
Favorite
1004 - Clinical Decision Support System Alerts for HIV Retention in Care – A Pilot Implementation Research Study
Favorite
1005 - Comparison of Weight Changes in Treatment-Naïve, HIV-Infected Patients Receiving Integrase Inhibitor-Based Therapy Versus Protease Inhibitor-Based Therapy
Favorite
1006 - Contraception, Pregnancy and ART in Women of Child-Bearing Years
Favorite
1007 - Criminal Justice Involvement Negatively Impacts Engagement in Treatments for HIV and Opioid Use Disorder in Vietnam
Favorite
1008 - Disease Severity Impact on Long-Term Virologic Response to Ibalizumab in Expanded Access Protocol (TMB-311)
Favorite
1009 - Dolutegravir and Doravirine in Combination: When Standard Antiretroviral Regimens are Unacceptable
Favorite
1010 - Effective Management of HIV in Rural Georgia Using Telemedicine
Favorite
1011 - Efficacy and Safety of Doravirine in Treatment-Naïve Adults ≥50 Years Old With HIV-1
Favorite
1012 - Efficacy, safety and tolerability of switching to bictegravir/emtricitabine/tenofovir alafenamide (B/F/TAF) in HIV-1 infected virologically-suppressed older adults in a real-world setting
Favorite
1014 - Factors Associated with Switching from Tenofovir Diproxil Phosphate to a Tenofovir Alafenamide Based Regimen in a Cohort with Unrestricted Access to Care and Medications
Favorite
1015 - Gastrointestinal (GI) Adverse Events With Darunavir/Cobicistat/Emtricitabine/Tenofovir Alafenamide (D/C/F/TAF) Through Week 96: An AMBER Post Hoc Analysis
Favorite
1016 - Global trends in Integrase Strand Transfer Inhibitor resistance among HIV-1B Infected Patients
Favorite
1017 - Haves vs. Have-Nots in Healthcare Communication: Examining the Paradox Where PLHIV Who Need Quality Discussions with their Providers the Most, Access it the Least
Favorite
1018 - Health Technology Assessment of New Long-Acting, Directly-Observed HIV Treatments in Canada: Impact of Real-World Adherence to Daily Oral Therapy on Treatment, Transmission and Cost-Effectiveness
Favorite
1019 - Healthcare Resource Utilization and Cost of People Living with HIV (PLWH) in US Commercial and Medicare Advantage Health Plans
Favorite
1020 - Higher efavirenz mid-dose plasma concentration is associated with less weight gain among virologically suppressed people living with HIV
Favorite
1021 - HIV-1 RNA Blips and Low-Level Replication During Phase III/IIIb Cabotegravir + Rilpivirine Long-Acting Studies Are Similar to Oral 3-Drug Therapy and Not Associated with Week 48 Virologic Outcome
Favorite
1022 - Impact of Hospitalization on Antiretroviral Therapy for People Living with HIV
Favorite
1023 - Impact of Physical Therapy in the Management of Musculoskeletal Pain in HIV Patients
Favorite
1024 - Impact of Treatment Adherence on Efficacy of DTG/3TC and DTG + TDF/FTC: Pooled Analysis of the GEMINI 1 and 2 Clinical Trials
Favorite
1025 - Integrating buprenorphine into an urban HIV primary care practice: Outcomes on viral load suppression and opioid use
Favorite
1026 - Is Empiric Coverage Necessary? Incidence of
Pseudomonas aeruginosa
and Methicillin-Resistant
Staphylococcus aureus
in Foot Infections
Favorite
1027 - Long-Term Efficacy, Safety, and Durability of Ibalizumab-Based Regimens in Subgroup of TMB-202 Participants
Favorite
1028 - Long-term Follow-up After a Switch to Bictegravir, Emtracitabine, Tenofovir Alafenamide from Dolutegravir, Abacavir, Lamivudine
Favorite
1029 - Long-Term Patient Adherence and Management of Treatment Interruptions With Long-Acting Injectable Cabotegravir + Rilpivirine for Maintenance Therapy in Phase IIb/III Studies
Favorite
1030 - Medicaid Expansion: How Does it Impact HIV Outcomes in One Non-urban Southeastern Ryan White HIV/AIDS Program Clinic?
Favorite
1031 - Mobility and Structural Barriers Contribute to Loss to Follow up from HIV Care in Rural South Africa
Favorite
1032 - More Similar than You May Think: A Comparison of Perinatally vs. Behaviorally Infected Young Adults Living with HIV
Favorite
1033 - One year of Bictegravir in Mexico City: Differences in the Neuropsychiatric Adverse Events vs. Efavirenz
Favorite
1034 - Patient Perspectives on Implementation of a Long-Acting Injectable Antiretroviral Therapy Regimen in HIV US Healthcare Settings: Interim Results from the CUSTOMIZE study
Favorite
1035 - Patient-Reported Outcomes on Long-Acting Cabotegravir + Rilpivirine as Maintenance Therapy: FLAIR 96-Week Results
Favorite
1036 - Persistence of Guideline-Recommended Antiretroviral Therapy Regimens among Persons Living with HIV Newly Initiating Treatment in the US
Favorite
1037 - Qualitative Findings from a Hybrid III Implementation-Effectiveness Study to Explore Perspectives of Health-care Staff on Early Implementation of Cabotegravir and Rilpivirine Long Acting (CAB+RPV LA) Injectable HIV treatment in the US (CUSTOMIZE)
Favorite
1038 - Rapid Start: A Changing Algorithm for the Management of HIV Infection
Favorite
1039 - Real World Community-Based HIV Rapid Start Antiretroviral with BFTAF Versus Conventional HIV Antiretroviral Therapy Start – The RoCHaCHa Study, a Pilot Study.
Favorite
1040 - Real-World Implementation of Dolutegravir-Lamivudine to Achieve and Maintain HIV-1 Viral Suppression at an Academic Medical Center
Favorite
1041 - Tenofovir alafenamide associated weight change in persons living with HIV
Favorite
1042 - The Attitude of Patients With HIV about Telehealth for Their HIV Care
Favorite
1043 - The impact of integrase strand transfer inhibitors (InSTIs) on weight gain among adults with HIV in clinical care
Favorite
1044 - The Incidence and Severity of Drug interactions Before and After Switching Antiretroviral Therapy to Bictegravir/Emtricitabine/Tenofovir Alafenamide in Treatment Experienced Patients
Favorite
1045 - Treatment-Related Physical, Emotional, and Psychosocial Challenges and their Impact on Indicators of Quality of Life
Favorite
1046 - Week 48 Outcomes from the BRAAVE 2020 Study: A Randomized Switch to B/F/TAF in African American Adults with HIV
Favorite
1047 - Weight change associated with switching to bictegravir/emtricitabine/tenofovir alafenamide in virally suppressed people with HIV
Favorite
1048 - Weight Gain after Initiation of Anti-Retroviral Therapy in Acute HIV-1.
Favorite
1049 - Weight Gain in Persons Living with HIV (PLWH) Treated with Bictegravir Compared to Other Integrase Strand Transfer Inhibitors
Favorite
Infections in Immunocompromised Individuals
1075 -
Absolute Lymphocyte Count as a Predictor of Cytomegalovirus (CMV) Infection and Recurrence in Hematopoietic Stem Cell Transplant (HSCT) Recipients
Favorite
1076 -
Gaps in Measles and Mumps Seroprevalence Among Cancer Patients
Favorite
1077 -
Infectious complications after second allogeneic hematopoietic cell transplant (allo-HCT) in adult patients with hematological malignancies
Favorite
1078 -
Renal Transplant Recipient Resistomes Reveal Expansive Sub-Clinical Burden of Resistance After Treatment for ESBL-Producing Bacterial Infections.
Favorite
1079 -
The Risk of Cytomegalovirus (CMV) Infection and Recurrence Among Solid Organ Transplant Recipients
Favorite
1080 - Changing Epidemiology and Long-Term Outcome of Bloodstream Infection Due to Enterococcus for Patients with Acute Leukemia: Impacts and Limitations on Strategy of Restricting Antibiotics
Favorite
1081 - Characteristics and Outcomes of Nocardiosis in a Solid Organ Transplant Cohort
Favorite
1082 - Characterization of Ceftriaxone-Resistant Viridans Streptococci Bacteremia Among Patients at a Comprehensive Cancer Center
Favorite
1083 - Clinical Efficacy of Tedizolid for the Treatment of
Mycobacterium abscessus
complex Infections in Solid Organ Transplant Recipients
Favorite
1084 - Epidemiology and Long-term Outcomes of
Cytomegalovirus
(CMV) in Pediatric Liver Transplant Recipients (PLTR) at Texas Children’s Hospital (TCH)
Favorite
1085 - Epidemiology and Outcomes of Histoplasmosis in Transplant Recipients
Favorite
1086 - Epidemiology, Risk Factors, and Effect of Antifungal Prophylaxis on Early Invasive Fungal Infection in Heart Transplant Recipients
Favorite
1087 - Evaluation of Risk Factors for Infection among Patients Receiving Ibrutinib
Favorite
1088 - Extracorporeal Photopheresis and Infectious Complications in Patients with Chronic Graft Versus Host Disease
Favorite
1089 - Health Resource Utilization and Costs Associated with Multi-Virus Infection after Allogeneic Hematopoietic Cell Transplantation
Favorite
1090 - HHV-6 Encephalitis following Chimeric Antigen Receptor T-cell Therapy: Report of 2 Cases
Favorite
1091 - Incidence of Post-Transplant Lymphoproliferative Disorders among Epstein-Barr Virus Donor Positive, Recipient Negative Adult Solid Organ Transplant Recipients
Favorite
1092 - Increased Risk of Serious Infections in Mantle Cell Lymphoma Versus Other Hematologic Malignancies in Patients on Ibrutinib
Favorite
1093 - Infectious Complications after Pancreatic Islet Transplantation
Favorite
1094 - Infective Endocarditis During Index Hospitalization for Solid Organ Transplantation in the United States
Favorite
1095 - Investigation of Risk Factors Associated with Serious Bacterial, Viral and Invasive Fungal Infections in Hematologic Patients on Ibrutinib
Favorite
1096 - Linezolid versus Tedizolid for the Treatment of Nontuberculous Mycobacteria in Solid Organ Transplant Recipients: An Assessment of Safety
Favorite
1097 - Microbial Cell Free DNA Sequencing for Prediction of Culture-Negative Infection Events in Children with Cancer
Favorite
1098 - Norovirus Infection in Cancer Patients Undergoing Chimeric Antigen Receptor T-cell Immunotherapy (CAR-T)
Favorite
1099 - Opportunistic Infections Among Long Term Survivors of Kidney Transplantation: Defining Risk Factors
Favorite
1100 - Outcomes of HIV-Associated Lymphoma Treatments: A Contemporary Single Center Cohort Study.
Favorite
1101 - Pulmonary Aspergillosis Complicating Non-Influenza Respiratory Virus Infections Among Solid Organ Transplant Recipients
Favorite
1102 - Reconstitution of CMV-specific cell-mediated immunity during letermovir prophylaxis in hematopoietic stem cell recipients
Favorite
1103 - Respiratory Virus Infections In Solid Organ Transplant Recipients: A Single Center Experience
Favorite
1104 - Risk Factors and Outcomes of Refractory and/or Resistant Cytomegalovirus (CMV) Infection after Allogeneic Hematopoietic Stem Cell Transplantation
Favorite
1105 - The Burden of Infections Prior to Chimeric Antigen Receptor (CAR) Modified T-cell Therapy Predicts Post-CAR T-cell Infectious Complications
Favorite
1106 - The incidence and risk factors associated with varicella zoster virus infection in kidney transplant recipients after 1-month acyclovir prophylaxis in a CMV preemptive therapy era
Favorite
1107 - Third Generation Cephalosporins
Monotherapy Experience in Pediatric Patients with High-Risk Febrile Neutropenia
Favorite
1108 - Transplantation and Immigration: Comparing Infectious Complications Between Foreign-born vs. U.S.-born Kidney Transplant Recipients in Minnesota
Favorite
1109 - Valgancyclovir Dosing for Cytomegalovirus Prophylaxis in Heart Transplant Recipients
Favorite
1110 - Very Late Onset Infections Amongst Long Term Survivors of Kidney Transplantation
Favorite
Infectious Diseases Medical Education
1111 - #BeASteward: Transforming Infectious Diseases Fellows Into Antimicrobial Stewards Using the IDSA Antimicrobial Stewardship Curriculum
Favorite
1112 - #EducationInTheTimeofCOVID: Using Twitter to Disseminate Evidence-Based Medicine during a Pandemic
Favorite
1113 -
A Novel Means of Acquiring High Quality Feedback for Training Programs –
The Program Director Ombudsperson
Favorite
1114 -
Identifying and Addressing Knowledge Gaps in Influenza Management with Targeted Continuing Medical Education
Favorite
1115 - A Longitudinal Medical Education Program for Infectious Diseases Fellows
Favorite
1116 - AIMS-trained Residents Exhibit Specific Communication Skills in a Standardized Patient Model of Vaccine Hesitancy
Favorite
1117 - An HIV Primary Care Rotation Improved HIV and STI Knowledge, Enhanced Sexual History-Taking Skills, and Increased Interest in a Career in Infectious Diseases among Medical Students and Residents
Favorite
1118 - Development of a Curriculum for Internal Medicine Residents on Latent and Active Pulmonary TB: A Targeted Needs Assessment
Favorite
1119 - Impact of Real-World and Real-Time Interdisciplinary Cases on Infectious Diseases Content Knowledge and Confidence in Pharmacy Students Enrolled in an Infectious Diseases Elective Course
Favorite
1120 - Impact of Training Residents to Improve HIV Screening in a Teaching Hospital in Mexico City
Favorite
1121 - Implementation and Evaluation of a Virtual Microbiology Laboratory for Pharmacy Students
Favorite
1122 - Improving Knowledge of Infectious Disease Fellows Regarding Infection Prevention & Antibiotic Stewardship Using a Multi-Faceted Approach
Favorite
1123 - Improving Quality Improvement:
Increasing QI Competency in Internal Medicine Subspecialty Fellows
Favorite
1124 - Increasing Student Confidence in Antimicrobial Prescribing with a Novel Teaching Framework
Favorite
1125 - Innovative Virtual Learning in the Midst of a Pandemic - Patients, Populations, and Pandemics: Responding to COVID-19
Favorite
1126 - Learner Driven Call Center to increase Convalescent Plasma Donation in COVID-19
Favorite
1127 - Medical School in the Era of COVID-19: Innovations in Direct Near Peer Teaching of Immunology/Microbiology Content During the Pandemic
Favorite
1128 - Online Spaced Education to Teach Microbiology to Medical Students in a Threaded Medical School Curriculum
Favorite
1129 - Optimizing Feedback Strategies on the Infectious Diseases Inpatient Service
Favorite
1130 - Optimizing Use of COVID-19 Personal Protective Equipment among Resident Physicians at a Veterans Affairs Hospital
Favorite
1131 - Point-of-Care Interactive Decision Support Tool Demonstrates Discordance Between Healthcare Practitioner Approaches and AASLD Guideline Recommendations in the Management of HBV Infection
Favorite
1132 - Professional Development Curriculum for Fellows in Infectious Diseases
Favorite
1133 - Qualitative Analysis of Pharmacists’ Therapeutic Reasoning Processes Applied to Antimicrobial Selection and Stewardship Activities
Favorite
1134 - Substance Use Disorder Patients' Perspectives of a Multidisciplinary Antimicrobial Infusion Service
Favorite
1135 - The PEST Approach to Choosing Antimicrobial Therapy
Favorite
1136 - Trends in Speaker Representation at the Infectious Diseases Society of America (IDSA) IDWeek Conference, 2013-2019
Favorite
1137 - What Do We Know? Teaching Medical Students to Deal with Uncertainty as a Pandemic Unfolds
Favorite
1138 - Works Well Enough? Program Directors’ Perceptions of the Effectiveness and Transparency of Competency-Based Evaluations in Assessing Infectious Diseases Fellow Performance
Favorite
Interesting Cases from the IDWeek Call for Cases
A 32 year old male with ulcerative colitis and cirrhosis presents with lung and brain masses.
Favorite
A 49 year old female with acute hypoxic respiratory failure and tracheal debris
Favorite
A kidney transplant recipient with labial cellulitis and multiple skin lesions
Favorite
A man from Nepal with a cavitary lung lesion.
Favorite
A Man with Recurrent Pneumonia and Headache
Favorite
A young woman presenting with acute rash, diarrhea, and fever
Favorite
Disseminated Blastomycosis in a Novel Occupational Exposure
Favorite
Headaches That Persist May Have a Fungus That Exists.
Favorite
One in a million: Diagnosis of Sporadic Creutzfeldt-Jakob Disease in the Context of Negative Neuroimaging.
Favorite
Spontaneous hemoptysis in a COVID-19 patient
Favorite
“The Cost of Swine Dining”: A case of human
Streptococcus suis
Favorite
Maternal-child Infections
1139 - Adherence to Zika virus-related Pediatric Follow-up Care in Puerto Rico
Favorite
1140 - Awareness of Cytomegalovirus (CMV) Among Postpartum Mothers: Education Needed!
Favorite
1141 - Composition of Placental Cultures and Correlation with Maternal and Infant Blood Cultures in Mothers with Suspected Chorioamnionitis
Favorite
1142 - Increased Odds of Psychiatric Illness Among Mothers of Infants with Congenital Syphilis
Favorite
1143 - Late-Onset Hearing Loss and Antiviral Therapy for Congenital Cytomegalovirus Infection
Favorite
1144 - Prevention of Mother-to-Child Transmission of Hepatitis B at UNC Hospitals
Favorite
1145 - The Role of Maternal Vaccination on Healthcare Visits for Acute Respiratory Infections in HIV-Exposed but Uninfected (HEU) Infants
Favorite
1146 - Thrombocytosis in Infants with Congenital Cytomegalovirus Infection Being Treated with Valganciclovir
Favorite
Medical Mycology
1147 -
Short Course of Voriconazole Therapy as a Risk Factor for Relapse of Invasive Pulmonary Aspergillosis
Favorite
1148 - Activity of Posaconazole and Comparator Antifungal agents Tested Against Filamentous Fungi
Favorite
1149 - Baseline Chest CT Findings in Patients with Pulmonary Mold Infections: A Post-Hoc Analysis from the Phase 3 SECURE Study that Compared Isavuconazole to Voriconazole for the Primary Treatment of Invasive Mold Disease
Favorite
1150 - Breakthrough Invasive Fungal Disease (IFD) in Patients with Acute Myeloid Leukemia (AML)
Favorite
1151 - Candida Colonization Alters Pathogenic Pulmonary Infection in Pediatric Patients with Cystic Fibrosis
Favorite
1152 - Characteristics of Patients with Invasive Infections Caused by
Trichosporon asahii
Favorite
1153 - Characterization of Invasive Mold Infections in Acute Leukemia and Hematopoietic Stem Cell Transplant Recipient Patients and Risk Factors for Mortality - a Single Center Experience
Favorite
1154 - Characterizing fungemic outcomes among adult inpatients at a community teaching hospital: a retrospective cohort study
Favorite
1155 - Clinical and Epidemiological Characteristics of Patients with Paracoccidioidomycosis in Asuncion Paraguay
Favorite
1156 - Clinical and epidemiological features and outcomes of Blastomycosis in a tertiary hospital in Kentucky
Favorite
1157 - Clinical Safety, Efficacy, and Pharmacokinetics of Fosmanogepix, a Novel First-in-class Antifungal, in Patients with Renal Insufficiency: Subset Analysis from a Phase 2 Candidemia Trial
Favorite
1159 - Echinocandins Dosing in Obese Patients: A Systematic Review
Favorite
1160 - Ecological Study for Pulmonary
Blastomycosis
Favorite
1161 - Effectiveness of Posaconazole in the Treatment of Rare Invasive Fungal Infections: A Systematic Literature Review
Favorite
1163 - Epidemiology of Candidemia: Can
Candida
Spread from Patient to Patient in the Hospital?
Favorite
1164 - Epidemiology of Cryptococcal Infections in Non-HIV Patients: A 20-year Single Center Experience
Favorite
1165 - Epidemiology, management and outcomes of fungal keratitis: A single center study from tertiary hospital in Thailand
Favorite
1166 - Evaluating the Impact of the 2016 Candidemia Guidelines on the Incidence of Ocular Complications of Candidemia
Favorite
1167 - Got Micafungin? The Incidence of Fungemia in Patients with Septic Shock
Favorite
1168 - Higher Glycosylated Hemoglobin (A1c) Levels are Associated with Increased Mortality from
Cryptococcus
Infection
Favorite
1169 - In Vitro Activity of Posaconazole versus Voriconazole for the Treatment of Invasive Aspergillosis in Adults Enrolled in a Clinical Trial
Favorite
1170 - Invasive Fungal Infections and Colonization in Critically Ill Patients: Impact of Diagnosis and Management on Outcomes
Favorite
1171 - Lower Mortality with Adjuvant Corticosteroid Therapy in non-HIV Infected Patients with
pneumocystis jirovecii
pneumonia: A Single US Cohort Study and a Proposed Novel Mechanism of Corticosteroids
Favorite
1172 - Mucormycosis Treated with Isavuconazole: A Matched-Pair Analysis from the FungiScope
®
Registry
Favorite
1173 - Ocular Candidiasis in Patients with Candidemia Diagnosed by Blood Culture Versus T2Candida® Assay
Favorite
1174 - Phase 2 STRIVE Clinical Trial of Rezafungin for Treatment of Candidemia and/or Invasive Candidiasis Demonstrates Consistent Trough Concentrations Across Diverse Patient Populations
Favorite
1175 - Pulmonary Aspergillosis in Critically Ill Patients with COVID-19: A Case Series
Favorite
1176 - Quality of Life of Previously Healthy Subjects following Cryptococcal Meningoencephalitis.
Favorite
1177 - Rapid, Non-invasive Detection of Invasive Mucormycosis Caused by
Syncephalastrum monosporum
Using Next-Generation Sequencing of Circulating Microbial Cell-free DNA in Plasma
Favorite
1178 - Risk factors for death among patients with Candida endocarditis: An observational study in US academic medical centers
Favorite
1179 - Septic shock in
Coccidioides immitis
Infection
Favorite
1180 - Seroincidence and Risk of Coccidioidomycosis Infection Among Active Duty Personnel Stationed at Naval Air Station Lemoore in the San Joaquin Valley of California
Favorite
1181 - Spectrum and Risk Factors of Early Onset versus Late Onset Neonatal Candidemia from Pakistan.
Favorite
1182 - The Real-World Use of Isavuconazole as Primary or salvage Therapy of Invasive Fungal infections in High-Risk Patients with Hematologic Malignancy or Stem Cell Transplant
Favorite
Microbial Pathogenesis
1183 - A Prospective Epidemiological & Immunological Study of Cytomegalovirus infection in SLE Patients Receiving Immunosuppressant
Favorite
1184 - Activity of anti-pseudomonal antibiotics among all
Pseudomonas aeruginosa
(PSA) at an academic medical health system, including β-lactam, multi-drug (MDR) and extensively drug resistant (XDR) strains
Favorite
1185 - Association Between Blood Product Transfusion and Development of Hospital Acquired Infections or Mortality in Patients Admitted to the Hospital Wards. A Retrospective Case-Control Study
Favorite
1186 - Cefazolin inoculum effect predicts reduced susceptibility to other antibiotics and patient outcomes in MSSA endovascular infections
Favorite
1187 - CFTR Function Impacts Proinflammatory Cytokine Expression of Bronchial Epithelial Cells During
Pseudomonas aeruginosa
and
Staphylococcus aureus
Infections
Favorite
1189 - Correlation of BK polyomavirus (BKPyV)-specific Immunity and BKPyV Viruria within 6 months after Kidney Transplantation: A Prospective Cohort Study
Favorite
1190 - Dual-Plasmid Technology for Precision Genome Editing in
Staphylococcus aureus
Favorite
1191 - Evolution of Hepatitis C Virus Points to Postpartum Recovery of CD8+ T-Cell Selection Pressure
Favorite
1192 - H-NS-like Proteins in
Pseudomonas aeruginosa
Coordinately Silence Intragenic and Antisense Transcription
Favorite
1193 - Human Transcriptomic Analysis of Periprosthetic Joint Infection
Favorite
1194 - Identification and Characterization of Extracellular Inducers of Persistence in
Staphylococcus epidermidis
and
Staphylococcus
aureus
Favorite
1195 - Influence of
Histoplasma capsulatum
Infection on Endothelin-1 mRNA Gene Expression in Bone Marrow Derived Macrophages
Favorite
1196 - Influence of antibiotic use on the effectiveness and safety of immune checkpoint inhibitors in Japan.
Favorite
1197 - Inhibitory Effect of Ursodeoxycholic Acid on
Clostridioides difficile
Growth
Favorite
1198 - Measurement of Pre-transplant Anti-cytomegalovirus (CMV) Immunoglobulin G Titer to Predict Risk of CMV Infection in CMV-seropositive Kidney Transplant Recipients
Favorite
1199 - Phylogenomic analysis of
Campylobacter jejuni
isolated from gastroenteritis cases in Michigan
Favorite
1200 - Risk of group A streptococcal Transmission Among the Pediatric Population in the Houston Area
Favorite
1202 - Subinhibitory Concentrations of Omadacycline Inhibit
Staphylococcus aureus
Hemolytic Activity in Vitro
Favorite
1203 - Systemic, Mucosal Immune Activation And Psycho-sexual Health in HIV-Infected And Uninfected Women: Evaluation of Biomarkers And Environmental Stimuli
Favorite
1204 - The Effect of Coinfection with Babesiosis and Lyme Disease on Novel Biomarkers
Favorite
Microbiome in Health and Disease
1205 -
Protectin D1 Induced by
Clostridium butyricum
MIYAIRI 588 Has an Anti-inflammatory Effects on Antibiotic-induced Intestinal Disorder
Favorite
1206 - Association of Aging, Frailty and Place of Residence with Skin, Oral and Gut Microbiome Characteristics and Pathogenicity Reservoirs
Favorite
1207 - Combining standard bacterial vaginosis treatment with cystine uptake inhibitors to block growth of
Lactobacillus iners
is a potential a target for shifting the cervicovaginal microbiota towards health-associated
Lactobacillus crispatus
-dominant communities
Favorite
1208 - Development of a Novel Synthetic Glycan to Prevent Bacterial Infections and Ameliorate Respiratory Viral Infections
Favorite
1209 - Impact of Respiratory
Staphylococcus aureus
Abundance on Risk for Ventilator-Associated Pneumonia During Long-Term Care
Favorite
1210 - K-mer Profiling Powered by Reference-assisted Assembly of NGS Data: A Highly Sensitive Protocol to Infer the Plasma Microbiome Using Cell-free DNA Sequence Data
Favorite
1211 - Response to Fecal Microbiota Transplant (FMT) in Refractory
Clostridioides difficile
Infection (CDI) is Modest Compared to Recurrent CDI in Hospitalized Patients
Favorite
1212 - Temporal Dynamics of the Plasma Microbiome in Recipients at Early Post-liver Transplantation
Favorite
New Approaches to Diagnostics
1213 -
A TRAIL/IP-10/CRP Signature Distinguishes between Viral and Bacterial Infection in Chronic Obstructive Pulmonary Disease Patients
Favorite
1214 -
Clinical characteristics of patients with adrenal insufficiency presenting fever
Favorite
1215 -
Evaluation of the Carba-R NxG Assay in a Global Challenge Set of
Pseudomonas aeruginosa
Favorite
1216 - Benchmarking Published Gene Signatures for Robust Infection Classification
Favorite
1217 - Clinical and Microbiological Characteristics of Patients with Bacteremia and Normal Procalcitonin at Single Tertiary Care Medical Center
Favorite
1218 - Comparing the Diagnostic Accuracy of Clinician Judgement to a Novel Host Response Diagnostic for Acute Respiratory Illness
Favorite
1219 - Diagnosing vaginal discharge syndrome and its potential impact on clinical practice in a regional hospital in Taiwan
Favorite
1220 - Disruption of the Body Temperature Circadian Rhythm in Hospitalized Patients
Favorite
1222 - Fosfomycin Susceptibility Testing using the new ETEST
®
FO
Favorite
1223 - Impact of
Helicobacter pylori
Infection on Duodenal Microbial Community Structures and Microbial Metabolic Pathways
Favorite
1224 - Investigation of Infectious Etiologies in the Lower Respiratory Tract from Pediatric Patients with Unexpected Cardiopulmonary Deterioration using Next-Generation Sequencing
Favorite
1225 - Next-Generation Sequencing in Clinical Practice: A Survey of Infectious Disease Providers
Favorite
1226 - Performance of a Host Response Test for Bacterial/Viral Discrimination in Immunocompromised Patients
Favorite
1227 - Plazomicin Susceptibility Testing using ETEST
®
MIC for
Enterobacterales
Favorite
1228 - The Role of Procalcitonin (PCT) and Lactic Acid in Febrile Neutropenic Cancer Patients in an Oncological Emergency Center
Favorite
1229 - Volatile Biomarkers of Influenza Infection in the Breath
Favorite
New Drug Development
1230 -
Clinical and Microbiologic Outcomes by Causative Pathogen in Hospital-Acquired or Ventilator-Associated Bacterial Pneumonia (HABP/VABP) Treated with Imipenem/Cilastatin (IMI)/Relebactam (REL) Versus Piperacillin/Tazobactam (PIP/TAZ)
Favorite
1231 -
VIR-2482: A potent and broadly neutralizing antibody for the prophylaxis of influenza A illness
Favorite
1232 - Efficacy and Safety of Intravenous Sulopenem Followed by Oral Sulopenem etzadroxil/Probenecid Versus Intravenous Ertapenem Followed by Oral Ciprofloxacin or Amoxicillin-clavulanate in the Treatment of Complicated Urinary Tract Infections (cUTI): Results from the SURE-2 Trial
Favorite
1233 - Identification of Novel Inhibitors of
Clostridioides difficile
Enoyl-Reductase II (FabK) by High-Throughput Virtual and Experimental Screening
Favorite
1235 - On the Edge of Tomorrow: Expedited Regulatory Pathways for Anti-Infective Therapies
Favorite
1236 - Safety and Immunogenicity of a 20-Valent Pneumococcal Conjugate Vaccine (PCV20) in Healthy Infants in the United States
Favorite
New Vaccines
1237 -
Robust Adjuvant Activity and Dose-sparing Potential of the Novel Semisynthetic Saponin Adjuvant TQL1055 for Seasonal and Pandemic Influenza.
Favorite
1238 -
The Novel Semisynthetic Saponin Adjuvant TQL1055 Enhances the Antibody Response to Pertussis Vaccine with an Improved Tolerability Profile over QS-21
Favorite
1239 - Different Dose Levels of a Respiratory Syncytial Virus Maternal Vaccine Candidate (RSVPreF3) Administered to Non-pregnant Women in a Randomized Clinical Trial Are Immunogenic and Well Tolerated
Favorite
1240 - Persistence of Circulating Antibody Through 12 Months Following Vaccination With a 20-Valent Pneumococcal Conjugate Vaccine in Adults 60–64 Years of Age
Favorite
1241 - PfSPZ Vaccine Administered by Direct Venous Inoculation to Prevent
Plasmodium falciparum
Malaria is as Safe as Normal Saline – a Meta-analysis of 12 Randomized Controlled Clinical Trials
Favorite
1242 - Safety and Immunogenicity of Novel 24-Valent Pneumococcal Vaccine in Healthy Adults
Favorite
1243 - Semi-Quantitative Benefit-Risk Assessment for a New Quadrivalent Meningococcal Conjugate Vaccine (MenACYW-TT) in Individuals 2 Years of Age and Older
Favorite
Novel Agents
1244 -
Assessment of the
In Vivo
Activity of Human-Simulated Exposure of WCK 4282 (High Dose Cefepime [FEP]-Tazobactam [TZB]) against
Enterobacterales
(EB) and
Pseudomonas aeruginosa
(PA) in the Neutropenic Murine Thigh Infection Model
Favorite
1245 -
In Vivo
Efficacy of WCK 4282 (High Dose Cefepime [FEP]-Tazobactam [TZB]) Against β-Lactamase-Producing (BLP) Gram-Negative Bacteria in a Neutropenic Murine Pneumonia Model
Favorite
1247 -
Dalbavancin in Osteomyelitis and Joint Infections: An Analysis From an Observational, Multicenter, Retrospective Cohort Study of the Real-World Use in Adult Patients
Favorite
1248 -
Efficacy and Safety of Oral Ibrexafungerp in 41 Patients with Refractory Fungal Diseases, Interim Analysis of a Phase 3 Open-label Study (FURI)
Favorite
1249 -
Genetic Evidence That Gepotidacin Shows Well-balanced Dual Targeting against DNA Gyrase And Topoisomerase IV in
Neisseria
gonorrhoeae
Favorite
1250 -
Novel Boronic Acid Transition State Analogs (BATSI) with
in vitro
inhibitory activity against class A, B and C β-lactamases
Favorite
1251 -
Prevention of
Pneumocystis
Pneumonia by Ibrexafungerp in a Murine Prophylaxis Model
Favorite
1252 -
In Vitro
Activity of Cefiderocol Against Metallo-β-Lactamase-Producing Gram-Negative Bacteria Collected in North America and Europe Between 2014 and 2017: SIDERO-WT-2014–2016 Studies
Favorite
1253 -
In Vitro
Activity of Omadacycline against 7000 Bacterial Pathogens from the United States Stratified by Infection Type (2019)
Favorite
1254 -
In vitro
activity of sulbactam-durlobactam against recent global clinical
Acinetobacter baumannii-calcoaceticus
complex isolates
Favorite
1255 -
In Vitro
Activity of Vancapticin against Methicillin-Resistant
Staphylococcus aureus
from Periprosthetic Joint Infection
Favorite
1256 -
In Vivo
Activity and Structural Characterization of a New Generation γ-Lactam Siderophore Antibiotic Against Multidrug-Resistant Gram-Negative Bacteria and
Acinetobacter
spp.
Favorite
1257 - A phase II Prospective Randomized Study to Assess Ceftolozane-Tazobactam in the Management of Febrile Neutropenia in Patients with Hematological Malignancies
Favorite
1258 - Activity of a Series of Investigational Compounds Tested Against Invasive Fungal Isolates
Favorite
1259 - Activity of eravacycline against staphylococci isolated from periprosthetic joint infections
Favorite
1260 - Activity of Manogepix (APX001A) against 2,669 Fungal Isolates from the SENTRY Surveillance Program (2018-2019) Stratified by Infection Type
Favorite
1261 - Antimicrobial Activity of Aztreonam-Avibactam against Gram-negative Bacteria Isolated from Patients Hospitalized with Pneumonia in Europe, Latin America, and Asia in 2019
Favorite
1262 - Antimicrobial Activity of Gepotidacin against Clinical Isolates of
Escherichia coli
and
Staphylococcus saprophyticus
Collected Worldwide in 2019
Favorite
1263 - Assessment of Cefepime (FEP)-Taniborbactam (TAN) Human Exposures to Suppress the Emergence of Resistance among Serine (SBL)- and Metallo-β-Lactamase (MBL)-Producing Gram-Negative Bacteria (GNB) in a Hollow Fiber Infection Model (HFIM)
Favorite
1264 - Assessment of In Vivo Efficacy of CF-296 in addition to Vancomycin (VAN) and Daptomycin (DAP) against
Staphylococcus aureus
in the Neutropenic Murine Thigh Infection Model
Favorite
1265 - AT-527, an Oral Purine Nucleotide Prodrug Exhibiting Potent
In Vitro
Antiviral Activity Against Human Coronaviruses, Including SARS-CoV-2
Favorite
1266 - Characterization of Shifts in Minimum Inhibitory Concentrations During Treatment with Cefiderocol or Comparators in the Phase 3 CREDIBLE-CR and APEKS-NP Studies
Favorite
1267 - Comparative activity of omadacycline against extended-spectrum beta-lactamase positive and negative
Escherichia coli
and
Klebsiella pneumoniae
strains recovered from urine specimens
Favorite
1268 - Dalbavancin for the Treatment of Infections due to Staphylococcus aureus
Favorite
1269 - Differences in Interpretative Breakpoints Between CLSI, FDA and EUCAST Impact Reporting of Susceptibility and Resistance to Cefiderocol
Favorite
1270 - Early Real-world Evidence in the Use of Eravacycline for the Management of Draconian Infections
Favorite
1271 - Efficacy and Safety of Cefiderocol and Best Available Therapy in Patients with Serious Infections Caused by Carbapenem-Resistant Gram-Negative Infections: Results of the Pathogen-Focused Phase 3 CREDIBLE-CR Study
Favorite
1272 - Efficacy of a Non-Peptide, Small Molecule Mimic of Host Defense Proteins in Mouse Models of Disseminated Candidiasis and Aspergillosis.
Favorite
1273 - Efficacy of Cefiderocol against carbapenem-resistant
A. baumannii
and
P. aeruginosa
in ventilator-associated pneumonia mouse model
Favorite
1274 - Evaluating the Activity of SPR719, a Novel Aminobenzimidazole, against Nontuberculous Mycobacteria
Favorite
1275 - Evaluation of
in vitro
activity of manogepix against multidrug-resistant and pan-resistant
Candida auris
from the New York Outbreak
Favorite
1276 - Evaluation of CD377, a Novel Antiviral Fc-Conjugate (AVC), In Vitro Activity and In Vivo Efficacy in Immune-Competent and -Deficient (SCID) Lethal Mouse Models
Favorite
1278 - Impact of Different Breakpoint Criteria on the Susceptibility Rates of
Enterobacterales
resistant Subsets to the Aminoglycosides
Favorite
1279 - In Vitro Activity of Nacubactam (OP0595) Alone and in Combination with β-Lactams against β-Lactamase-Producing Enterobacterales Isolated in Japan
Favorite
1281 - Longitudinal and Spatial Variation in the Human Microbiome in a Phase 2a Clinical Study of Gepotidacin in Adult Females with Uncomplicated Urinary Tract Infection
Favorite
1282 - Manogepix, the Active Moiety of the Investigational Agent Fosmanogepix, Demonstrates
In vitro
Activity Against Members of the
Fusarium oxysporum
and
Fusarium solani
Species Complexes
Favorite
1283 - New Generation Antiviral Conjugate (AVC): Stable, Safe, and Single
Favorite
1284 - Outcomes by Baseline Pathogens and Susceptibility in the STRIVE Phase 2 Trial of Once-Weekly Rezafungin for Treatment of Candidemia and Invasive Candidiasis Compared with Caspofungin
Favorite
1285 - Outcomes in Patients with Gram-Negative Bacteremia from Phase 2 and Phase 3 Clinical Trials of Cefiderocol, a Novel Siderophore Cephalosporin
Favorite
1286 - Pharmacokinetics, Excretion, and Mass Balance of [
14
C]-Rezafungin Following Intravenous (IV) Administration in Healthy Adults
Favorite
1287 - Pharmacokinetics, Safety, and Tolerability of Nacubactam after Single Coadministration with β-Lactams in Japanese Healthy Subjects
Favorite
1288 - Phase 1 First-in-Human Single- and Multiple-Ascending Dose Trial Demonstrates Pharmacokinetics (PK) and Tolerability of SPR720, an Oral DNA GyrB Inhibitor for Mycobacterial Infections
Favorite
1289 - Pravibismane is a Potent, Broad Spectrum Anti-Infective Small Molecule that Rapidly Disrupts Bacterial Bioenergetics and Halts Bacterial Growth
Favorite
1290 - Real-World Experience with Omadacycline for Nontuberculous Mycobacterial and Gram-Negative Infections: A Multicenter Evaluation
Favorite
1291 - Safety of Isavuconazole Compared with Voriconazole as Primary Antifungal Prophylaxis in Allogeneic Hematopoietic Cell Transplant Recipients
Favorite
1292 - Safety Profile of the Novel Siderophore Cephalosporin Cefiderocol in Randomized Phase 2 and Phase 3 Clinical Studies of Serious Gram-Negative Infections
Favorite
1293 - Sulbactam-durlobactam is active against recent, multi-drug resistant
Acinetobacter baumannii
clinical isolates from the Middle East
Favorite
Pediatric Antimicrobial Stewardship (inpatient/outpatient pediatric focused)
1330 -
Development of a Pediatric Emergency Department (ED) Uropathogen Antibiogram and Empiric Urinary Tract Infection (UTI) Treatment Algorithm
Favorite
1331 -
Reducing Inpatient Antimicrobial Treatment Duration for Febrile Infants through Implementation of Rapid Diagnostic Testing and Clinical Risk Definition
Favorite
1332 -
Single Dose Oral Amoxicillin Challenge is a Safe and Effective Strategy to
Delabel Penicillin Allergies among Low Risk Hospitalized Children
Favorite
1333 - A Cross-Sectional Analysis of Inappropriate Outpatient Antibiotic Use in Children Insured by Kentucky Medicaid
Favorite
1334 - A Qualitative Assessment of Drivers of Antimicrobial Prescribing for Pediatric Patients in Diverse Ambulatory Settings
Favorite
1335 - Accuracy of Outpatient Antibiotic Prescriptions for Urinary Tract Infection in Pediatric Ambulatory Care
Favorite
1336 - Alcohol Impregnated Caps and Ambulatory CLABSI: Multicenter Cluster Randomized, Crossover Trial
Favorite
1337 - An Outpatient Antimicrobial Stewardship Initiative for Urinary Tract Infections in Primary Care Pediatrics
Favorite
1338 - Analysis of Prescription Guideline Adherence in Pediatric Outpatient Pneumonia Treatment
Favorite
1339 - Antibiotic Prescribing Varies among Patients with a Documented Penicillin or Cephalosporin Adverse Drug Reaction
Favorite
1340 - Assessment of the impact of multiplex PCR panels in sepsis evaluations of young febrile infants
Favorite
1341 - Blood Volume Collected for Blood Cultures in Infants with Suspected Neonatal Sepsis in the NICU
Favorite
1342 - Clinical failure rates of amoxicillin for the treatment of acute otitis media in young children.
Favorite
1343 - Clinical Outcome of Penicillin Skin Testing as an Antimicrobial Stewardship Initiative in the pre-surgical clinic in a community hospital.
Favorite
1344 - Impact of Pharmacist-Physician Team on Antimicrobial Utilization at a Pediatric Hospital
Favorite
1345 - Impact of the COVID-19 Pandemic on Pediatric Ambulatory Antibiotic Use in an Academic Health System
Favorite
1346 - Implementation of a Multidisciplinary 48 Hour Antibiotic Timeout in a Pediatric Population
Favorite
1347 - Improved Antibiotic Prescribing Practices for Respiratory Infections Through Use of Computerized Order Sets and Educational Sessions in Pediatric Clinics
Favorite
1348 - Indirect Standardization to Improve Comparison of Children’s Hospitals’ Antimicrobial Use
Favorite
1349 - Institutional Antibiograms Are Insufficient to Guide Clindamycin Use in Pediatric Skin and Soft Tissue Infections
Favorite
1350 - Optimizing Blood Culture Use in Critically Ill Children: Year One of a Multi-Center Diagnostic Stewardship Collaborative
Favorite
1351 - Pediatric Antibioitic Use in the North Carolina Medicaid Population
Favorite
1352 - Pediatric azithromycin prescriptions in a healthcare system from 2016-2018
Favorite
1353 - Pediatric Urinary Tract Infections: A Choosing Wisely Initiative to Advance Antimicrobial Stewardship and Diagnostic Accuracy in the Emergency Department
Favorite
1354 - Reducing vancomycin utilization rate in a level 4 NICU
Favorite
1355 - Resistance in Gram-Negative Bacteria in the Pediatric Patient Population by Age and Sex
Favorite
1356 - Ribavirin Use in Hospitalized Children
Favorite
1357 - Urinary Symptom Management in Children with Neuropathic Bladder Presenting to the Emergency Department
Favorite
1358 - Using natural language processing to optimize case ascertainment of acute otitis media in a large, state-wide pediatric practice network
Favorite
1359 - Utilization of West Virginia Pediatric Medicaid Claims Data to Guide Outpatient Antimicrobial Stewardship Interventions
Favorite
1360 - Variation in Duration of Antibiotic Therapy for Central-line Associated Blood Stream Infections Caused by Gram Negative Bacilli in Hospitalized Children
Favorite
1361 - Variation in Perioperative Antibiotic Use for Children Undergoing Congenital Heart Disease Surgery in U.S. Academically Affiliated Centers
Favorite
Pediatric Bacterial Studies (natural history and therapuetic)
1362 - Antibiotic Prescribing for Acute Otitis Media in Commercially Insured Pediatric Patients in the United States
Favorite
1363 - Assessment and Quantification of Nasopharyngeal
Streptococcus pneumoniae
Colonization Does Not Discriminate Between Children with Viral and Bacterial Respiratory Infection
Favorite
1364 - Effect of Cefepime Prophylaxis on Bacterial Bloodstream Infections in Neutropenic Patients with Acute Myelogenous Leukemia
Favorite
1365 - How Severe Are Rickettsial Infections Among Children
Favorite
1366 - Microbiology of Acute Hematogenous Osteomyelitis in Hospitalized Children
Favorite
1367 - Reduced Ceftaroline Susceptibility Among Invasive MRSA Isolates at a Tertiary Children’s HospitalReduced Ceftaroline Susceptibility Among Invasive MRSA Isolates at a Tertiary Children’s Hospital
Favorite
1368 - The Clinical Impact of BioFire BCID2 Compared to BCID in a U.S. Pediatric Hospital
Favorite
1369 - The Spectrum of Chronic Osteomyelitis in Children
Favorite
1370 - Three of Hearts: A Case Series and Literature Review of Pediatric Purulent Pericarditis
Favorite
1371 - Trends in Antibiotic Resistance Among Uropathogens in the Pediatric Population: A Single Center Experience in the US
Favorite
1372 - Urinary Tract Infections Caused by Gram-Positive Bacteria in Patients Younger than 19 Years: Prediction Analysis in a 13-year Hospital-Based Cohort
Favorite
1373 - Vaccine Effectiveness and Pneumococcal Serotypes in Pediatric Otitis Media in the Era of Routine 13-valent Pneumococcal Vaccination in the United States
Favorite
Pediatric Healthcare-associated Infection Epidemiology and Prevention
1374 - Carbapenem-Resistant Enterobacterales Infection in Children: Clinical and Molecular Data from a Prospective Multicenter Cohort Study
Favorite
1375 - Characterization of Recurrent Central Line-associated Bloodstream Infections at Texas Children’s Hospital
Favorite
1376 - Oral Vancomycin as Secondary Prophylaxis Against
Clostridioides difficile
Infection in Pediatric Patients
Favorite
1377 - Perinatal Transmission Dynamics of Antimicrobial Resistance
Favorite
1378 - Reservoirs of Transmission of Resistant Gram-negative Pathogens Responsible for Neonatal Sepsis among Hospitalized Neonates in Pune, India
Favorite
Pediatric Vaccines
1379 -
Caregiver Burden related to Rotavirus Gastroenteritis: a systematic literature review
Favorite
1380 -
Current status of the legal landscape regarding Rotavirus Vaccination in the United States
Favorite
1381 -
Rotavirus Gastroenteritis among older adults: discussion based on a systematic literature review
Favorite
1382 -
Varicella Burden Disease in Argentina:
4 Years after National Vaccination Strategy
Favorite
1383 - Characterizing Real-world Patterns of Early Childhood Vaccination
Favorite
1384 - Conceptual Economic Model Methodology for Infant Pneumococcal Conjugate Vaccine Program and its Impact on Antimicrobial Resistance
Favorite
1385 - Concomitant Administration of Liquid Porcine Circovirus-free Human Rotavirus Vaccine with Routine Pediatric Vaccines Does Not Impact Immune Responses in Infants: Results from a Phase 3, Randomized Trial in the United States
Favorite
1386 - Current Estimates of the Impact of Routine Childhood Immunizations in Reducing Vaccine-Preventable Diseases in the United States
Favorite
1387 - Current practices in the diagnosis and treatment of varicella infections in the United States
Favorite
1388 - DTaP-containing combination vaccines use and adherence to the recommended infant-toddler vaccination series among privately insured children in the US
Favorite
1389 - Economic Evaluation of Universal Varicella Vaccination in Mexico
Favorite
1390 - Effectiveness of M-M-R
®
II in outbreaks - a systematic literature review of real-world observational studies
Favorite
1391 - Enhanced Education and Administration of Influenza Vaccine in a Pediatric Subspecialty Practice.
Favorite
1392 - Evaluation of the Impact of a Single-dose Hepatitis A Vaccination in Brazil: a time-series analysis
Favorite
1393 - Factors Associated with Co-administration of Pentavalent DTaP-IPV/Hib and Monovalent Hepatitis B Vaccine in the United States (US)
Favorite
1394 - Impact of 7-Valent and 13-Valent Pneumococcal Conjugate Vaccines in the United States: A Systematic Literature Review
Favorite
1395 - Influenza B-Associated Pediatric Mortality in the US Between 2010 and 2019
Favorite
1396 - Live Virus Vaccination Following Pediatric Liver Transplantation: Results from Two Academic Children’s Hospitals
Favorite
1397 - Long term impact of the 13-valent pneumococcal conjugate vaccine use in infant immunization program on all-cause pneumonia hospitalizations in British Columbia, Canada: a time series analysis
Favorite
1399 - Parental Perceptions of the Childhood Vaccination Schedule and Combination Vaccines in the United States (US)
Favorite
1400 - Physician Attitudes towards Combination Vaccine Use in Infants up to 24 months of age in the United States (US)
Favorite
1401 - Real-World Effectiveness of Inactivated and Live Attenuated Influenza Vaccines in Children During Three Recent Seasons: 2016–2019
Favorite
1402 - Smart Technology and Education for Smart Protection against the Flu: Impact of a Multifaceted Quality Improvement (QI) Intervention on Influenza Vaccination Rates in Children
Favorite
1403 - The Pediatric Emergency Room as a Promising Setting for Receiving the Flu Shot
Favorite
1404 - Twenty-year impact of Pneumococcal Conjugate Vaccines (PCV) on the burden of invasive pneumococcal disease in US children less than 5 years of age
Favorite
Pediatric Viral Studies (natural history and therapeutic)
1405 - Clinical and laboratory features of fatal dengue fever in children: a case-control study
Favorite
1406 - Comparison of Clinical Presentations and Burden of Respiratory Syncytial Virus in Infants Across Three Distinct Healthcare Settings
Favorite
1407 - Cytomegalovirus (CMV) infection in the first year of life in a cohort of infants in rural Guatemala
Favorite
1408 - Enterovirus D68 RNA Visualized in the Anterior Horn of the Spinal Cord of a Pediatric Patient with Flaccid Paralysis
Favorite
1410 - Neonatal Herpes Simplex Virus (HSV) Infection: Is It the Only Pathogen?
Favorite
1411 - Risks and Outcomes of Adenovirus Disease in Pediatric HSCT Recipients –Comparison of Current Antiviral Treatment Options
Favorite
1412 - The utility of respiratory viral panel testing for nosocomial fever in the neonatal intensive care unit
Favorite
1413 - Trends in Risk of Respiratory Syncytial Virus Hospitalizations in Preterm Infants Over a 10-Year Period
Favorite
PK/PD studies
1295 -
Activity of SPR206, a Polymyxin B Derivative, Compared to Colistin Alone and in Combination Against Multidrug-Resistant
Pseudomonas aeruginosa
Strains
Favorite
1296 -
Efficacy of Human-Simulated Exposures of Meropenem/Vaborbactam (MVB) and Meropenem (MEM) against OXA-48
β-lactamase-producing
Enterobacterales
in the Neutropenic Murine Thigh Infection Model
Favorite
1297 -
In-Vitro Antibacterial Activities of Cefiderocol (S-649266) Alone and With the Addition of Beta-Lactamase Inhibitors Against Multidrug-resistant
Acinetobacter baumannii
Favorite
1298 -
Population Pharmacokinetics of Ceftazidime-avibactam among Critically-ill Patients with and without Receipt of Continuous Renal Replacement Therapy
Favorite
1299 -
In Vitro
-
In Vivo
Discordance with β-lactams against Metallo-β-lactamase-Producing Enterobacterales: Implications for Susceptibility Testing
Favorite
1300 - ACOG Committee Opinion #797 and the Dose of Intrapartum Vancomycin: a Potential Danger to Mother and Newborn Alike
Favorite
1301 - Breakthrough Invasive Fungal Infections based on CYP2C19 Levels in Patients Who were on Voriconazole as Primary Antifungal Prophylaxis in Acute Myeloid Leukemia (AML) undergoing Induction Chemotherapy
Favorite
1302 - Cefiderocol Population Pharmacokinetics and Probability of Target Attainment in Plasma and Epithelial Lining Fluid in Patients with Pneumonia, Bloodstream Infection/Sepsis, or Complicated Urinary Tract Infections
Favorite
1303 - Characterization of Isavuconazole Serum Concentrations with Various Administration Routes in a Hospitalized Cohort
Favorite
1304 - Characterization of Tebipenem Pivoxil Hydrobromide Pharmacokinetics-Pharmacodynamics (PK-PD) in a Neutropenic Murine Acute Pyelonephritis (AP) Model
Favorite
1305 - Comparison of Pharmacokinetics of DSTA4637S, a novel THIOMAB
TM
Antibody-Antibiotic Conjugate, in Patients with
Staphylococcus aureus
Bacteremia Receiving Standard-of-Care Antibiotics with Pharmacokinetics in Healthy Volunteers
Favorite
1306 - Comparison of the Use of Extended and Intermittent Infusion Cefepime and Piperacillin/tazobactam in Non-critically Ill, Obese Patients
Favorite
1308 - Ex vivo Impact of Autologous Blood Transfusion (ABT) on Concentrations of Antibiotics used for Surgical Prophylaxis
Favorite
1309 - Imipenem/Cilastatin/Relebactam (I/R) Alone and in Combination against
Pseudomonas aeruginosa
(PSA) in the
In Vitro
Pharmacodynamic Model
Favorite
1310 - Implementation of AUC:MIC Pharmacy to Dose in an Academic Medical Center: A Pilot Study
Favorite
1311 - Intrapulmonary Pharmacokinetics of Cefiderocol in Hospitalized and Ventilated Patients Receiving Standard of Care Antibiotics for Bacterial Pneumonia
Favorite
1312 - Metallo-β-lactamase-Producing Enterobacterales (MBL-EB): Is it Time to Rethink Our Assessment Tools?
Favorite
1313 - MIC Profiling of Ceftazidime-Avibactam (CAZ/AVI) Against Two Carbapenemase producing
Klebsiella
pneumoniae
Isolates
Favorite
1314 - Neonatal Serum Gentamicin Concentrations following Maternal Once-daily Gentamicin Dosing
Favorite
1315 - No Dose Adjustment of Metformin with Fostemsavir Coadministration Based on Mechanistic Static and Physiologically Based Pharmacokinetic Models
Favorite
1316 - Pharmacokinetic/Pharmacodynamic Analyses of Cefiderocol in Critically Ill Patients
Favorite
1317 - Pharmacokinetics (PK) of Ampicillin-Sulbactam (SAM) during Orthotopic Liver Transplantation (OLT)
Favorite
1318 - Pharmacokinetics and Safety of Cefepime-Taniborbactam (formerly Cefepime/VNRX-5133) in Subjects with Renal Impairment
Favorite
1319 - Pharmacokinetics of Ceftolozane/Tazobactam in Patients with Burns
Favorite
1320 - Pharmacokinetics of Isavuconazole Administered as Isavuconazonium Sulfate Intravenous Solution via Nasogastric Tube or Orally in Healthy Volunteers
Favorite
1321 - Population Pharmacokinetic (PK) and Pharmacokinetic/Pharmacodynamic (PK/PD) Target Attainment Analyses for Dalbavancin in Pediatric Patients
Favorite
1322 - Quantifying the Effects of Frequently Prescribed Antimicrobials with Perceived Potential for QT Interval Prolongation during the COVID-19 Era
Favorite
1323 - Substantial Doses of Daptomycin and Rifampin Eradicate
S. epidermidis
Biofilm in an In Vitro Pharmacodynamic (IVPD) Model
Favorite
1324 - Target Attainment of Exebacase, a First-In-Class Antibacterial Lysin, to Determine Optimal Doses for Adult Patients with
Staphylococcus aureus
(
S. aureus
) Bloodstream Infections (Bacteremia) Including Endocarditis
Favorite
1325 - Things that go Bump in the Night: Combating
Klebsiella pneumoniae
co-producing New Delhi metallo-beta-lactamase (NDM) and Mobile Colistin Resistance (MCR)
Favorite
1326 - Vancomycin Area Under the Concentration-Time Curve (AUC) Estimation Using a Bayesian Approach Versus First-Order Pharmacokinetic Equations: A Pilot Study
Favorite
1327 - Vancomycin Dosing by AUC
24
/MIC in Comparison to Traditional Trough Dosing in Office Infusion Centers (OICs)
Favorite
1328 - Vancomycin exposure and utilization following implementation of an AUC-guided monitoring guideline in children
Favorite
1329 - Vancomycin Therapeutic Drug Monitoring: How to hit the Curve
Favorite
Public Health
1414 - #Vaccine Twitter Influencers: is it Just About Reach and Followers?
Favorite
1415 -
A qualitative study of intersectional stigma among older adults living with HIV who are victims of childhood sexual abuse
Favorite
1416 -
Assessing the potential for interspecies transmission of Clostridioides difficile on dairy farms
Favorite
1418 -
Injections and Infections: Understanding Harm Reduction Utilization in a Rural State
Favorite
1419 -
National ambulatory health resource utilization and geographic disparities of influenza in the United States, 2009 to 2016
Favorite
1420 - A One Health Approach Examining the Potential Linkage between Agricultural Livestock and Human Antibiotic Resistance at the Watershed Level
Favorite
1421 - Assessing Serious Infections Common in Persons Who Inject Drugs in the United States and Tennessee
Favorite
1422 - Burden of Pertussis in South Korea: Implications for adults
Favorite
1423 - Clinical Presentation Of Brucellosis: An Experience Of 29-Year Period
Favorite
1424 - Factors Associated with Failure to Clear Candidemia Infection: Surveillance Data from Eight States, 2017
Favorite
1425 - Impact of Social Determinants on Racial Differences in Carbapenem-Resistant Enterobacteriaceae Incidence, Atlanta, 2012-2018
Favorite
1426 - Increased Visits to Respiratory Protection Webpages during COVID-19
Favorite
1427 - Key Clinical Research Questions Asked During Epidemic Respiratory Outbreaks: A Systematic Review of the Literature Published on Severe Acute Respiratory Syndrome and Middle East Respiratory Syndrome
Favorite
1428 - Lyme Disease Treatment in the United States: Prescribing Patterns from a Nationwide Commercial Insurance Database, 2016-2018
Favorite
1429 - Meningococcal Disease Outbreak in a Refugee Reception Identification Center in Greece and Administration of Mass Antibiotic Prophylaxis
Favorite
1430 - Novel Transmission of
Burkholderia pseudomallei
from a Freshwater Aquarium to a Human — Maryland, 2019
Favorite
1431 - Occurrence of Sporadic Human Ascariasis in Non-Endemic Regions: The Importance of Zoonotic Transmission from Swine
Favorite
1432 - Population-based Surveillance of Carbapenem-Resistant Enterobacteriaceae (CRE) in Alameda County, 2017-2020
Favorite
1433 - Promoting Vaccination of Vaccine Preventable Diseases in Newly Employed Nurses and Doctors Guided by Serological Study
Favorite
1434 - Rickettsial Infections Complicated With Acute Renal Failure
Favorite
1436 - Use of Whole Genome Sequencing to Characterize Antimicrobial-resistant S
almonella B
erta Isolates from Clinical and Retail Meat Sources
Favorite
Resistance Mechanisms
1437 -
Biochemical characterization of L1 and L2 β-lactamases from clinical isolates of
Stenotrophomonas maltophilia
Favorite
1438 -
Dissecting the Multifaceted Nature of Antibiotic Resistance in Clinical Isolates of
Neisseria
gonorrhoeae
by Natural Transformation
Favorite
1440 -
The Genetic Basis for a
Neisseria
gonorrhoeae
Clinical Isolate That Contains
mtrR
-79
Mutation But Is Highly Susceptible to Antibiotics Effluxed by the Mtr Pump System
Favorite
1441 -
Using Carbapenem Resistance Levels to Discriminate Between Carbapenemase Producing and Non-Carbapenemase Producing Carbapenem Resistant
Enterobacteriaceae
Favorite
1442 - Acquisition and Transferability Mechanisms of Mercury Resistance Genes in Latin-American
Staphylococcus aureus
Strains
Favorite
1443 - Activity of Ceftazidime-Avibactam against Carbapemenase-negative Carbapenem-resistant
Enterobacterales
(CRE) Isolates from US Hospitals
Favorite
1444 - Characterization of a Novel Pathogen in Immunocompromised Patients:
Elizabethkingia Anopheles
Favorite
1445 - Deciphering the Role of the Y221H Ω-loop Substitution in
Pseudomonas
-derived Cephalosporinase (PDC) in Cephalosporin Resistance
Favorite
1446 - Dynamics of
Enterococcus faecalis
Cardiolipin Synthase Gene Expression Reveal Compensatory Roles in Daptomycin Resistance
Favorite
1447 - Emergence of Avibactam Resistance in Multidrug-Resistant
Enterobacteriaceae
Favorite
1448 - Forgiveness of BIC/FTC/TAF: In Vitro Simulations of Intermittent Poor Adherence Find Limited HIV-1 Breakthrough and High Barrier to Resistance
Favorite
1449 - Frequency and Antimicrobial Susceptibility of Coagulase-Negative Staphylococcal (CoNS) Species Isolated from Clinical Specimens in United States and European Hospitals
Favorite
1450 - Frequency of Carbapenem-resistant
Pseudomonas aeruginosa
Among Respiratory Pathogens Impacts First-Line Beta-Lactam Susceptibility: Potential Role for Ceftolozane/Tazobactam (C/T) and/or Imipenem/Relebactam (I/R)
Favorite
1451 - Genetic Analysis of Antibiotic Resistance Profiles of
Acinetobacter baumannii
Using Whole Genome Sequencing
Favorite
1452 - Molecular Profile of β-Lactamase Genes and Siderophore-Dependent Iron Transporter Genes of Cefiderocol High MIC Isolates from SIDERO-WT Studies
Favorite
1453 - PBP2, PBP2a and PBP4 Clone-specific Polymorphisms are not Associated to Ceftaroline (CPT) Susceptibility in Chilean Clinical Isolates of Methicillin-Resistant
Staphylococcus aureus
(MRSA)
Favorite
1454 - Plazomicin Activity against
Enterobacterales
Isolates Producing Extended-Spectrum β-Lactamases (ESBLs), Carbapenemases, and Aminoglycoside-Modifying Enzymes (AMEs) from United States (US) Hospitals
Favorite
1455 - Potential Mechanisms of Cefiderocol MIC Increase in Enterobacterales in
In Vitro
Resistance Acquisition Studies
Favorite
1456 - Resistance Mechanisms of Tigecycline in
Enterococcus faecalis
Favorite
1457 - Serial Passage of Enterobacteriaceae to Explore Development of Carbapenem Resistance
Favorite
1458 - Uncharted territories: applying “precision medicine” to understand the treacherous landscape of extensively and multidrug resistant (XDR and MDR)
Pseudomonas aeruginosa
in a patient with cystic fibrosis and lung transplantation
Favorite
1459 - Whole Genome Sequencing Analysis of
Enterococcus faecium
Clinical Isolates Reveals High Strain Diversity and High Accuracy Prediction of Antimicrobial Resistance
Favorite
Respiratory Infections - Bacterial
1460 -
Imipenem/Cilastatin (IMI)/Relebactam (REL) in Hospital-Acquired/Ventilator-Associated Bacterial Pneumonia (HABP/VABP): Subgroup Analyses of Critically Ill Patients in the RESTORE-IMI 2 Trial
Favorite
1461 -
Impact of the Ampicillin/Sulbactam Shortage on Antibiotic Prescribing and Clinical Outcomes for Adult Inpatients with Aspiration Pneumonia
Favorite
1462 -
The protective effect of pneumococcal vaccination on cardiovascular disease in adults: A systematic review and meta-analysis
Favorite
1463 - Activity of Delafloxacin against Multi-Drug-Resistant Fastidious Respiratory Pathogens from European Medical Centers (2014-2019)
Favorite
1464 - Adjuvant Systemic Steroid Therapy and Length of Hospital Stay in Pneumonia Patients: A Retrospective Cohort Study in a Community Hospital
Favorite
1465 - Age-Dependent Interactions Among Clinical Characteristics, Viral Loads and Disease Severity in Young Children with Respiratory Syncytial Virus Infection (RSV) Infection
Favorite
1466 - Antibiotic utilization reports may reduce prescribing practices for Upper Respiratory Infections
Favorite
1467 - Association between Pathogen Load in the Upper Respiratory Tract and Severe Acute Respiratory Infections in Guatemalan Adults:
Haemophilus influenzae, Staphylococcus aureus, Moraxella catarrhalis, Streptococcus pneumoniae, Klebsiella pneumoniae
Favorite
1468 - Culture Conversion and Mortality in Patients With
Mycobacterium abscessus
(MAB) Lung Disease: A Systematic Literature Review
Favorite
1469 - Effect of pneumonia and pneumonia hospitalization episodes on mobility in older adults: results from the Lifestyle Interventions and Independence for Elders (LIFE) Study
Favorite
1470 - Epidemiology of Invasive Pneumococcal Disease (IPD) Following 18 years of Pneumococcal Conjugate Vaccine (PCV) Use in the United States
Favorite
1471 - Evaluation of Antibiotic De-escalation in Post Cardiac Arrest Patients with Culture-Negative versus Culture-Positive Aspiration Pneumonia
Favorite
1472 - Frequency of Occurrence and Antimicrobial Susceptibility of Bacteria Isolated from Patients Hospitalized with Bacterial Pneumonia in the United States, Western Europe, and Eastern Europe: Results from the SENTRY Program (2016-2019)
Favorite
1473 - Guideline Adherence in Pediatric Ambulatory Visits for Acute Otitis Media
Favorite
1474 - Impact of 13-valent Pneumococcal Conjugate Vaccine (PCV13) on Non-bacteremic Pneumococcal Pneumonia (NBPP) among Adults in the United States, 2013-2017
Favorite
1475 - Impact of a Routine Infant PCV Program on the Serotype Distribution of Episodes of Invasive Pneumococcal Disease (IPD) and Non-bacteremic Pneumococcal Pneumonia in Adults
Favorite
1477 - Impact Of Resistance Thresholds On Mortality In Hospital-Acquired And Ventilator-Associated Pneumonia
Favorite
1478 - Impact of Short versus Long Treatment Durations for Respiratory Tract Infections Caused by Non-fermenting Gram-negative Bacilli in Lung Transplant Recipients
Favorite
1479 - Incidence of Acute Otitis Media in Children in the United States before and after the introduction of Pneumococcal Conjugate Vaccines (PCV7 and PCV13) during 1998-2018
Favorite
1480 - Incidence of Non-Invasive Pneumococcal Pneumonia in Children in the United States before and after Introduction Pneumococcal Conjugate Vaccines (PCV7 and PCV13) during 1998-2018
Favorite
1481 - Incidence of Pertussis in Older Adults in England and the United Kingdom: A Large, Retrospective Database Analysis
Favorite
1482 - Local validation of the drug resistance in pneumonia clinical prediction score at a large academic medical center and a community hospital
Favorite
1483 - Maternal Tdap Vaccination During Pregnancy and Immune Response: A Comparison Between Infants Born to Mothers Primed with Acellular or Whole Cell Pertussis Vaccines
Favorite
1484 - Microbial Etiology of Community-acquired Pneumonia in Immunocompromised Patients
Favorite
1485 - Mobile Bedside Ultrasound (mBSUS) and Use of an Artificial Intelligence Algorithm for Diagnosis of Pediatric Pneumonia in Limited Resource Settings
Favorite
1486 - Phylogenetic and alpha toxin variant analyses of
Staphylococcus aureus
strains isolated from patients during the SAATELLITE study
Favorite
1487 - Pneumonia due to Co-Infection in the ICU: Detection and Clinical Significance
Favorite
1488 - Relationship Between Culture Conversion and Clinical Outcomes in Patients With
Mycobacterium abscessus
(MAB) Lung Disease: A Systematic Literature Review
Favorite
1489 - Safety and Performance of a Pharmacist-Driven Nasal MRSA PCR Protocol for De-escalation of Empiric Vancomycin for Suspected Pneumonia at an Academic Medical Center
Favorite
1490 - Serious Infections Caused by Carbapenem Susceptible and Carbapenem Resistant
Acinetobacter baumannii-calcoaceticus
Complex - A Retrospective Review
Favorite
1492 - Targeted Substitution of Omadacycline in Place of Standard of Care for CABP Treatment is Associated with a Risk Reduction of
Clostridioides difficile
Infection and Financial Cost Savings in the Acute Care Setting
Favorite
1493 - The Incremental Burden of Nontuberculous Mycobacterial Lung Disease (NTMLD) among Patients with chronic obstructive pulmonary disease (COPD): Hospitalizations and ER Visits among US Medicare Beneficiaries
Favorite
1494 - Validation of Methicillin-Resistant
Staphylococcus aureus
(MRSA) Risk Factors in Predicting MRSA Community-Acquired Pneumonia at an Academic Medical Center
Favorite
Respiratory Infections - Viral
1495 -
Aspergillosis Complicating Severe Influenza in ICU Patients: A Retrospective Cohort Study
Favorite
1496 -
Aspergillosis Complicating Severe Respiratory Syncytial Virus (RSV) in ICU Patients: A Retrospective Cohort Study
Favorite
1497 -
Epidemiology of RSV infection in Japan: A nationwide claims database analysis
Favorite
1498 -
Etiology of Community-acquired Pneumonia in Adults:
A Systematic Review
Favorite
1499 -
Incidence of Community Acquired Pneumonia by Age and Comorbid Conditions in the Veterans Health Administration (VHA)
Favorite
1500 -
Population-based incidence, health care resource utilization and cost among children < 5 years of age hospitalized with RSV, Utah
Favorite
1501 -
Pragmatic Assessment of Influenza Vaccine Effectiveness in the DoD (PAIVED): Updates from Year 2
of multi-site trial
Favorite
1502 -
Psychological Stress and Anxiety among Parents of Children Younger than 5 Years Hospitalized with RSV
Favorite
1504 -
Risk of Influenza-Associated Hospitalization Among Older Adults Living with Diabetes — United States, 2012–2017
Favorite
1505 - Antiviral and Antibiotic Prescribing Among Patients at an Ambulatory Cancer Center with Laboratory-Confirmed Influenza
Favorite
1506 - Burden of Respiratory Syncytial Virus (RSV) and Other Lower Respiratory Tract Viral Infections During the First Two Years of Life: a Prospective Study
Favorite
1507 - Clinical Characteristics of Common Respiratory Viruses Detected in Infants Across Different Clinical Settings
Favorite
1508 - Hospitalizations and Emergency Department Visits for Respiratory Syncytial Virus Among Infants Aged < 1 year in the United States: An Analysis of Nationwide Inpatient and Emergency Room Data
Favorite
1509 - Impact of Respiratory Viral Infection on Outcomes of Congenital Heart Repair Surgery
Favorite
1510 - Infant Pneumonia and Subsequent Risk of Chronic Respiratory Disorders
Favorite
1511 - Influenza antiviral use in patients hospitalized with laboratory-confirmed influenza in the United States, FluSurv-NET, 2015 – 2019
Favorite
1512 - Influenza vaccine effectiveness wanes over the influenza season: results from five military treatment facilities
Favorite
1513 - Medically Attended Respiratory Syncytial Virus Hospitalizations (RSVH) and All-Cause Bronchiolitis Hospitalizations (BH) Among Children Aged ≤ 24 Months at RSV Season Start With Higher-Risk Congenital Heart Disease (CHD) Before and After the 2014 American Academy of Pediatrics (AAP) Policy
Favorite
1514 - Mortality and Readmission in Adults during the First Year Following Hospitalization for Community-Acquired Pneumonia in the US
Favorite
1515 - Nationwide trends of invasive pneumococcal disease in Spain for the period 2009-2019
Favorite
1516 - Outbreak of SARS-CoV-2 among Migrant Farm Workers in North Florida
Favorite
1517 - Outcomes of Influenza Infection among Vaccinated and Un-Vaccinated Patients presenting to a Suburban hospital in Perth, Western Australia (WA), 2019 Southern Hemisphere Influenza Season.
Favorite
1518 - Real-World Comparative Effectiveness of Baloxavir Marboxil versus Oseltamivir on Influenza-Related Complication and Resource Utilization
Favorite
1519 - Reduction of healthcare-associated viral infections during COVID-19 pandemic
Favorite
1520 - Respiratory Syncytial Virus Hospitalizations (RSVH) and All-Cause Bronchiolitis Hospitalizations (BH) Among Children Aged ≤ 24 Months at the Start of RSV Season With Bronchopulmonary Dysplasia/Chronic Lung Disease of Prematurity (BPD/CLDP) Before and After the 2014 American Academy of Pediatrics (AAP) Policy
Favorite
1521 - Risk factors associated with complications of influenza A or B infection, southern Puerto Rico, 2016-2019.
Favorite
1522 - Safety and Efficacy of CR6261 in an Influenza A H1N1 Healthy Human Challenge Model
Favorite
1523 - Seasonal Human Coronavirus Infections Following Allogeneic Hematopoietic Cell Transplantation: Factors Associated With Lower Respiratory Tract Infection
Favorite
1524 - Sex Differences in Influenza: The Challenge Study Experience
Favorite
1526 - The economic impact of respiratory syncytial virus (RSV) in infants in the United States: systematic literature review
Favorite
Sexually Transmitted Infections
1527 -
Incident Sexually Transmitted Infections among Southern Men Who Have Sex with Men Living with HIV in the Era of Biomedical Prevention
Favorite
1528 -
Prevalence of Human Papillomavirus Infection and Cervical Intra-Epithelial Lesions in A Subset of Arab American Women in Southeast Michigan
Favorite
1529 -
Sexually-Transmitted Infection Testing and Positivity among Adults Receiving HIV Pre-Exposure Prophylaxis within an Integrated Health Care Delivery System in the United States
Favorite
1530 - A Cluster of Disseminated Gonococcal Infections in a Non-Immunocompromised Veteran Population
Favorite
1531 - Antibiotic Selection for
Neisseria gonorrhoeae
among Penicillin Allergic Patients in the Emergency Department
Favorite
1532 - Demographics and Population Epidemiology of Mycoplasma genitalium infection: Correlation to Co-Infection and prior STI history.
Favorite
1534 - Gonorrhea Testing and Ceftriaxone Resistance in the Department of Veterans Affairs (VA), 2010-2019
Favorite
1535 - Impact of Defunding Family Planning Health Centers on Gonorrhea and Chlamydia Cases in Iowa: A Spatiotemporal Analysis
Favorite
1536 - Impact of Type of Provider on Appropriateness of Treatment for Gonorrhea and Chlamydia in Outpatient Clinics
Favorite
1537 - Incidence, Reinfection, and Discrepancy Between Site Positivity and Reported Sexual Practice of Sexually Transmitted Infections in HIV-Positive Adolescents and Young Adults in Atlanta, GA
Favorite
1538 - Pilot Study of Self-collected Pharyngeal Testing for Chlamydia and Gonorrhea in the Setting of COVID19 Restrictions
Favorite
1539 - Pilot Study of Sexual Networks and Sexually Transmitted Infection Risk in a Military Population
Favorite
1540 - Prevalence and Risk Factors associated with HIV and Syphilis Co-infection in the African Cohort Study
Favorite
1541 - Prevalence of Asymptomatic Sexually Transmitted Infections (STIs) in a Philadelphia Ryan White HIV population
Favorite
1542 - Provider Uptake of Extragenital Screening for Gonorrhea and Chlamydia in Active Duty Air Force Members with Incident HIV Diagnosis
Favorite
1543 - Risk Reduction service delivery during the COVID Pandemic to a marginalized urban population in Newark, NJ
Favorite
1544 - Sexually Transmitted Infection Laboratory Testing and Education Trends Among Physician Office Visits in the United States, 2009-2016
Favorite
1545 - Three Site Testing for Sexually Transmitted Infections for People Living with HIV in One Southeastern Ryan White HIV/AIDS Program Clinic: First Year of Experience
Favorite
1546 - Update in Syphilis Proctitis: Insights from a Case Series and Literature Review
Favorite
Skin and Soft Tissue
1547 - Activity of Tedizolid and Comparator Agents against Gram-Positive Bacterial Isolates Causing Skin and Skin Structure Infections in Pediatric Patients during 2015-2019 in the US
Favorite
1549 - Association of Skin Infections with Sharing of Injection Drug Preparation Equipment among People who Inject Drugs
Favorite
1550 - Beyond Skin Deep:
Cellulitis Induced Splenic Abscess
Favorite
1551 - Cat Scratch Disease as a Mimicker of Malignancy: Rare and Elusive
Favorite
1552 - Clinical Outcomes and Healthcare Costs of Inpatients with Tetanus in Korea in 2011–2019
Favorite
1553 - Efficacy and Safety of Dalbavancin and Oritavancin in the Treatment of Gram-Positive Infections
Favorite
1554 - Epidemiology of Adult Bacterial Hand Infections at Two Urban Hospitals
Favorite
1555 - Evaluation of Local Pathogens and Management of Diabetic Foot Infections
Favorite
1556 - Financial Analysis of Dalbavancin for Acute Bacterial Skin and Skin Structure Infections in a self-pay population
Favorite
1557 - First Report of
Nocardia veterana
Soft Tissue Abscess
Favorite
1558 - Injection Drug Use-Related Skin and Soft Tissue Infections Serve as Sentinel Events for Healthcare Utilization in a Vulnerable Population
Favorite
1559 - Methicillin Susceptible
Staphylococcus aureus
Is The Predominant Organism In Septic Bursitis With The Majority Involving The Olecranon Bursa: A Study Of 61 Cases
Favorite
1560 - Microbiology of Necrotizing Fasciitis and Implications on Antimicrobial Stewardship
Favorite
1561 - Recurrent Bilateral Culture Negative Abscesses Mimicking a Diabetic Foot Infection
Favorite
1562 - Reduction in Healthcare Utilization and Overdose after Skin and Soft Tissue Infections for Injection Drug Users through Addiction Medicine Consultation
Favorite
1563 - Variations in the clinical spectrum of the
Streptococcus anginosus
group: a report of two rare presentations
Favorite
Treatment of Antimicrobial Resistant Infections
1564 -
Activity of bacteriophage against
multidrug resistant Klebsiella pneumoniae
Favorite
1565 -
In Vitro
Activities of Ceftaroline and Comparator Agents against Bacterial Pathogens Collected from Patients with Skin and Skin Structure Infections: ATLAS Global Surveillance Program 2012-2018
Favorite
1566 -
In vitro
Activities of Ceftaroline and Comparator Agents against Gram-positive Bacterial Pathogens Causing Blood Stream Infections in a Global Population: ATLAS Surveillance Program 2012-2018
Favorite
1567 -
In Vitro
Activity of Aztreonam-Avibactam and Comparator Agents Against Multidrug-Resistant Enterobacterales Collected Globally as Part of the ATLAS Surveillance Program, 2016-2018
Favorite
1568 -
In Vitro
Activity of Ceftazidime-Avibactam and Comparator Agents Against Enterobacterales and
Pseudomonas aeruginosa
Collected < 48 Hours and ≥48 Hours Post-Admission from Pediatric Patients, ATLAS Surveillance Program 2015-2018
Favorite
1569 -
In Vitro
Activity of Ceftazidime-avibactam and Comparator Agents against Enterobacterales and
Pseudomonas aeruginosa
Collected from Patients with Bloodstream Infections as Part of the ATLAS Global Surveillance Program, 2015-2018
Favorite
1570 -
In Vitro
Activity of Ceftazidime-Avibactam and Comparator Agents Against Enterobacterales from ICU and Non-ICU Wards Collected in Latin America and Globally as part of the ATLAS Surveillance Program 2017-2018
Favorite
1571 -
In Vitro
Activity of Ceftazidime-Avibactam and Comparator Agents Against MDR Enterobacterales and
Pseudomonas aeruginosa
Collected in Latin America During the ATLAS Global Surveillance Program 2017-2018
Favorite
1572 -
Combination Cefuroxime and Sulopenem is active
in vitro
against
Mycobacterium abscessus
Favorite
1574 -
Multivariate Regression Analysis to Determine Independent Predictors of Treatment Outcomes in the RESTORE-IMI 2 Trial
Favorite
1575 -
Predictors of Negative Clinical Outcomes among Patients treated with Meropenem-Vaborbactam for Serious Gram-Negative Bacterial Infections: Impact of Delayed Appropriate Antibiotic Selection
Favorite
1576 -
R
e-
E
valuation of cefepime or piperacillin-tazobactam to
D
ecrease
U
se of
C
arbapenems in
E
SBL-Producing
Enterobacterales
B
lood
S
tream
I
nfections (REDUCE-BSI)
Favorite
1577 -
Real-World, Multicenter Experience with Eravacycline for Various Infections
Favorite
1578 -
Treatments for complicated urinary tract infections (cUTI) caused by
multidrug resistant (MDR)
Gram-negative (GN) pathogens- a systematic review and network meta-analysis (NMA)
Favorite
1579 -
Burkholderia
Returns: Are Two Drugs Better or Back to Bactrim?
Favorite
1580 -
In Vitro
Activity of Ceftazidime-Avibactam Against Enterobacterales and
Pseudomonas aeruginosa
Collected in Latin America as part of the ATLAS Global Surveillance Program, 2017-2019
Favorite
1581 -
In Vitro
Activity of Ceftolozane/Tazobactam against
Pseudomonas aeruginosa
from ICU and Non-ICU Patients with Respiratory Tract Infections in the Asia/Pacific region – SMART 2016-2018
Favorite
1582 -
In Vitro
Activity of Ceftolozane/Tazobactam against Enterobacterales and
Pseudomonas aeruginosa
Isolates from Geriatric Patients in the Asia/Pacific region – SMART 2016-2018
Favorite
1583 -
In Vitro
Activity of Imipenem/Relebactam against
Klebsiella pneumoniae
and
Pseudomonas aeruginosa
from Patients in ICUs in the Asia/Pacific region – SMART 2015-2018
Favorite
1584 -
In Vitro
Activity of Imipenem/Relebactam against Gram-Negative Pathogens from Patients with Bloodstream Infections in the United States and Canada – SMART 2018
Favorite
1585 -
Stenotrophomonas maltophilia
Infections and Approaches to Treatment
Favorite
1586 - A Comparative Analysis of In Vitro Susceptibilities of Vancomycin-Resistant Enterococci Against Doxycycline, Minocycline, Tigecycline, Eravacycline and Omadacycline
Favorite
1587 - Activity of Ceftolozane/Tazobactam against Gram-Negative Isolates from Lower Respiratory Tract Infections – SMART United States 2018
Favorite
1588 - Activity of Imipenem/Relebactam Against Clinical Isolates of
P. aeruginosa
and
K. pneumoniae
Collected in Asia/Pacific Countries – SMART 2016-2018
Favorite
1589 - Activity of Meropenem-Vaborbactam and Comparators against Globally Disseminated
Klebsiella pneumoniae
Sequence Type 258
Favorite
1590 - Activity of Meropenem-Vaborbactam and Single-Agent Comparators against
Enterobacterales
Isolates Including KPC-Producing Isolates, from European Patients Hospitalized with Pneumonia Including Ventilator-Associated Pneumonia (2014-2019)
Favorite
1591 - Antibiotic Utilization Trends in Veterans Affairs (VA) Patients with Carbapenem Resistant Enterobacteriaceae (CRE) Infections
Favorite
1592 - Antimicrobial Activity of Ceftazidime-Avibactam and Comparator Agents Against
Enterobacterales
and
Pseudomonas aeruginosa
With Overexpression of AmpC β-Lactamase From Phase 3 Clinical Trials
Favorite
1593 - Antimicrobial Activity of Ceftazidime-Avibactam and Comparator Agents Against OXA-48 β-lactamase–Producing
Enterobacterales
Collected in International Medical Centers, Including the United States, in 2017–2018
Favorite
1594 - Antimicrobial Resistance Monitoring through the ATLAS Global Surveillance Program 2012-2018
Favorite
1595 - Ceftobiprole Activity against Gram-Positive Pathogens Causing Bone and Joint Infections in the United States from 2016 through 2019
Favorite
1596 - Ceftolozane/tazobactam (Zerbaxa) for the Treatment of
Pseudomonas aeruginosa (
PSA
)
Bacteremia: A Systematic Literature Review (SLR)
Favorite
1597 - Ceftolozane-Tazobactam and Meropenem Synergy Testing Against Multi-Drug and Extensively-Drug Resistant
Pseudomonas aeruginosa
Favorite
1598 - Clinical implications of azole-resistant
vs.
azole-susceptible invasive aspergillosis in hematological malignancy (CLARITY) – a multicenter study
Favorite
1599 - Clinical Outcomes for Patients Treated with Fluoroquinolones for Bacteremia Caused by Enterobacteriaceae Reclassified as Not Susceptible by Updated CLSI Breakpoints
Favorite
1600 - Closing the gap on moxifloxacin breakpoints for
Stenotrophomonas maltophilia
Favorite
1602 - Comparative Activity of Ceftolozane-Tazobactam (C/T) and Ceftazidime-Avibactam (CZA) against
Pseudomonas aeruginosa
(PSA) from Patients with Cystic Fibrosis (CF)
Favorite
1603 - Comparison of Ceftolozane/Tazobactam, Ceftazidime/Avibactam, and Meropenem/Vaborbactam Activity Against
P. aeruginosa:
A Multicenter Evaluation
Favorite
1604 - Cost-Effectiveness of Ceftazidime-Avibactam for Patients with Hospital-Acquired Pneumonia Caused by Multi-Drug Resistant Enterobacteriaceae or Pseudomonas in China
Favorite
1605 - Differences in Clinical Characteristics of Third Generation Cephalosporin Resistance and Treatment Outcomes in
Escherichia coli
and
Klebsiella pneumoniae
Bacteremia in Patients with Liver Cirrhosis
Favorite
1606 - Distinct Effectiveness of Oritavancin Against Tolerance-Induced
Staphylococcus aureus
Favorite
1608 - Efficacy of Ceftolozane/Tazobactam for Multidrug-Resistant Gram-Negative Infections in Multiple Urban Hospitals
Favorite
1609 - Epidemiology and Susceptibility to Imipenem/Relebactam of Gram-Negative Pathogens from Patients with Lower Respiratory Tract Infections – SMART United States 2017-2018
Favorite
1610 - Epidemiology and Treatment Heterogeneity in A
cinetobacter baumanii
Infections
Favorite
1611 - Evaluating Clinical Outcomes and Efficacy of Daptomycin in Combination with a Beta-Lactam for the Treatment of Vancomycin-Resistant
Enterococcus
(VRE) Bacteremia
Favorite
1612 - Evaluation of the Use of Ceftolozane/Tazobactam for the Treatment of ESBL-producing
Enterobacterales
Infections Using International Data from SPECTRA (Study of Prescribing Patterns and Effectiveness of Ceftolozane/Tazobactam Real World Analysis)
Favorite
1613 - Global 2018 Surveillance of Eravacycline Against Gram-negative Pathogens, Including Multi-drug Resistant Isolates
Favorite
1614 - Gwt1 Inhibitor, APX2104, Protects Against Invasive Aspergillosis in Neutropenic Mouse Model.
Favorite
1617 - Mecillinam susceptibility against Enterobacterales isolated from urinary tract infections from US patients in 2018
Favorite
1618 - Meropenem-vaborbactam vs standard of care for multidrug resistant carbapenem-resistant Enterobacteriaceae
Favorite
1619 - Meta-analysis of Randomized Control Trials Evaluating New Beta-Lactamase Combination Antibiotics
Favorite
1620 - Minocycline Activity Against Unusual Clinically Significant Gram-Negative Pathogens
Favorite
1621 - Novel Beta-lactam Beta-lactamase Inhibitors Against Alternative Antibiotics for the Treatment of Complicated Urinary Tract Infections and Pyelonephritis Caused by Carbapenem-resistant
Enterobacterales
Favorite
1622 - Outcomes of Colistin Weight-Based Dosing Versus The Non-Weight-Based Dosing
Favorite
1623 - Outcomes of Critically Ill Adults, Hospitalized Patients (Pts) with
Pseudomonas aeruginosa
(PSA) Hospital- and Ventilator-Associated Pneumonia (HAP/VAP) Who Received an Active Anti-Pseudomonal β-Lactam (ASPB): Does “S” Equal Success in the Presence of Resistance to other ASPB?
Favorite
1624 - Real World Experience with Daptomycin (DAP) and Ceftaroline (CPT) Combination Therapy for Methicillin-resistant
Staphylococcus aureus
(MRSA) bacteremia
Favorite
1625 - Real-World Outpatient Utilization of Ceftolozane/Tazobactam in Physician Office Infusion Centers (OICs)
Favorite
1626 - Synergistic Effect of Cefiderocol with Other Antibiotics Against PER-Producing
Acinetobacter baumannii
Isolates from the Multinational SIDERO-WT Studies
Favorite
1627 - Tedizolid is Well-tolerated Among Patients Receiving Prolonged Treatment Courses, Including Those Who are Intolerant of Alternative Agents
Favorite
1628 - Treatment Heterogeneity in
Pseudomonas aeruginosa
Pneumonia
Favorite
1629 - Vancomycin Resistance in
Enterococcus faecium
Clinical Isolates Responsible for Bloodstream Infections in US Hospitals Over Ten Years (2010-2019) and Activity of Oritavancin
Favorite
Tuberculosis and other Mycobacterial Infections
1631 -
Mycobacterium septicum
: A 6-year Clinical Experience from a Tertiary Hospital and Reference Laboratory
Favorite
1632 -
Comparing the epidemiology and clinical characteristics of childhood tuberculosis through active and passive case finding
Favorite
1635 -
Oral Delivery of Amikacin-Lipid NanoCrystal Formulations Safely and Effectively Treat Macrolide Resistant
Mycobacteria
Infections in a Mouse Model of Cystic Fibrosis
Favorite
1636 -
Risk of Latent Tuberculosis Reactivation in Patients Treated with Checkpoint Inhibitors Immunotherapy Compared to Other Anti-Cancer Therapies including Hematopoietic Cell Transplantation
Favorite
1637 -
SPR720, A Novel Benzamidazole Gyrase Inhibitor, Demonstrates Potent Efficacy Against
Mycobacterium avium
ATCC 700898 in a Chronic
C3HeBFeJ Mouse Infection Model
Favorite
1639 -
Lung Transplant Outcomes in Patients with Chronic Respiratory Disease and Pre-Operative Nontuberculous Mycobacterial Disease
Favorite
1640 - A Clinical Audit and Cost Analysis of Tuberculosis Management at a Tertiary Referral Centre in the Republic of Ireland
Favorite
1641 - A Comparative Analysis Of Lymph Node Tuberculosis Between Children And Adults
Favorite
1642 - A Novel β-lactamase Inhibitor (Durlobactam, DUR) and β-Lactams Enhance Susceptibility Against Multidrug-Resistant (MDR)
Mycobacterium abscessus
(Mab)
Favorite
1643 - A scoping review of pediatric latent tuberculosis care cascades: Initial steps are lacking
Favorite
1644 - “And the stick to fight TB is IPT”: Perspectives on TPT Implementation Among Senior Nurses in Rural South Africa
Favorite
1645 - Atypical Presentations of TB – A Diagnostic Challenge of Tuberculosis in a Community Hospital
Favorite
1647 - Breast Tuberculosis: A Diagnostic Challenge
Favorite
1648 - CD4 T Lymphocyte and Monocyte Activation within One Year After Treatment Completion for Pulmonary Tuberculosis: A Pilot Study
Favorite
1649 - Characterizing Factors Associated with Pediatric Latent Tuberculosis Infection in an Urban Health System to Improve Screening Practices
Favorite
1650 - Clinical Features and Risk Factors of Active Tuberculosis in Patients with Behçet’s Disease
Favorite
1651 - Describing the Tuberculosis Infection Cascade of Care Based on Electronic Health Record Data
Favorite
1652 - Diagnoses of Non- Tuberculosis Mycobacterium (NTM) in patients with granuloma on lung biopsy
Favorite
1653 - Estimation of country-specific tuberculosis antibiograms using a wide and deep neural net on a large genomic dataset
Favorite
1654 - Evaluation of a rapid detection method of clarithromycin resistance genes in
Mycobacterium avium
using the Amplification Refractory Mutation System-Loop-Mediated Isothermal Amplification method
Favorite
1655 - Extrapulmonary Tuberculosis in a Large Healthcare System
Favorite
1656 - Factors associated with low TB preventative therapy prescription rates among healthcare workers in rural South Africa
Favorite
1657 - Musculoskeletal Tuberculosis in a Large Healthcare System
Favorite
1658 - Particularities Of Pulmonary Tuberculosis Among Children
Favorite
1659 - Pharmacokinetics/pharmacodynamics of the Novel Gyrase Inhibitor SPR719/SPR720 and Clinical Dose Selection to Treat Pulmonary
Mycobacterium avium-complex
Disease
Favorite
1660 - Prevalence and Predictors of Anxiety and Depression among Leprosy Patients using the Hospital Anxiety and Depression Scale-Pilipino Score in a Tertiary Hospital
Favorite
1661 - The association of spirometric impairment and history of TB: a population based study in Uganda
Favorite
1662 - The Prevalence of
M. tuberculosis
among Acid Fast Cultures from Military Health System Beneficiaries from Hawaii and Pacific Islands from January 2002 to November 2019.
Favorite
1663 - The Significance of Acid Fast Cultures in Peritoneal Dialysis-associated Infections: A Non-tuberculous Mycobacteria
Case Series
Favorite
1664 - The Utilization of Hospital Inpatient Care due to Tuberculosis, Republic of Ireland, 2015-2018
Favorite
1665 - Using Electronic Health Records to Describe TB in Community Health Settings: a Cohort Analysis in a Large Safety-Net Population
Favorite
1666 - Yield of Tuberculosis Contact Tracing among Veterans after Outpatient Exposure
Favorite
UTIs
1667 -
Change in characteristics of community-onset ciprofloxacin-resistant
E. coli
isolates causing community-acquired acute pyelonephritis in South Korea.
Favorite
1669 - Antimicrobial Resistance Patterns of Uropathogenic
Escherichia coli
: Comparison of Infection Setting and Community Classification
Favorite
1670 - Clinical Characteristics and Demographics of Patients with Complicated Urinary Tract Infections (cUTI) and Antibiotic Resistance or Treatment Failure: A Retrospective Database Analysis
Favorite
1672 - Eligibility and Outcomes of Conversion to Oral (PO) Therapy in Patients Hospitalized with Enterobacteriaceae (ENT) Urinary Tract Infection (UTI) in the United States (US): A Multicenter Analysis
Favorite
1673 - Epidemiology of Complicated Urinary Tract Infections (cUTIs) Presenting in Emergency Departments Across the United States (US)
Favorite
1674 - Epidemiology of Urinary Tract Infections in the Renal Transplant Population in a Large Urban Midwestern Hospital: A Retrospective Cohort Study
Favorite
1676 - Evaluation of Antibiotic Overuse for Asymptomatic Bacteriuria in a Hospital with Low Baseline Antibiotic Use
Favorite
1677 - Evaluation of Optimal Treatment for Urinary Tract Infections in Outpatient Clinics at an Academic Medical Center
Favorite
1678 - Evaluation of Sodium-Glucose Co-Transporter 2 Inhibitor Therapy and Other Potential Risk Factors for the Development of Bacteremia in Patients with Urosepsis
Favorite
1679 - Evaluation of the Treatment of Urinalyses and Urine Cultures in Multiple Sclerosis Patients
Favorite
1680 - Evaluation of the Urinalysis Reflex to Culture Sensitivity and Impact on Antibiotic Utilization
Favorite
1681 - Female Urinary Metagenomic Analysis and Natural Language Processing Enhances the Infectious Diagnostic Yield in Precision Medicine
Favorite
1682 - Health Resource Utilization in Patients with Complicated Urinary Tract Infections (cUTI) and Antibiotic Resistance or Treatment Failure: A Retrospective Database Analysis
Favorite
1683 - Hospital Admission Patterns in Adult Patients with Complicated Urinary Tract Infections (cUTIs): Identification of Potentially Avoidable Hospital Admissions Across United States (US) Hospitals
Favorite
1684 - Hospital Costs and Reimbursement in Patients with Resistant Enterobacteriaceae (ENT) Urinary Tract Infection (UTI) in the United States (US): A Multicenter Analysis
Favorite
1685 - Inappropriate Treatment of Asymptomatic Bacteriuria in Elderly Patients: A Quality Improvement Study
Favorite
1686 - Microbiology of Community-Onset Urinary Tract Infections in the United States, 2012-2017
Favorite
1687 - Omadacycline in Female Adults With Acute Pyelonephritis: Results from a Randomized, Double-Blind, Adaptive Phase 2 Study
Favorite
1688 - Omadacycline in Female Adults With Cystitis: Results From a Randomized, Double-Blinded, Adaptive Phase 2 Study
Favorite
1689 - Oral Beta-lactam Step Down in Bacteremic
E. coli
Urinary Tract Infections
Favorite
1690 - Oral Fosfomycin for the Treatment of Bacterial Prostatitis
Favorite
1691 - Pre- and Post-Hospitalization Resource Utilization and Costs Associated with Urinary Tract Infection (UTI) in both Commercial and Medicare Populations
Favorite
1692 - Retrospective Review on the Safety and Efficacy of Nitrofurantoin for the Treatment of Cystitis in the Veteran Population With or Without Renal Insufficiency
Favorite
1693 - Risk Factors and Outcomes of Histologic Acute Graft Pyelonephritis following Kidney Transplantation
Favorite
1694 - Successful Gut Decolonization of Extended-Spectrum β-lactamase Producing
Klebsiella pneumoniae
Using Oral Lyophilized Fecal Microbiota Transplant (FMT) in a Woman with Recurrent Urinary Tract Infections
Favorite
1695 - Tebipenem: An Oral Carbapenem with activity against Multi-drug Resistant Urinary Tract Infection isolates of
Escherichia coli
collected from US Medical Centers during 2019
Favorite
1696 - The Black Box of Using Health Claims-Based Analyses to Estimate UTI Prevalence in Community-Dwelling Women
Favorite
1697 - The Burden Of Multidrug-Resistant Urinary Tract Infections
Favorite
1698 - Trends in Antimicrobial Resistance Among Outpatient Urine
E. coli
Isolates in US Females ≥ 12 Years of Age: A Multicenter Evaluation From 2011 to 2019
Favorite
1699 - Variation of Antimicrobial Resistance by Age Groups for Outpatient UTI Isolates in US Females: A Multicenter Evaluation From 2011 to 2019
Favorite
1700 - What Is Specific With Bacterial Escherichia Coli Urinary Tract Infection
Favorite
Virology: Studies of the Epidemiology of Viral Infections
1706 -
Association between
Cytomegalovirus
Infection/Disease and Morbidity and Mortality in Kidney Transplantation: A Systematic Literature Review of Observational Studies
Favorite
1707 -
Clinical Profile of Human T-Lymphotropic Virus Type I Infection in Pediatric Population in a Referral Hospital in Colombia.
Favorite
1708 -
Impacts of age and season on rates of hospitalization for respiratory syncytial virus (RSV) in infants in the United States and their use of mechanical ventilation and charges
Favorite
1709 -
Influenza Surveillance in the U.S. Department of Veterans Affairs (VA): 2019-2020 Season
Favorite
1710 - Comparison of herpes simplex prevalence in serum and semen-cervical sample of infertility patients: A systematic review and meta-analysis
Favorite
1711 - Comparison of the clinical course and prognosis of dengue cases with and without Diabetes Mellitus
Favorite
1712 - Epidemiology, Clinical Characteristics, and Outcomes of Influenza-Associated Hospitalizations in Children in the post-2009 Pandemic Era
Favorite
1713 - Factors Associated with Viral Rebound post Blip in Patients from a Community HIV Clinic
Favorite
1714 - Influenza C Virus in U.S. Children with Acute Respiratory Infection 2016-2019
Favorite
1715 - Influenza-like Illness (ILI) Experience Among Healthcare Workers in Military Treatment Facilities: An Offshoot of the Pragmatic Assessment of Influenza Vaccine Effectiveness in the DoD (PAIVED) Study
Favorite
1716 - Prospective Multicenter Observational Cohort Study to Assess the Burden of Herpes Zoster Disease in the Eye: Baseline Results of Initial Patients
Favorite
1717 - Relationship between Neighborhood Census-tract Level Poverty and Respiratory Syncytial Virus (RSV)-associated Hospitalizations in U.S. adults, 2015-2017
Favorite
1718 - Respiratory Syncytial Virus (RSV) Surveillance in the Department of Veterans Affairs (VA), 2010-2018
Favorite
1719 - Respiratory Syncytial Virus-Associated Hospitalization Rates among US Infants: A Systematic Review and Meta-Analysis
Favorite
Virology: Studies of Treatment and Prevention of Viral Infections
1701 - Added Benefits of Pre-exposure Prophylaxis Use on HIV Incidence with Minimal Changes in Efficiency in the Context of High Treatment Engagement among Men Who Have Sex with Men
Favorite
1702 - Assessing the Safety and Efficacy of Valganciclovir Dosing for Cytomegalovirus Prophylaxis in Solid Organ Transplant Recipients on Hemodialysis
Favorite
1703 - Hematologic Toxicity of Valganciclovir Prophylaxis in Solid Organ Transplant Recipients as a Function of Weight-adjusted Ganciclovir Exposure
Favorite
1704 - Regional and Racial Disparities in Response to Antiretroviral Therapy (ART) among People Living with Human Immunodeficiency Virus (PLWH)
Favorite
1705 - Treatment of Disseminated Adenovirus with Cidofovir in a Patient with HIV and ESRD
Favorite
Back to Top